000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki|ţp|N05AX08|01.04.2000||R|A||0|0|*|0|JAS|0|1|0|100|SEK|1648|3233|lyfalmen|V0045|1588|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1648||1648|3233| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|34385|45036|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||34385||34385|45036| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|51656|66711|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||51656||51656|66711| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10894|15881|lyfalmen|V0457|8262|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10894||10894|15881| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31751|42393|lyfalmen|V0475|25430|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||31751||31751|42393| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|41293|54368|lyfalmen|V0540|44002|00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||41293||41293|54368| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22211|30420|lyfalmen|V0456|15698|00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22211||22211|30420| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|5173|7466|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||5173||5173|7466| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7826|15200|vetalmen|||00|100|0||Vistor hf|Boehringer Ingelheim|||7826||7826|15200| 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|13857|19273|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||13857||13857|19273| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|20841|28701|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||20841||20841|28701| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|40453|53314|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||40453||40453|53314| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5500|8503|lyfalmen|||00|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5500||5500|8503| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SPL|0|0|1|100|DKK|3377|5598|lyfalmen|||0|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3377|5598| 000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|28768|38649|lyfalmen|||02|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||28768||28768|38649| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|LTH|0|0|0|100|SEK|1855|3516|lyfalmen|||06|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1855||1855|3516| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5028|7857|lyfalmen|||23|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||5028||5028|7857| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|3779|6148|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3779||3779|6148| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||00|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|LTH|0|0|0|100|SEK|5510|8516|lyfalmen|||00|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5510||5510|8516| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7324|10570|lyfsjukr|||00|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||7324||7324|10570| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3169|5314|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3169||3169|5314| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3902|6317|lyfalmen|||23|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3902||3902|6317| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|174045|220309|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||174045||174045|220309| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|23119|30897|lyfsjukr|||02|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||23119||23119|30897| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|5900|8515|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5900||5900|8515| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1506|3039|lyfalmen|V0037|2476|00|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1506||1506|3039| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6576|9975|lyfalmen|||00|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6576||6576|9975| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|21760|29854|lyfalmen|V0115|18735|00|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||21760||21760|29854| 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2415|4282|lyfalmen|||43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2415||2415|4282| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|29498|38902|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||29498||29498|38902| 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|2646|2523|lyfalmen|V0278|2233|00|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||1129||1129|2523| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NAS|0|0|0|100|DKK|6315|9618|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6315||6315|9618| 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4473|7098|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4473||4473|7098| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2187|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4339|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22733|30412|lyfsjukr|||00|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||22733||22733|30412| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|15747|22308|lyfalmen|V0034|19779|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15747||15747|22308| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33125|43454|lyfsjukr|||00|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||33125||33125|43454| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|2507|3618|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2507||2507|3618| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4228|6763|lyfalmen|V0444|6763|06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4228||4228|6763| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|867|2165|lyfalmen|V0004|464|00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||867||867|2165| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|6936|10467|lyfalmen|V0294|10467|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|1|100|SEK|4443|7057|lyfalmen|||00|45|0||Icepharma hf|Bioglan AB|Capsaicin||4443||4443|7057| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|3353|5566|lyfalmen|V0292|5566|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9268|13657|lyfalmen|V0161|13440|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9268||9268|13657| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4517|7158|lyfalmen|V0004|1856|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4517||4517|7158| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5263|8178|lyfalmen|V0293|8178|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8968|13247|lyfalmen|V0011|3647|0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8968||8968|13247| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1424|2927|lyfalmen|V0005|474|00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1424||1424|2927| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6321|9626|lyfalmen|V0005|1897|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6321||6321|9626| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5514|8522|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5514||5514|8522| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5535|8551|lyfalmen|V0011|3256|00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5535||5535|8551| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26761|35468|lyfsjukr|||00|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||26761||26761|35468| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13745|19795|lyfalmen|V0011|6512|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13745||13745|19795| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10080|14768|lyfalmen|V0012|3256|00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10080||10080|14768| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|K|2|0|0|*|0|NAS|0|0|0|100|DKK|3235|5404|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3235||3235|5404| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|18278|25484|lyfalmen|V0012|6512|00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||18278||18278|25484| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|17746|24816|lyfalmen|V0492|20193|00|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||17746||17746|24816| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|108607|138184|lyfsjukr|||00|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||108607||108607|138184| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|55275|71253|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||55275||55275|71253| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|27964|36977|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||27964||27964|36977| 002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BYP|0|0|0|100|SEK|3316|5515|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3316|5515| 002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BYP|0|0|0|100|SEK|3316|5515|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3316||3316|5515| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1714|3324|lyfalmen|V0362|3324|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1714||1714|3324| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|224121|283154|lyfsjukr|||00|1|0||Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||224121||224121|283154| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|SEK|3586|6256|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3586||3586|6256| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1302|2760|lyfalmen|||07|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1302||1302|2760| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|31501|41416|lyfsjukr|||02|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||31501||31501|41416| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14666|15881|lyfalmen|V0089|4472|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10894||10894|15881| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|10841|15809|lyfalmen|V0515|10969|00|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10841||10841|15809| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|255006|321915|lyfsjukr|||02|2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||255006||255006|321915| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|18717|26035|lyfalmen|V0253|18223|00|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||18717||18717|26035| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|36368|48187|lyfalmen|V0516|32049|00|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||36368||36368|48187| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|10671|15576|lyfalmen|||00|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10671||10671|15576| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|15863|22453|lyfalmen|||00|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15863||15863|22453| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BYP|0|0|0|100|SEK|197063|249197|lyfsjukr|||02|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||197063||197063|249197| 003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9646|14174|lyfalmen|V0356|12953|0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9646||9646|14174| 003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8941|13210|lyfalmen|||00|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8941||8941|13210| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|61615|79872|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||61615||61615|79872| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|4549|7202|lyfalmen|||00|28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4549||4549|7202| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|3352|5564|lyfalmen|||00|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3352||3352|5564| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|15718|22271|lyfalmen|||00|98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15718||15718|22271| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|6881|10392|lyfalmen|||00|28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6881||6881|10392| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|23485|32019|lyfalmen|||00|98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||23485||23485|32019| 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|909|2222|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||909||909|2222| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|2049|lyfalmen|V0151|2049|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|612|1816|lyfalmen|||67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||612||612|1816| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2389|4247|lyfalmen|V0322|4247|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|75747|96945|lyfsjukr|||00|60|0|6,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||75747||75747|96945| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2217|4012|lyfalmen|V0469|2454|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2217||2217|4012| 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|22724|30401|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||22724||22724|30401| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8249|12263|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8249||8249|12263| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4286|6842|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4286||4286|6842| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|A|5|0|0|0|0|PER|0|1|0|100|DKK|617|1823|lyfalmen|||00|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||617||617|1823| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1104|2489|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1104||1104|2489| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PER|0|1|0|100|DKK|5704|8782|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5704||5704|8782| 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|7919|11812|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7919||7919|11812| 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|11123|16195|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||11123||11123|16195| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|661|1883|lyfalmen|V0366|1112|00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||661||661|1883| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|0|0|ORG|0|1|0|100|DKK|6177|9429|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6177||6177|9429| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|21954|29435|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||21954||21954|29435| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1724|3337|lyfalmen|V0366|3337|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1724||1724|3337| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7398|11099|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7398||7398|11099| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4827|7582|lyfalmen|V0458|7482|00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4827||4827|7582| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4998|9769|vetalmen|||16|100|0||Vistor hf|Boehringer Ingelheim|||4998||4998|9769| 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3384|5608|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3384||3384|5608| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|664|1887|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||664||664|1887| 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4514|7154|lyfalmen|V0226|2844|00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4514||4514|7154| 004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6375|9700|lyfalmen|V0227|4354|00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6375||6375|9700| 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8485|12586|lyfalmen|V0228|5615|00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8485||8485|12586| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2271|4086|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2271||2271|4086| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3760|6122|lyfalmen|V0494|3352|00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||3760||3760|6122| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4475|lyfalmen|V0318|4475|00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4475| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|K|3|0|1|0|1|EMA|0|0|0|100|SEK|37312|48709|lyfsjukr|||00|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||37312||37312|48709| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1478|3001|lyfalmen|||20|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1478||1478|3001| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3353|5566|lyfalmen|||00|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3353||3353|5566| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|2164|lyfalmen|V0071|2164|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|7418|lyfalmen|V0320|7418|00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7418| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|2040|lyfalmen|V0062|2040|00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|2040| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4676|lyfalmen|V0317|4676|00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4676| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|1921|lyfalmen|V0067|1921|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1921| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1796| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|39719|51730|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||39719||39719|51730| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3411|lyfalmen|V0318|2506|00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|141487|179449|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||141487||141487|179449| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|K|3|0|1|0|1|EMA|0|0|0|100|SEK|186559|236014|lyfsjukr|||00|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||186559||186559|236014| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11156|16240|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11156||11156|16240| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7172|7720|lyfalmen|V0250|5418|0|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4928||4928|7720| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|9267|8996|lyfalmen|V0251|4969|10|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5861||5861|8996| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|677|1905|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||677||677|1905| 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|15488|12775|lyfalmen|V0282|9226|00|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||8623||8623|12775| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|5644|8146|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5644||5644|8146| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|389|1511|lyfalmen|V0352|733|41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||389||389|1511| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|684|1915|lyfalmen|V0352|1283|41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||684||684|1915| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1294|2749|lyfalmen|V0352|2749|41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1294||1294|2749| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1840|3496|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1840||1840|3496| 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2410|4276|lyfalmen|||00|1|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2410|4276| 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|ASP|0|0|0|100|XEU|9126|7333|lyfalmen|V0148|4423|00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4645||4645|7333| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|A|2|0|0|0|0|ACA|0|0|1|100|DKK|1154|2558|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1154||1154|2558| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|A|2|0|0|0|0|ACA|0|0|1|100|DKK|1330|2798|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1330||1330|2798| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|A|2|0|0|0|0|ACA|0|0|1|100|DKK|1818|3466|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1818||1818|3466| 005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|28937|38861|lyfalmen|V0356|38860|00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28937||28937|38861| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|53166|69268|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||53166||53166|69268| 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3487|5749|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3487||3487|5749| 005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1173|2584|lyfalmen|||00|2|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1173||1173|2584| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|64305|83248|lyfalmen|V0451|81749|00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||64305||64305|83248| 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1548|3096|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1548||1548|3096| 005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|30761|19062|lyfalmen|V0283|12214|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13161||13161|19062| 005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|39122|51643|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39122||39122|51643| 005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1287|2739|lyfalmen|V0545|2738|23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1287||1287|2739| 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0||Actavis Group hf|Actavis hf|Blöndur|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6521|9899|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6521||6521|9899| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6872|10379|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6872|10379| 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4250|6793|lyfalmen|||00|0|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4250||4250|6793| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|LLS|0|0|0|100|DKK|1664|3255|lyfalmen|||00|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1664||1664|3255| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|LLS|0|0|0|100|DKK|2901|4947|lyfalmen|V0020|3839|00|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2901||2901|4947| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|LLS|0|0|0|100|DKK|7704|11518|lyfalmen|V0020|11518|00|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7704||7704|11518| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|LLS|0|0|0|100|DKK|4233|6769|lyfalmen|V0020|5759|00|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4233||4233|6769| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|1862|3526|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1862||1862|3526| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6923|9418|lyfalmen|V0324|3536|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6169||6169|9418| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|3283|5125|lyfalmen|V0035|3745|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3031||3031|5125| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|18679|32585|vetorma|||16|5|0||Vistor hf|Merial (MSD)|||18679||18679|32585| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6526|9906|lyfalmen|V0325|3251|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6526||6526|9906| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|11009|14760|lyfalmen|V0325|5805|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||10074||10074|14760| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5273|7754|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4953||4953|7754| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3118|5244|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3118||3118|5244| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3641|5960|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3641||3641|5960| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|918|2235|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||918||918|2235| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|10688|15600|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10688||10688|15600| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|17045|21635|lyfalmen|V0326|5793|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15211||15211|21635| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3719|6066|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3719||3719|6066| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6735|9091|lyfalmen|V0246|4655|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5930||5930|9091| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9838|12977|lyfalmen|V0072|3707|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8771||8771|12977| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|13197|19107|lyfalmen|V0327|3244|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13197||13197|19107| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4887|7664|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4887||4887|7664| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13370|18474|lyfalmen|V0073|3707|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12692||12692|18474| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|87680|111921|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||87680||87680|111921| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NAS|0|0|0|100|DKK|6023|9218|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6023||6023|9218| 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|108744|138356|lyfsjukr|||00|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||108744||108744|138356| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|5843|8972|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5843||5843|8972| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|163276|206794|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||163276||163276|206794| 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|83047|106106|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||83047||83047|106106| 006172|S01XA2007|Simplex|augnsm|||4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003|31.03.2012|R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2941|lyfalmen|||00|4|1||Parlogis hf|Parlogis - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||1434||1434|2941| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2667|4627|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2667||2667|4627| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986|31.03.2012|R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2800|4809|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2800||2800|4809| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|9184|17807|vetalmen|||00|50|0||Vistor hf|Boehringer Ingelheim|||9184||9184|17807| 006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13512|19503|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13512||13512|19503| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7276|10932|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7276||7276|10932| 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12889|18721|lyfalmen|||00|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12889||12889|18721| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|1,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|15256|21691|lyfalmen|||00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||15256||15256|21691| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4714|7427|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4714||4714|7427| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|756|2013|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||756||756|2013| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|26473|51005|vetalmen|||27|20|0||Vistor hf|Boehringer Ingelheim Danmark|||26473||26473|51005| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14251|20430|lyfalmen|V0117|20430|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14251||14251|20430| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2215|4009|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2215||2215|4009| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7108|10702|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7108||7108|10702| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21513|29544|lyfalmen|V0118|29544|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21513||21513|29544| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5626|8675|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5626||5626|8675| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8934|13200|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8934||8934|13200| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|26911|36318|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||26911||26911|36318| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|174400|220755|lyfsjukr|||00|1|0||Icepharma hf|Baxter|Prótein C||174400||174400|220755| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|332810|419559|lyfsjukr|||00|1|0||Icepharma hf|Baxter|Prótein C||332810||332810|419559| 007278|C08CA0302|Lomir Retard|forđahlk|2,5|mg|30|stk|1|ţpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2006|3723|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2006||2006|3723|29.02.2012 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|3117|5243|lyfalmen|V0377|4511|00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3117||3117|5243| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|102379|130368|lyfsjukr|||00|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||102379||102379|130368| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|292689|369207|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||292689||292689|369207| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PER|0|0|0|100|DKK|3365|5582|lyfalmen|V0374|4463|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3365||3365|5582| 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8959|12930|lyfsjukr|||02|50|0||Icepharma hf|Clintec parenteral SA|||8959||8959|12930| 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|123119|156397|lyfsjukr|||00|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|||123119||123119|156397| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|24355|32448|lyfsjukr|||00|250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||24355||24355|32448| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2051|3578|vetorma|||16|7|0||Icepharma hf|Bayer Animal Health GmbH|||||2051|3578| 007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6507|9880|lyfalmen|||00|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6507||6507|9880| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3791|6165|lyfalmen|V0079|6165|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3791||3791|6165| 007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|5165|8044|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5165||5165|8044| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|4681|6756|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4681||4681|6756| 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22361|30608|lyfalmen|||02|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||22361||22361|30608| 007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|10066|14749|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||10066||10066|14749| 007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6680|10117|lyfalmen|||00|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6680||6680|10117| 007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|22679|31007|lyfalmen|||00|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||22679||22679|31007| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3099|lyfalmen|V0290|3099|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4169|6682|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4169||4169|6682| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1350|2826|lyfalmen|||00|5|0||K.Pétursson hf|Alcon|Ólópatadín||1350||1350|2826| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|187241|236870|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||187241||187241|236870| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|21353|28681|lyfsjukr|||00|10|0||Ísaga ehf|AGA AB|Nituroxíđ||21353||21353|28681| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|46817|60638|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||46817||46817|60638| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|SEK|631|1842|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||631||631|1842| 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|24708|32891|lyfsjukr|||00|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||24708||24708|32891| 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|30655|40355|lyfsjukr|||00|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||30655||30655|40355| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5737|8827|lyfalmen|||00|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5737||5737|8827| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|57526|74078|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||57526||57526|74078| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|115054|146275|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||115054||115054|146275| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|91684|116946|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||91684||91684|116946| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|135631|172099|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||135631||135631|172099| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|159327|201838|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||159327||159327|201838| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1588|3151|lyfalmen|||20|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1588||1588|3151| 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|298|1387|lyfalmen|||20|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||298||298|1387| 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|38228|49859|lyfsjukr|||00|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||38228||38228|49859| 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29934|39450|lyfsjukr|||00|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||29934||29934|39450| 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|583|1776|lyfalmen|||33|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||583||583|1776| 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34976|45777|lyfsjukr|||00|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||34976||34976|45777| 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|928|2091|lyfalmen|||00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||813||813|2091| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.1998|31.01.2012|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2876|4913|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2876||2876|4913| 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1315|2778|lyfalmen|||33|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1315||1315|2778| 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2997|5079|lyfalmen|V0226|5079|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2997||2997|5079| 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4968|7775|lyfalmen|V0227|7775|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4968||4968|7775| 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6704|10027|lyfalmen|V0228|10027|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6614||6614|10027| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|160041|202734|lyfsjukr|||02|2|0||Vistor hf|Genzyme BV|Thýrótrópín||160041||160041|202734| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|855|2148|lyfalmen|V0153|2148|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||855||855|2148| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|743|1995|lyfalmen|V0154|1995|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||743||743|1995| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|0|0|0|100|USD|5207|9083|vetorma|||00|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5207||5207|9083| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|13216|25549|vetalmen|||00|50|0||Icepharma hf|Chanelle Pharmaceuticals |||13216||13216|25549| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|ţpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|APS|0|0|1|100|DKK|4256|6801|lyfalmen|||00|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4256||4256|6801| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NAS|0|0|0|100|DKK|3010|5096|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3010||3010|5096| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|113704|144581|lyfsjukr|||00|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||113704||113704|144581| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|119945|152413|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||119945||119945|152413| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|3206|5365|lyfalmen|||00|15|0||Vistor hf|Meda AB|Pímekrólímus||3206||3206|5365| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3791|6165|lyfalmen|V0094|6165|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3791||3791|6165| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|2017|3738|lyfalmen|||20|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2017||2017|3738| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6288|9581|lyfalmen|V0145|9046|00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6288|9581| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12387|18091|lyfalmen|V0145|18091|00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12387|18091| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|5409|8378|lyfalmen|||00|30|0||Vistor hf|Meda AB|Pímekrólímus||5409||5409|8378| 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|9122|13165|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9122||9122|13165| 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|9122|13165|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9122||9122|13165| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|IPI|0|0|1|100|DKK|14894|21237|lyfalmen|||03|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14894||14894|21237| 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|9122|13165|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9122||9122|13165| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|54330|70067|lyfsjukr|||00|30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||54330||54330|70067| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1846| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5669|8734|lyfalmen|||00|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5669||5669|8734| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1188|2604|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1188||1188|2604| 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1311|2772|lyfalmen|V0130|1711|23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1311||1311|2772| 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1516|3053|lyfalmen|V0131|2511|23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1516||1516|3053| 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1899|3577|lyfalmen|V0132|2788|23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1899||1899|3577| 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7546|10891|lyfsjukr|||00|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7546||7546|10891| 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7546|10891|lyfsjukr|||00|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7546||7546|10891| 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7546|10891|lyfsjukr|||00|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7546||7546|10891| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|207397|262166|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||207397||207397|262166| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5490|8489|lyfalmen|||00|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5490||5490|8489| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|62062|79770|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||62062||62062|79770| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|9064|13378|lyfalmen|||02|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9064||9064|13378| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8531|12649|lyfalmen|||00|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8531||8531|12649| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8371|12430|lyfalmen|||17|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8371||8371|12430| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|9811|14400|lyfalmen|||00|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9811||9811|14400| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8546|12669|lyfalmen|||17|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8546||8546|12669| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8400|12470|lyfalmen|||02|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8400||8400|12470| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|2263|4075|lyfalmen|V0329|2533|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2263||2263|4075| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|4308|6872|lyfalmen|||00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4308||4308|6872| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|6157|9401|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||6157||6157|9401| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|235960|298012|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||235960||235960|298012| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|7567|10921|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7567||7567|10921| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|13374|19330|lyfalmen|V0331|5397|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13374||13374|19330| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|18857|26211|lyfalmen|V0332|8892|00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18857||18857|26211| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|A||0|0|E|0|LBK|0|0|0|100|DKK|14905|21251|lyfalmen|||00|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14905|21251| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|24163|32870|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||24163||24163|32870| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3861|6261|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3861||3861|6261| 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|7676|11479|lyfalmen|||51|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7676||7676|11479| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|13072|18951|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||13072||13072|18951| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|ELA|0|0|0|100|DKK|77137|134562|vetorma|||00|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||77137||77137|134562| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|7125|10726|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7125||7125|10726| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|7551|10898|lyfsjukr|||00|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7551||7551|10898| 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9599|13854|lyfsjukr|||00|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9599||9599|13854| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1236|2670|lyfalmen|||00|5|0||Icepharma hf|Santen Oy|Levófloxacín||1236||1236|2670| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5964|9137|lyfalmen|V0207|1466|00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5964||5964|9137| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6196|8942|lyfsjukr|||00|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6196||6196|8942| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|9529|13753|lyfsjukr|||00|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9529||9529|13753| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4215|6083|lyfsjukr|||00|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4215||4215|6083| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2417|3488|lyfsjukr|||00|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2417||2417|3488| 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|A||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|9177|13533|lyfalmen|V0377|13533|00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||9177||9177|13533| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|9517|13735|lyfsjukr|||00|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9517||9517|13735| 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|A||0|0|E|0|RAT|0|0|0|100|XEU|2554|3456|lyfalmen|V0006|3013|00|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1811||1811|3456| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6832|9860|lyfsjukr|||00|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6832||6832|9860| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4147|5985|lyfsjukr|||00|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4147||4147|5985| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|15419|6176|lyfalmen|V0207|4397|00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3799||3799|6176| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2232|3221|lyfsjukr|||00|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2232||2232|3221| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACT|0|0|0|100|DKK|368448|464285|lyfsjukr|||00|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||368448||368448|464285| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACL|0|0|0|100|DKK|368448|464285|lyfsjukr|||00|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||368448||368448|464285| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|1415|2086|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||809||809|2086| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|XEU|5143|6401|lyfalmen|V0006|5381|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||3964||3964|6401| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|3315|4136|lyfalmen|V0006|3013|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2308||2308|4136| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|50903|65766|lyfsjukr|||03|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||50903||50903|65766| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3296|4757|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3296||3296|4757| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3094|5211|lyfalmen|||00|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||3094||3094|5211| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|21100|29026|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21100||21100|29026| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20854|28717|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20854||20854|28717| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35926|47632|lyfalmen|||00|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35926||35926|47632| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35682|47326|lyfalmen|||00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35682||35682|47326| 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|19851|27458|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||19851||19851|27458| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4713|7426|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4713||4713|7426| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4897|7678|lyfalmen|||00|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4897||4897|7678| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|21204|27513|lyfalmen|V0327|5793|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19895||19895|27513| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|1250|2689|lyfalmen|||00|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1250||1250|2689| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|801|2075|lyfalmen|||00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||801||801|2075| 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|7727|8702|lyfalmen|V0457|8262|00|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||5646||5646|8702| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12718|18506|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12718||12718|18506| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|1108|2495|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1108||1108|2495| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|3057|3707|lyfalmen|V0069|3707|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1994||1994|3707| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9673|14211|lyfalmen|V0357|12988|00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9673||9673|14211| 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7468|11195|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7468||7468|11195| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|9507|13721|lyfsjukr|||02|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9507||9507|13721| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|2540|3666|lyfsjukr|||00|50|0||Icepharma hf|Pfizer ApS|Esketamín||2540||2540|3666| 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9801|14386|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9801||9801|14386| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|2011|4000|vetalmen|||00|25|0||Icepharma hf|Chanelle Pharmaceuticals |||2011||2011|4000| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|5177|7472|lyfsjukr|||00|20|0||Icepharma hf|Pfizer ApS|Esketamín||5177||5177|7472| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1667|3259|lyfalmen|||00|64|0||Gróco ehf|Oy Leiras Finland Ab|Estradíól||1667||1667|3259| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|ROA|0|0|0|100|DKK|92278|117691|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||92278||92278|117691| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|10761|15699|lyfalmen|||00|60|0||Vistor hf|Meda AB|Pímekrólímus||10761||10761|15699| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1486|2049|lyfalmen|V0152|2049|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4738|6676|lyfalmen|V0323|6676|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6676| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4606|6648|lyfsjukr|||02|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4606||4606|6648| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2665|3846|lyfsjukr|||02|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2665||2665|3846| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8347|12397|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8347|12397| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|42433|55136|lyfsjukr|||00|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||42433||42433|55136| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|13595|19607|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13595||13595|19607| 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|A||0|0|E|0|GSK|0|0|0|100|GBP|4732|7452|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4732||4732|7452| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6266|9550|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6266||6266|9550| 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|ţpakki||A10BB12|01.09.1997|31.03.2012|R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|503|1667|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríđ||503||503|1667| 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|12487|18216|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||12487||12487|18216| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|467247|588277|lyfsjukr|||00|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||467247||467247|588277| 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961| 012921|G03AA1301|Evra|forđapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4887|7664|lyfalmen|||00|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4887||4887|7664| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|7072|10653|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7072||7072|10653| 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|A||0|0|E|0|RGM|0|0|0|100|XEU|3502|5418|lyfalmen|V0250|5418|00|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||3245||3245|5418| 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|A||0|0|E|0|RGM|0|0|0|100|XEU|3813|4969|lyfalmen|V0251|4969|00|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2917||2917|4969| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6446|9797|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6446||6446|9797| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7280|14151|vetalmen|||00|100|0||Icepharma hf|Pfizer Oy Animal Health|||7280||7280|14151| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9732|14292|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9732||9732|14292| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1833|3646|vetalmen|||00|20|0||Icepharma hf|Pfizer Oy Animal Health|||1833||1833|3646| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23140|30923|lyfsjukr|||00|2|0||Ísaga ehf|AGA AB|Nituroxíđ||23140||23140|30923| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|7325|10572|lyfsjukr|||17|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7325||7325|10572| 013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|30888|40647|lyfsjukr|||00|250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||30888||30888|40647| 013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|52280|67494|lyfsjukr|||00|500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||52280||52280|67494| 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3517|4856|lyfalmen|V0042|4856|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2834||2834|4856| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4781|9353|vetalmen|||00|100|0||Icepharma hf|Pfizer Oy Animal Health|||4781||4781|9353| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11157|21596|vetalmen|||00|100|0||Icepharma hf|Pfizer Oy Animal Health|||11157||11157|21596| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1171|2329|vetalmen|||00|20|0||Icepharma hf|Pfizer Oy Animal Health|||1171||1171|2329| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|196912|249007|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||196912||196912|249007| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|425183|472789|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||375224||375224|472789| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|33136|43468|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||33136||33136|43468| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|131275|166633|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||131275||131275|166633| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|65639|84259|lyfsjukr|||00|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||65639||65639|84259| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|5665|8728|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Ezetimíb||5665||5665|8728| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|DKK|19289|26753|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||19289||19289|26753| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1375|2860|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1375||1375|2860| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2628|4574|lyfalmen|||00|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2628||2628|4574| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978|31.03.2012|R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1465|2983|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1465||1465|2983| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|426|1562|lyfalmen|||00|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||426||426|1562| 013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|39096|50948|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||39096||39096|50948| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|4907|7691|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4907||4907|7691| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|1009|2359|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||1009|2359| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|6484|9849|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6484||6484|9849| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|2701|4674|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2701||2701|4674| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|4843|7604|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4843||4843|7604| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|394637|497152|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||394637||394637|497152| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|2614|4555|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2614||2614|4555| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|9423|13600|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9423||9423|13600| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|18962|26342|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18962||18962|26342| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|59703|77472|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||59703||59703|77472| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31127|40947|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||31127||31127|40947| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|29018|38963|lyfalmen|V0357|38963|00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||29018||29018|38963| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1612|3184|lyfalmen|||00|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1612||1612|3184| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||29|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20676|27831|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||20676||20676|27831| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27067|35852|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||27067||27067|35852| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|NOK|2759|4753|lyfalmen|||00|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2759||2759|4753| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2391|4756|vetalmen|||00|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2391|4756| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|BOY|0|0|0|100|SEK|19226|26674|lyfalmen|||23|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||19226||19226|26674| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|86464|110395|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||86464|110395| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PAL|0|0|0|100|XEU|5944|11586|vetalmen|||16|24|0||Icepharma hf|Pfizer Oy Animal Health|||5944||5944|11586| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|251953|318084|lyfsjukr|||00|60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||251953||251953|318084| 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2401|4263|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2401||2401|4263| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1396|2889|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1396||1396|2889| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|65852|84527|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||65852||65852|84527| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|105361|134111|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||105361||105361|134111| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|917|2233|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||917|2233| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|20178|27869|lyfalmen|||00|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||20178||20178|27869| 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|A||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|60887|78958|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||60887||60887|78958| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|40529|53409|lyfalmen|||00|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||40529||40529|53409| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|802|2076|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||802||802|2076| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|XEU|3334|5540|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3334||3334|5540| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|8990|13277|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8990||8990|13277| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|XEU|1154|2533|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1136||1136|2533| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754| 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1139|2537|lyfalmen|V0129|1731|23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1139||1139|2537| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2003|3601|lyfalmen|V0234|3170|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3601| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2861|4724|lyfalmen|V0233|4110|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4724| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|10711|15631|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10711||10711|15631| 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|361314|455332|lyfsjukr|||00|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||361314||361314|455332| 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|96035|122406|lyfsjukr|||00|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||96035||96035|122406| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5554|8576|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5554||5554|8576| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14120|20266|lyfalmen|||00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14120||14120|20266| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5554|8576|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5554||5554|8576| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15264|21701|lyfalmen|V0264|21700|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15264||15264|21701| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|73667|94335|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||73667||73667|94335| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|73667|94335|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||73667||73667|94335| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|64059|82277|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||64059||64059|82277| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5554|8576|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5554||5554|8576| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13971|20079|lyfalmen|||00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13971||13971|20079| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|73667|94335|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||73667||73667|94335| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|23622|32191|lyfalmen|||00|120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||23622||23622|32191| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|49204|64296|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||49204||49204|64296| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3332|5813|vetorma|||16|2|0||Icepharma hf|Bayer Animal Health GmbH|||3332||3332|5813| 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4682|8168|vetorma|||16|12|0||Icepharma hf|Bayer Animal Health GmbH|||4682||4682|8168| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2972|5185|vetorma|||16|1|0||Icepharma hf|Bayer Animal Health GmbH|||2972||2972|5185| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3727|6502|vetorma|||16|3|0||Icepharma hf|Bayer Animal Health GmbH|||3727||3727|6502| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4749|7475|lyfalmen|V0200|5710|10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4749||4749|7475| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4175|7283|vetorma|||16|8|0||Icepharma hf|Bayer Animal Health GmbH|||4175||4175|7283| 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|A||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||23|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2096|3846|lyfalmen|||0|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||2096|3846| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2354|4199|lyfalmen|||00|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2354||2354|4199| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1624|3200|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1624||1624|3200| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3332|5813|vetorma|||16|1|0||Icepharma hf|Bayer Animal Health GmbH|||3332||3332|5813| 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|A||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||23|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|A|3|0|0|0|0|GSK|0|1|0|100|GBP|2072|3813|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2072||2072|3813| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15456|21942|lyfalmen|V0117|20847|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15456||15456|21942| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1206|2629|lyfalmen|||02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1206||1206|2629| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|23144|31591|lyfalmen|V0118|30147|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||23144||23144|31591| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1279|2729|lyfalmen|||02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1279||1279|2729| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|2643|4594|lyfalmen|V0236|3962|00|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2643||2643|4594| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|||24|stk|1|ţpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8023|11954|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||8023||8023|11954| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2780|4782|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2780||2780|4782| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6997|10550|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6997||6997|10550| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|MSE|0|0|0|100|SEK|5332|8273|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5332||5332|8273| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10611|15494|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10611||10611|15494| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1833|3486|lyfalmen|||00|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1833||1833|3486| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|15415|21891|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||15415||15415|21891| 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|9253|13637|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||9253||9253|13637| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4258|6804|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4258||4258|6804| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PER|0|0|0|100|DKK|100686|128243|lyfsjukr|||00|70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||100686||100686|128243| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|4458|6434|lyfsjukr|||00|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4458||4458|6434| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2735|4720|lyfalmen|||00|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2735||2735|4720| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|18391|25626|lyfalmen|||00|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18391||18391|25626| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7440| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35926|47632|lyfalmen|V0295|47631|00|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35926||35926|47632| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|2367|00|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|193687|244960|lyfsjukr|||00|2|0|120,0000|Icepharma hf|Roche|Epóetín||193687||193687|244960| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8199|12195|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8199||8199|12195| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3127|5256|lyfalmen|||10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3127||3127|5256|31.03.2012 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5772|8875|lyfalmen|||10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5772||5772|8875|31.03.2012 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|64089|82977|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||64089||64089|82977| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|94435|121061|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||94435||94435|121061| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|30518|40845|lyfalmen|||00|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||30518||30518|40845| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2107|3861|lyfalmen|||00|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2107||2107|3861| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|A||0|0|0|0|PER|0|0|0|100|DKK|3725|6075|lyfalmen|V0007|6075|00|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3725|6075| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|8214|12215|lyfalmen|V0007|10631|00|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||8214||8214|12215| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|41608|54101|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||41608||41608|54101| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|14614|20886|lyfalmen|||00|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||14614||14614|20886| 016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3299|5492|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3299||3299|5492| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PAL|0|0|0|100|DKK|19710|38019|vetalmen|||16|60|0||Icepharma hf|Pfizer Oy Animal Health|||19710||19710|38019| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26761|35468|lyfsjukr|||00|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||26761||26761|35468| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|1605|3174|lyfalmen|||03|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1605||1605|3174| 017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1503|3035|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1503||1503|3035| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|277094|349635|lyfsjukr|||00|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||277094||277094|349635| 017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|8296|12327|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||8296||8296|12327| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|187089|236679|lyfsjukr|||00|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||187089||187089|236679| 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|42292|54959|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||42292||42292|54959| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1432|2938|lyfalmen|V0046|2309|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1432||1432|2938| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIB|0|0|0|100|XEU|134135|170222|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||134135||134135|170222| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|50263|65625|lyfalmen|||00|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||50263||50263|65625| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|156086|198433|lyfalmen|||00|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||156086||156086|198433| 017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5728|8815|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5728||5728|8815| 017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|10907|15899|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10907||10907|15899| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2831|4852|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2831||2831|4852| 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|DKK|9477|13678|lyfsjukr|||00|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||9477||9477|13678| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|930|2251|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||930||930|2251| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3130|5261|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3130||3130|5261| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1459|2724|lyfalmen|V0168|2641|00|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2724| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7034|13679|vetalmen|||00|100|0||Vistor hf|Boehringer Ingelheim|||7034||7034|13679| 017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|42211|33173|lyfalmen|V0350|33173|00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||24405||24405|33173| 017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|13753|12290|lyfalmen|V0348|12290|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||8269||8269|12290| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10949|15957|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10949||10949|15957| 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|45371|59486|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||45371||45371|59486| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|9999|14657|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9999||9999|14657| 018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BYP|0|0|0|100|SEK|7467|11193|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7467||7467|11193| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2382|4237|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2382||2382|4237| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3498|5764|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3498||3498|5764| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|11290|16423|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||11290||11290|16423| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|7858|11728|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7858||7858|11728| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4039|6504|lyfalmen|||02|0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4039||4039|6504| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4411|7013|lyfalmen|||02|0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4411||4411|7013| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|9338|13753|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9338||9338|13753| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2552|lyfalmen|V0243|2552|00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1150||1150|2552| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2926|4982|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2926||2926|4982| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8663|12829|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8663||8663|12829| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14366|19912|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||14366||14366|19912| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|ţpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1471|2991|lyfalmen|||00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1471||1471|2991|29.02.2012 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|21240|29201|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||21240||21240|29201| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3067|5174|lyfalmen|||00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3067||3067|5174| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|SEK|1011|2362|lyfalmen|V0414|2023|00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||1011||1011|2362| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6135|9371|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6135||6135|9371| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|17294|24249|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17294||17294|24249| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|36142|47903|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||36142||36142|47903| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|130750|165974|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||130750||130750|165974| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|ţpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|APS|0|0|1|100|DKK|3057|5161|lyfalmen|||00|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3057||3057|5161| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|ţpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|APS|0|0|1|100|DKK|9877|14490|lyfalmen|||00|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9877||9877|14490| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|62167|79902|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||62167||62167|79902| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|626|1835|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||626||626|1835| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1398|2781|vetalmen|||27|100|0||Icepharma hf|Kela Laboratoria NV|||1398||1398|2781| 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|10677|15585|lyfalmen|V0221|11772|00|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10677||10677|15585| 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|22755|30440|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||22755||22755|30440| 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|7631|11418|lyfalmen|V0220|9299|00|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7631||7631|11418| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|25681|34112|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||25681||25681|34112| 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4231|6767|lyfalmen|V0219|5812|00|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4231||4231|6767| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|35653|46627|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||35653||35653|46627| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|36557|47762|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||36557||36557|47762| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|44668|57941|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||44668||44668|57941| 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9932|14565|lyfalmen|V0223|13554|00|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9932||9932|14565| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|14715|21012|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14715||14715|21012| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5047|7883|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5047||5047|7883| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|54491|70269|lyfsjukr|||00|1|0||Gróco ehf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||54491||54491|70269| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|THE|0|0|0|100|XEU|777958|978220|lyfsjukr|||00|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||777958||777958|978220| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|22185|42771|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||22185|42771| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7155|10767|lyfalmen|||00|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7155||7155|10767| 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|54921|70808|lyfsjukr|||AC|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||54921||54921|70808| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7155|10767|lyfalmen|||00|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7155||7155|10767| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|628|1838|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||628||628|1838| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|3918|5655|lyfsjukr|||00|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3918||3918|5655| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|657|1878|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||657||657|1878| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|17211|23482|lyfsjukr|||00|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||17211||17211|23482| 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|203947|257836|lyfsjukr|||AC|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||203947||203947|257836| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1163|2570|lyfalmen|V0159|2567|10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1163||1163|2570| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|207475|262264|lyfsjukr|||00|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||207475||207475|262264| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13491|19476|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13491||13491|19476| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13491|19476|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13491||13491|19476| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|58364|75792|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||58364||58364|75792| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13491|19476|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13491||13491|19476| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13491|19476|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13491||13491|19476| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13491|19476|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13491||13491|19476| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|823886|1035859|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||823886||823886|1035859| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|410|1540|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||410||410|1540| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|70446|90292|lyfsjukr|||00|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||70446||70446|90292| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1742|3306|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1701||1701|3306| 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|3051|5153|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3051||3051|5153| 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|27467|37016|lyfalmen|||00|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||27467||27467|37016| 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2973|5046|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2973||2973|5046| 020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|605|1807|lyfalmen|V0333|1625|00|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||605||605|1807| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7123|10723|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7123||7123|10723| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|55601|72324|lyfalmen|||02|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||55601||55601|72324| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6522|8192|lyfalmen|V0530|8105|00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||5273||5273|8192| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|14533|10028|lyfalmen|V0531|9920|00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6615||6615|10028| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|25091|34034|lyfalmen|||02|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||25091||25091|34034| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|632|1843|lyfalmen|||20|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||632||632|1843| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|5967|9141|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5967||5967|9141| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1924|3611|lyfalmen|||20|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1924||1924|3611| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|17378|24355|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||17378||17378|24355| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2325|4056|vetorma|||16|8|0||Vistor hf|Merial SAS|||2325||2325|4056| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|163651|207265|lyfsjukr|||00|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||163651||163651|207265| 020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|A||0|0|0|0|VET|0|0|0|100|XEU|2719|4743|vetorma|||16|52|0||Dýraheilsa ehf|Vetcare Ltd.|||2719||2719|4743| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2116|3873|lyfalmen|V0174|3873|00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2116||2116|3873| 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|A||0|0|0|0|SEV|0|0|0|100|DKK|3154|5293|lyfalmen|||00|30|0|37,5000|Icepharma hf|Servier|Perindópríl||3154||3154|5293| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2596|4530|lyfalmen|||00|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2596||2596|4530| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen|||00|12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2367|lyfalmen|||00|12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2367|31.01.2012 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|A|2|0|0|E|0|ACA|0|0|1|100|IKR|453|1389|lyfalmen|V0188|1389|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1389| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1064|2434|lyfalmen|||00|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1064||1064|2434| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|A|2|0|0|E|0|ACA|0|0|1|100|IKR|1187|2116|lyfalmen|V0189|2116|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2116| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|18070|25223|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||18070||18070|25223| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|DKK|17953|25076|lyfalmen|V0490|11015|63|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17953||17953|25076| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A||0|0|E|0|DAC|0|0|1|100|SEK|1747|3315|lyfalmen|V0443|3315|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1708||1708|3315| 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|18238|25434|lyfalmen|V0491|20192|63|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||18238||18238|25434| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1656|2390|lyfsjukr|||02|100|0||Icepharma hf|Fresenius Kabi|Própófól||1656||1656|2390| 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4602|7274|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4602||4602|7274| 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|14086|20223|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14086||14086|20223| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15111|21509|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15111||15111|21509| 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|7444|11162|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíţjóđ|Desmópressín||7444||7444|11162| 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|A||0|0|B|0|FER|0|0|0|100|DKK|15817|22395|lyfalmen|||00|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15817||15817|22395| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16559|22664|lyfsjukr|||02|1000|0||Icepharma hf|Fresenius Kabi|Própófól||16559||16559|22664| 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|23711|32302|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||23711||23711|32302| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16559|22664|lyfsjukr|||02|500|0||Icepharma hf|Fresenius Kabi|Própófól||16559||16559|22664| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25488|34533|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||25488||25488|34533| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4710|7422|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4710||4710|7422| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9522|13743|lyfsjukr|||02|500|0||Icepharma hf|Fresenius Kabi|Própófól||9522||9522|13743| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|4805|6935|lyfsjukr|||02|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4805||4805|6935| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20405||20405|28153| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|4007|6460|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4007||4007|6460| 021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|22603|30249|lyfsjukr|||00|2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||22603||22603|30249| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|5537|8553|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5537||5537|8553| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|19082|26493|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||19082||19082|26493| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20405||20405|28153| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|87866|112154|lyfsjukr|||00|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||87866||87866|112154| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|A||0|0|0|1|BAM|0|0|0|100|SEK|129210|164041|lyfsjukr|||00|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||129210||129210|164041| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|7541|11295|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7541||7541|11295| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|8838|13069|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8838||8838|13069| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|27100|36556|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||27100||27100|36556| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|K||0|0|*|0|SAA|0|0|0|100|NOK|5802|8916|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5802||5802|8916| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|9424|13870|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||9424||9424|13870| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|307500|387795|lyfsjukr|||00|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||307500||307500|387795| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|339350|427767|lyfsjukr|||00|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||339350||339350|427767| 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11828|20633|vetorma|||00|24|0||Icepharma hf|Bayer Animal Health GmbH|||11828||11828|20633| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|25748|34859|lyfalmen|||02|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||25748||25748|34859| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2378|4148|vetorma|||00|2|0||Icepharma hf|Bayer Animal Health GmbH|||2378||2378|4148| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|1359|2838|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1359||1359|2838| 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|ţpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1448|2526|vetorma|||00|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1448|2526| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|4016|2796|lyfalmen|V0056|2192|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1328||1328|2796| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|7060|3863|lyfalmen|V0057|2894|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2108||2108|3863| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2252|3929|vetorma|||00|1|0||Icepharma hf|Bayer Animal Health GmbH|||2252||2252|3929| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|658|1879|lyfalmen|||20|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||658||658|1879| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1974|3679|lyfalmen|||20|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1974||1974|3679| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|1458|2543|vetorma|||00|1|0||Icepharma hf|Bayer Animal Health GmbH|||1458||1458|2543| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4906|7690|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4906||4906|7690| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2129|2993|lyfalmen|V0321|2993|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2046|lyfalmen|V0321|1796|00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.11.2003|29.02.2012|R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13656|19683|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||13656||13656|19683| 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|27024|36460|lyfalmen|||00|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||27024||27024|36460| 022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|236633|298857|lyfsjukr|||00|3|0||Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||236633||236633|298857| 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|13512|19503|lyfalmen|||00|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13512||13512|19503| 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|A||0|0|E|0|GGL|0|0|0|100|GBP|20290|28009|lyfalmen|||00|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||20290||20290|28009| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2964| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196|67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196| 022962|V01AA1104|Alutard SQ, hrossavćrur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25488|34533|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|dýr||25488||25488|34533| 022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|dýr||20405||20405|28153| 023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5932|9094|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5932||5932|9094| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|87860|112147|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||87860||87860|112147| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|26974|36398|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||26974||26974|36398| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|42114|55398|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||42114||42114|55398| 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21327|29311|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21327||21327|29311| 023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5991|9174|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5991||5991|9174| 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21543|29582|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21543||21543|29582| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|5081|5753|lyfalmen|V0250|5418|00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||3490||3490|5753| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|3805|6184|lyfalmen|V0251|4969|00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3805||3805|6184| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|19321|26793|lyfalmen|||00|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||19321||19321|26793| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|7761|11201|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7761||7761|11201| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29842|39334|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||29842||29842|39334| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|22598|30243|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||22598||22598|30243| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|53818|69424|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||53818||53818|69424| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|36367|47523|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||36367||36367|47523| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8876|12810|lyfsjukr|||00|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8876||8876|12810| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|108395|137918|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||108395||108395|137918| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|22190|29731|lyfsjukr|||00|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||22190||22190|29731| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|15599|21459|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||15599||15599|21459| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|38591|50314|lyfsjukr|||00|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||38591||38591|50314| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|77182|98746|lyfsjukr|||00|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||77182||77182|98746| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|188901|238953|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||188901||188901|238953| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|154364|195609|lyfsjukr|||00|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||154364||154364|195609| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|14188|20351|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14188||14188|20351| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|141703|179720|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||141703||141703|179720| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|28569|33084|lyfalmen|V0029|10247|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||24334||24334|33084| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3775|6143|lyfalmen|||00|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3775||3775|6143| 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|A||0|0|0|1|BAX|0|0|0|100|SEK|162713|206087|lyfsjukr|||00|1500|0||Icepharma hf|Baxter|Sevóflúran||162713||162713|206087| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|59419|76453|lyfsjukr|||00|120|0|33,3300|Icepharma hf|Roche|Saquínavír||59419||59419|76453| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|IPI|0|0|0|100|DKK|80445|102841|lyfsjukr|||00|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||80445||80445|102841| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|3075|5185|lyfalmen|||00|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3075||3075|5185| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|81244|103844|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||81244||81244|103844| 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|2694|4664|lyfalmen|||00|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2694||2694|4664| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|20325|28053|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||20325||20325|28053| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1901|2744|lyfsjukr|||00|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1901||1901|2744| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|23777|31723|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||23777||23777|31723| 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|15131|15724|lyfalmen|V0456|15698|00|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||10779||10779|15724| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|67037|86677|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||67037||67037|86677| 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25488|34533|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|dýr||25488||25488|34533| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8024|11955|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8024||8024|11955| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|455|1601|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||455||455|1601| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8024|11955|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8024||8024|11955| 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13520|19513|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13520||13520|19513| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13542|19540|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13542||13542|19540| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13681|19715|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13681||13681|19715| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5785|8892|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5785||5785|8892| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|73504|94793|lyfalmen|||00|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||73504||73504|94793| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13681|19715|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13681||13681|19715| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1647|3232|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1647||1647|3232| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5785|8892|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5785||5785|8892| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8024|11955|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8024||8024|11955| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8024|11955|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8024||8024|11955| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1647|3232|lyfalmen|||02|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1647||1647|3232| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|667|1891|lyfalmen|||20|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||667||667|1891| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|dýr||20405||20405|28153| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2031|3757|lyfalmen|||20|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2031||2031|3757| 025180|R03BA0201|Pulmicort|innúđal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009|31.01.2012|R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2121|3880|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||2121||2121|3880| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|dýr||20405||20405|28153| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983|29.02.2012|R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|961|2293|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||961||961|2293| 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|14489|20729|lyfalmen|||00|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||14489||14489|20729| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|88222|112601|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||88222||88222|112601| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|82403|105298|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||82403||82403|105298| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|10111|19587|vetalmen|||00|20|0||Vistor hf|Boehringer Ingelheim|||10111||10111|19587| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|17503|24511|lyfalmen|||00|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||17503||17503|24511| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|20774|28617|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||20774||20774|28617| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6645|10069|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6645||6645|10069| 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|A||0|0|*|0|POF|0|0|0|100|DKK|2431|3366|lyfalmen|V0462|3366|00|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1745||1745|3366| 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|A||0|0|*|0|POF|0|0|0|100|DKK|2646|3646|lyfalmen|V0471|3646|00|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1950||1950|3646| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|DKK|1988|3698|lyfalmen|V0369|3075|06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1988||1988|3698| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5537|8553|lyfalmen|V0205|1726|00|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5537||5537|8553| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|14838|21167|lyfalmen|V0205|5177|00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14838||14838|21167| 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|A||0|0|*|0|POF|0|0|0|100|DKK|2845|3927|lyfalmen|V0472|3841|00|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||2155||2155|3927| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|56223|73105|lyfalmen|||00|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||56223||56223|73105| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7750|11185|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7750||7750|11185| 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25488|34533|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|dýr||25488||25488|34533| 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|A||0|1|0|1|CEE|0|0|0|100|XEU|60649|77997|lyfsjukr|||00|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||60649|77997| 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|A||0|0|B|0|POF|0|0|0|100|XEU|14062|20193|lyfalmen|V0492|20193|00|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||14062||14062|20193| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1055|2422|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1055||1055|2422| 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|A||0|0|B|0|POF|0|0|0|100|XEU|17056|20192|lyfalmen|V0491|20192|63|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||14061||14061|20192| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4957|8647|vetorma|||16|1|0||Vistor hf|Merial (MSD)|||4957||4957|8647| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|548|1729|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||548||548|1729| 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|A||0|0|B|0|POF|0|0|0|100|XEU|14384|11240|lyfalmen|V0490|11015|63|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||7501||7501|11240| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|2803|3634|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1941||1941|3634| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|A||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||10|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||| 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|A||0|0|0|0|VIR|0|0|0|100|SEK|2788|5526|vetalmen|||00|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2788||2788|5526| 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|A|5|0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|V0447|2101|10|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9765|17035|vetorma|||16|2|0||Vistor hf|Merial (MSD)|||9765||9765|17035| 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|24106|26109|lyfalmen|||00|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||17500||18776|26109|31.03.2012 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|dýr||20405||20405|28153| 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|45007|58366|lyfsjukr|||00|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||45007||45007|58366| 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|225061|284334|lyfsjukr|||00|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||225061||225061|284334| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|1918|3603|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1918|3603| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|7266|10918|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||7266|10918| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3788|6161|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3788|6161| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|15004|21375|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||15004|21375| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|22483|30761|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||22483|30761| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|29963|40149|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||29963|40149| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1523|3062|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1523||1523|3062| 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|A||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|A||0|0|0|0|DAC|0|0|1|100|SEK|1679|3205|lyfalmen|||10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1627||1627|3205|29.02.2012 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|A||0|0|0|0|DAC|0|0|1|100|SEK|1208|2567|lyfalmen|V0159|2567|10|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1161||1161|2567| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|453|1599|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||453||453|1599| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2849|4876|lyfalmen|V0199|3659|10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2849||2849|4876| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2537|4449|lyfalmen|||00|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2537||2537|4449| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|7447|11166|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7447||7447|11166| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|31129|33975|lyfalmen|V0341|29021|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||25044||25044|33975| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|34935|36508|lyfalmen|V0342|31126|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||27062||27062|36508| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|ţpakki||N03AX15|01.03.2007|29.02.2012|R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1765|3393|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|Zonisamíđ||1765||1765|3393| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7693|11503|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7693||7693|11503| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10138|14847|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||10138||10138|14847| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|ţpakki||N03AX15|01.03.2007|31.01.2012|R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|12301|17983|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Zonisamíđ||12301||12301|17983| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|886|2191|lyfalmen|V0153|2148|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||886||886|2191| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|886|2191|lyfalmen|V0154|1995|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||886||886|2191| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|106053|134979|lyfsjukr|||00|105|0|5,2500|Vistor hf|SP Europe|Posacónazól||106053||106053|134979| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|21639|29702|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21639||21639|29702| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|0|1|ELD|0|1|0|100|XEU|33644|44106|lyfsjukr|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||33644|44106| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25009|33931|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25009||25009|33931| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|0|1|ELD|0|1|0|100|XEU|49575|64099|lyfsjukr|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||49575||49575|64099| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|0|1|ELD|0|1|0|100|XEU|62450|80257|lyfsjukr|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||62450|80257| 028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5312|8245|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5312||5312|8245| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|A|2|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|25613|34689|lyfalmen|V0386|34689|00|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||25613||25613|34689| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3797|5363|lyfalmen|V0364|5363|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3205||3205|5363| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4149|6655|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4149|6655| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|19817|27415|lyfalmen|V0120|27415|00|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||19817|27415| 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13843|19918|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||13843|19918|29.02.2012 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|ţpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3982|6426|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||3982|6426|29.02.2012 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|ţpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13843|19918|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||13843|19918|29.02.2012 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|ţpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4590|7258|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4590|7258|29.02.2012 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|ţpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15967|22584|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||15967|22584|29.02.2012 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|ţpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4590|7258|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4590|7258|29.02.2012 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|ţpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15967|22584|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||15967|22584|29.02.2012 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|59823|76960|lyfsjukr|||00|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||59823||59823|76960| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2664|4623|lyfalmen|||02|0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2664||2664|4623| 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22361|30608|lyfalmen|||02|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||22361||22361|30608| 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8557|12684|lyfalmen|||02|1|0||Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||8557||8557|12684| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1987|3697|lyfalmen|V0202|3697|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1987||1987|3697| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2227|4025|lyfalmen|V0428|3509|10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2227||2227|4025| 028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|5549|8570|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5549||5549|8570| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8229|lyfalmen|V0245|8229|00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5300||5300|8229| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15148|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15148| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|839|1190|lyfalmen|V0266|1190|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||154||154|1190| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|1|0|0|100|DKK|8392|16286|vetalmen|||27|10|0||Icepharma hf|Orion Corporation (I)|||8392||8392|16286| 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|A||0|0|B|0|POF|0|0|0|100|XEU|4834|7592|lyfalmen|||63|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4834||4834|7592| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|5462|3366|lyfalmen|V0267|3366|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1745||1745|3366| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|19693|11511|lyfalmen|V0269|11511|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||7699||7699|11511| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|971|2307|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||971||971|2307| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1362|2842|lyfalmen|V0179|1824|10|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2842| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|4998|7816|lyfalmen|V0179|7816|10|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7816| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0180|875|10|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0180|1749|10|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498|10|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3757| 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1143|2542|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1143|2542| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|8010|11936|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Agómelatín||8010||8010|11936| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|22849|31221|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Agómelatín||22849||22849|31221| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|ţpakki||A03FA01|01.10.1995|31.03.2012|R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|627|1837|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||627||627|1837| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|267|1344|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||267|1344| 029307|A07EA0603|Entocort enema (D.A.C.)|endaţ.dr|0,02|mg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|SEK|7762|11445|lyfalmen|||56|7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||7651||7651|11445|29.02.2012 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7974|9694|lyfalmen|V0109|2300|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6371||6371|9694| 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|A||0|1|0|1|EIS|0|0|0|100|SEK|68300|87599|lyfsjukr|||00|2|0||Vistor hf|Eisai Ltd|Eribulin||68300||68300|87599| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|23760|31701|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||23760||23760|31701| 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|6143|8866|lyfsjukr|||00|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||6143||6143|8866| 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|4719|6811|lyfsjukr|||00|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4719||4719|6811| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5396|8360|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5396|8360| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16947|23814|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16947|23814| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5396|8360|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5396|8360| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16947|23814|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16947|23814| 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|A||0|0|0|0|GAN|0|0|1|100|SEK|6865|10370|lyfalmen|||00|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6865||6865|10370| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|105959|134861|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||105959||105959|134861| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|211916|267837|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||211916||211916|267837| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|5107|4478|lyfalmen|V0148|4423|00|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2558||2558|4478| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|24094|32783|lyfalmen|||00|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||24094||24094|32783| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||00|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9753|14321|lyfalmen|V0277|14319|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9753||9753|14321| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3111|5235|lyfalmen|V0276|5233|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||3111||3111|5235| 030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|17007|29668|vetorma|||00|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||17007|29668| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1472|2993|lyfalmen|V0051|2993|00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1472||1472|2993| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|2326|4161|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2326||2326|4161| 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|3|0|0|0|0|NEH|0|0|1|100|DKK|1302|2760|lyfalmen|||23|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín||1302||1302|2760| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3326|5529|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3326||3326|5529| 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|69266|88811|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||69266||69266|88811| 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|84390|107792|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||84390||84390|107792| 031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|186054|235380|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||186054||186054|235380| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2234|4035|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2234||2234|4035| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NAS|0|0|0|100|DKK|6276|9564|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6276||6276|9564| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|24581|32732|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||24581||24581|32732| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|2132|3895|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2132||2132|3895| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10181|14660|lyfsjukr|||0|4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||10181|14660| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14881|20558|lyfsjukr|||0|10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14881|20558| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|51489|66501|lyfsjukr|||0|50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||51489|66501| 032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|22311|30545|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22311||22311|30545| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4011|6997|vetorma|||27|50|0||Vistor hf|Merial (MSD)|||4011||4011|6997| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|15653|27306|vetorma|||27|200|0||Vistor hf|Merial (MSD)|||15653||15653|27306| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|22613|30262|lyfsjukr|||00|1|0|29,6300|Vistor hf|Ferring|Degarelix||||22613|30262| 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|45102|58486|lyfsjukr|||00|2|0|88,8900|Vistor hf|Ferring|Degarelix||||45102|58486| 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|A||0|0|0|0|NOB|1|0|0|100|XEU|1293|2256|vetorma|||16|7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||||1293|2256| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|9679|18758|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9679|18758| 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1305|2764|lyfalmen|||00|5|0||K.Pétursson hf|Alcon|Dexametasón||1305||1305|2764| 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|A||0|0|*|0|WIH|0|0|0|100|XEU|49241|43772|lyfalmen|V0185|43772|00|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||32850||32850|43772| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|85729|109472|lyfsjukr|||43|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||85729||85729|109472| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|111821|142218|lyfsjukr|||43|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||111821||111821|142218| 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2624|5211|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||||2624|5211| 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|789|2058|lyfalmen|||AC|0|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||789||789|2058| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|24666|32838|lyfsjukr|||00|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||24666||24666|32838| 034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|K||0|0|0|0|IAG|0|0|0|100|SEK|15964|22580|lyfalmen|||02|0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15964||15964|22580| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8590|12730|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8590|12730| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8590|12730|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8590|12730| 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|A||0|1|0|1|ORC|0|0|0|100|DKK|81209|103800|lyfsjukr|||00|40|0||Vistor hf|Orion Corporation|Dexmedetómid||81209||81209|103800| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1939|3631|lyfalmen|V0367|2763|00|6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1939||1939|3631| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3325|5527|lyfalmen|V0367|5527|00|12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||3325||3325|5527| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|184507|233439|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||184507||184507|233439| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7899|11400|lyfsjukr|||02|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7899||7899|11400| 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2399|3462|lyfsjukr|||00|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2399||2399|3462| 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|16931|23794|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16931||16931|23794| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3791|6165|lyfalmen|V0079|6165|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3791|6165| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3325|lyfalmen|V0244|3325|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1715||1715|3325| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|127406|161777|lyfsjukr|||00|1|0||Icepharma hf|Pfizer ApS|Pegaptaníb||127406||127406|161777| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|10872|15851|lyfalmen|V0080|13733|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10872||10872|15851| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|32309|39190|lyfalmen|||00|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||29199||29199|39190| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|151285|191745|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||151285||151285|191745| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6321|9626|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6321||6321|9626| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3102|5222|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3102||3102|5222| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|9035|13338|lyfalmen|V0081|11574|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9035||9035|13338| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|A||0|1|0|1|ABL|0|0|0|100|DKK|6428|9277|lyfsjukr|||00|30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6428||6428|9277| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|208487|263534|lyfsjukr|||00|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||208487||208487|263534| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|415846|523769|lyfsjukr|||00|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||415846||415846|523769| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|829945|1043463|lyfsjukr|||00|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||829945||829945|1043463| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|865|2162|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||865||865|2162| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1520|3058|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1520||1520|3058| 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|3000|5083|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||3000||3000|5083| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|910|2224|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||910||910|2224| 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12723|18513|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12723||12723|18513| 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|23357|31858|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||23357||23357|31858| 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|45679|59872|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||45679||45679|59872| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2663|4622|lyfalmen|V0434|4622|00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2663||2663|4622| 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SPL|0|0|1|100|DKK|1218|2645|lyfalmen|||0|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1218||1218|2645| 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2328| 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3806| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8902|13156|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8902|13156| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1499|lyfalmen|||00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2374|lyfalmen|V0321|1796|00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2374| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3155|lyfalmen|V0321|2993|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1103|2488|lyfalmen|||00|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1103||1103|2488| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2734|4719|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2734||2734|4719| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|184957|234004|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||184957||184957|234004| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|79942|102210|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||79942||79942|102210| 039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|44382|57582|lyfsjukr|||00|10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||44382||44382|57582| 039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|74191|94992|lyfsjukr|||00|20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||74191||74191|94992| 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|K||0|0|0|0|GLB|0|0|0|100|GBP|7420|11018|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7339||7339|11018| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|A||0|1|0|0|SAA|0|0|0|100|NOK|4937|7732|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4937|7732| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|A||0|1|0|0|SAA|0|0|0|100|NOK|24190|32904|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||24190|32904| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|3510|5780|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3510||3510|5780| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|607|1809|lyfalmen|||00|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||607||607|1809| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|683|1913|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||683||683|1913| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1366|2848|lyfalmen|||00|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1366||1366|2848| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1969|3672|lyfalmen|||00|22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1969||1969|3672| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|505|729|lyfsjukr|||00|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||505||505|729| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|3049|lyfalmen|V0110|3029|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|3049| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8902|10176|lyfalmen|V0182|10176|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6723||6723|10176| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|689|994|lyfsjukr|||00|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||689||689|994| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1928|2560|lyfalmen|V0033|2560|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1156||1156|2560| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1405|2028|lyfsjukr|||02|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1405||1405|2028| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||06|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723| 040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527|00|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2527| 041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BYP|0|0|0|100|SEK|3510|5780|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3510||3510|5780| 041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|K||0|0|0|0|IPF|1|0|0|100|DKK|29598|51632|vetorma|||00|240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||29598|51632| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4635|8086|vetorma|||AA|100|0||Icepharma hf|Intervet International B.V.|||4635||4635|8086| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1256|2697|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1256|2697| 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|A||0|0|0|0|APC|0|0|0|100|XEU|4238|1897|lyfalmen|V0005|1897|00|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||671||671|1897| 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1615|3188|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1615||1615|3188| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|13587|18934|lyfsjukr|||00|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||13587||13587|18934| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2676|3862|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2676||2676|3862| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3235|4669|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3235||3235|4669| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4580|6610|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4580||4580|6610| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4694|6775|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4694||4694|6775| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5980|8631|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5980||5980|8631| 042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2385|4241|lyfalmen|||00|500|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2385|4241| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7380|10651|lyfsjukr|||00|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7380||7380|10651| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3999|5772|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3999||3999|5772| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3061|4418|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3061||3061|4418| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2339|3376|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2339||2339|3376| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2928|4226|lyfsjukr|||02|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2928||2928|4226| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3843|5546|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3843||3843|5546| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2625|3789|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2625||2625|3789| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1891|2729|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1891||1891|2729| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6417|9261|lyfsjukr|||00|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6417||6417|9261| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2141|3090|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2141||2141|3090| 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|814|2092|lyfalmen|||02|0|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||814||814|2092| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3032|4376|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3032||3032|4376| 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15556|22068|lyfalmen|||02|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||15556||15556|22068| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|1415|2815|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1415||1415|2815| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2109|4195|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2109||2109|4195| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2827|5601|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2827||2827|5601| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|5655|11031|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5655||5655|11031| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|6503|12659|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6503||6503|12659| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2552|3683|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2552||2552|3683| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|A||1|0|0|0|MYL|0|0|0|100|SEK|561|1746|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||561||561|1746| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3365|4857|lyfsjukr|||00|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3365||3365|4857| 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|A||0|0|0|0|PSA|0|0|0|100|XEU|25147|32049|lyfalmen|V0516|32049|00|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||23509||23509|32049| 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|5133|6195|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3813||3813|6195| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6222|8980|lyfsjukr|||00|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6222||6222|8980| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|594|1791|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||594||594|1791| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1292|2746|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1292||1292|2746| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|CHF|13732|19779|lyfalmen|V0034|19779|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||13732||13732|19779| 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|401743|506070|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||401743|506070| 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|566930|713380|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||566930|713380| 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|24397|33163|lyfalmen|||00|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||24397||24397|33163| 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|93189|119497|lyfalmen|||00|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||93189||93189|119497| 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|2823|4841|lyfalmen|||00|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2823||2823|4841| 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|A||0|0|0|0|OCO|0|0|0|100|DKK|2199|4374|vetalmen|||16|3|0||Icepharma hf|Orion Corporation (I)|||2199||2199|4374| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7776|11616|lyfalmen|||02|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7776||7776|11616| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2300|lyfalmen|V0109|2300|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2300| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2095|lyfalmen|V0108|2095|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|2095| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|3107|4484|lyfsjukr|||00|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||3107||3107|4484| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|6213|8967|lyfsjukr|||00|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||6213||6213|8967| 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|A||0|0|0|0|AGT|0|0|1|100|XEU|396|1521|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||396||396|1521| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|22296|42984|vetalmen|||27|10|0||Icepharma hf|Pfizer vet.|||22296||22296|42984| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1082|2459|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1082||1082|2459| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|4146|6650|lyfalmen|V0382|6650|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||4146||4146|6650| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|713|1954|lyfalmen|V0021|1954|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||713||713|1954| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|1171|2581|lyfalmen|V0022|2581|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1171||1171|2581| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|1472|2993|lyfalmen|V0023|2993|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1472||1472|2993| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|6904|10423|lyfalmen|V0383|10423|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6904||6904|10423| 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|A||0|0|E|0|POF|0|0|0|100|GBP|5273|8105|lyfalmen|V0530|8105|00|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||5209||5209|8105| 046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|A||0|0|E|0|POF|0|0|0|100|GBP|6615|9920|lyfalmen|V0531|9920|00|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||6536||6536|9920| 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|10971|12214|lyfalmen|V0283|12214|00|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||8213||8213|12214| 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|A||0|0|E|0|POF|0|0|0|100|XEU|11398|5177|lyfalmen|V0205|5177|00|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||3069||3069|5177| 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|3540|3086|lyfalmen|V0279|2861|00|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1540||1540|3086| 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008|31.03.2012|R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|75502|96638|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||75502||75502|96638| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1076|2451|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1076||1076|2451| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|154965|196364|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||154965||154965|196364| 047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|26831|36218|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||26831||26831|36218| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|13273|14531|lyfalmen|V0420|14531|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||9907||9907|14531| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|25136|29188|lyfalmen|V0421|29188|00|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||21229||21229|29188| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5593|8072|lyfsjukr|||02|250|0||Icepharma hf|Baxter Medical AB|Albúmín||5593||5593|8072| 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|9224|13313|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||9224||9224|13313| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8828|12741|lyfsjukr|||02|100|0||Icepharma hf|Baxter Medical AB|Albúmín||8828||8828|12741| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|2843|3719|lyfalmen|V0324|3536|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2003||2003|3719| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2641|3745|lyfalmen|V0035|3745|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2022||2022|3745| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|8197|5805|lyfalmen|V0325|5805|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3528||3528|5805| 048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.04.2010|29.02.2012|R|A||0|0|0|0|APC|0|1|0|100|XEU|2991|4136|lyfalmen|||00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2308||2308|4136| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|8053|6059|lyfalmen|V0326|5793|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3714||3714|6059| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|4130|4655|lyfalmen|V0246|4655|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2687||2687|4655| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|16103|5805|lyfalmen|V0327|5793|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3528||3528|5805| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1234|2667|lyfalmen|||00|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1234||1234|2667| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14666|20951|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14666||14666|20951| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4362|6946|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4362||4362|6946| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1892|3567|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1892||1892|3567| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|65034|80586|lyfalmen|V0187|53370|00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||62184||62184|80586| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|A||0|1|0|1|GZE|0|0|0|100|XEU|1039453|1306396|lyfsjukr|||00|1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1039453||1039453|1306396| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GSH|0|0|1|100|DKK|508|1674|lyfalmen|V0230|1578|00|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||508||508|1674| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|2575|4501|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2575||2575|4501| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|18293|25503|lyfalmen|||00|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||18293||18293|25503| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2528|4437|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2528||2528|4437| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993|29.02.2012|L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|60|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|7010|10568|lyfalmen|||23|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||7010||7010|10568| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2095|lyfalmen|V0108|2095|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|2095| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2300|lyfalmen|V0109|2300|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2300| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3091|lyfalmen|V0110|3091|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|3091| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|4675|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1259|2685|lyfalmen|V0496|2685|00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1247||1247|2685| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||00|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|2594|3779|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2047||2047|3779| 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|65034|84163|lyfalmen|V0470|74256|00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||65034||65034|84163| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAP|0|0|0|100|SEK|598824|753407|lyfsjukr|||00|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||598824||598824|753407| 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|75722|96914|lyfsjukr|||00|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||75722|96914| 050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|7923|4014|lyfalmen|V0012|3647|00|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||2219||2219|4014| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3493|5757|lyfalmen|||00|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3493||3493|5757| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13682|19716|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13682||13682|19716| 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5807|5388|lyfalmen|V0042|4856|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3223||3223|5388| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A|3|0|0|0|0|AGT|0|0|0|100|XEU|5144|7295|lyfalmen|V0002|7295|00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4617||4617|7295| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A||0|0|E|0|AGT|0|0|0|100|XEU|4943|5467|lyfalmen|V0006|5381|00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3281||3281|5467| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|A||0|0|0|0|AGT|0|0|0|100|XEU|11811|8503|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||5500||5500|8503| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1793|3432|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1793||1793|3432| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|DKK|7275|8954|lyfalmen|||00|60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5830||5830|8954| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1852|3512|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1852||1852|3512| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1507|2860|lyfalmen|V0363|2860|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1375||1375|2860| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4098|6230|lyfalmen|V0365|6230|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3839||3839|6230| 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|0|0|1|UCB|0|0|0|100|DKK|32009|42054|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||32009||32009|42054| 051686|N05AE0402|Zeldox (DAC)|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2011||R|A|4|0|0|*|0|DAC|0|1|0|100|DKK|27435|36976|lyfalmen|||00|56|0|56,0000|D.A.C. ehf|D.A.C. ehf|Ziprasidon||27435||27435|36976|31.01.2012 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1642|2210|lyfalmen|V0056|2192|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||900||900|2210| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|2779|2894|lyfalmen|V0057|2894|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1400||1400|2894| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|226|1288|lyfalmen|V0047|1288|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||226||226|1288| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|532|1707|lyfalmen|V0305|1020|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||532||532|1707| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|362222|456471|lyfsjukr|||00|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||362222||362222|456471| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|377|1495|lyfalmen|V0439|1495|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||377|1495| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1210|2634|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1210||1210|2634| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|776|2040|lyfalmen|V0305|2040|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||776||776|2040| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|756683|951520|lyfsjukr|||00|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||756683||756683|951520| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|670660|843561|lyfsjukr|||00|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||670660||670660|843561| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|3988|6434|lyfalmen|||00|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3988||3988|6434| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|39175|51047|lyfsjukr|||00|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||39175||39175|51047| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31847|41850|lyfsjukr|||00|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||31847||31847|41850| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33620|44076|lyfsjukr|||00|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||33620||33620|44076| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|28128|37183|lyfsjukr|||00|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||28128||28128|37183| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37828|49357|lyfsjukr|||00|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||37828||37828|49357| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35125|45964|lyfsjukr|||00|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35125||35125|45964| 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|K||0|0|*|0|NAS|0|0|0|100|DKK|16351|23066|lyfalmen|||00|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||16351||16351|23066| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2518|4239|lyfalmen|V0313|4239|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2383||2383|4239| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2367|4217|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2367||2367|4217| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|65866|84544|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||65866||65866|84544| 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5970|9146|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5970||5970|9146| 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6427|9771|lyfalmen|||02|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6427||6427|9771| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|42125|55412|lyfalmen|V0453|45702|00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||42125||42125|55412| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|35360|46922|lyfalmen|V0454|41188|00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||35360||35360|46922| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|671|1787|lyfalmen|V0060|1787|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||591||591|1787| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|16422|23155|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16422||16422|23155| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1638|3220|lyfalmen|||00|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1638||1638|3220| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1221|2649|lyfalmen|||20|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1221||1221|2649| 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|8255|11240|lyfalmen|V0490|11240|63|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||7501||7501|11240| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2757|4750|lyfalmen|||02|0|0||Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2757||2757|4750| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|A||0|0|0|0|LEP|0|0|1|100|DKK|2888|4930|lyfalmen|||43|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2888||2888|4930| 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|A||0|0|0|0|LEP|0|0|1|100|DKK|3982|6426|lyfalmen|||43|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3982||3982|6426| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|ROA|0|0|0|100|DKK|68379|87698|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||68379||68379|87698| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1157|2562|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1157||1157|2562| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|A|3|0|0|0|0|ACA|0|1|0|100|XEU|1797|3437|lyfalmen|V0061|3437|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1797||1797|3437| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|A||1|0|0|0|REB|0|0|0|100|DKK|5081|9929|vetalmen|||27|10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||5081|9929| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8228|14353|vetorma|||16|20|0||Icepharma hf|Pfizer Oy Animal Health|||8228||8228|14353| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|A||0|0|0|0|ALA|0|0|1|100|USD|1805|3448|lyfalmen|||00|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1805|3448| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|825|2107|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||825||825|2107| 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|9856|14461|lyfalmen|||10|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9856||9856|14461| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005|31.03.2012|R|A||0|0|E|0|LDR|0|0|0|100|IKR|4350|6929|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Pýrazínamíđ||4350||4350|6929| 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|XEU|2300|3659|lyfalmen|V0467|3432|00|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1959||1959|3659| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527|00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2527| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3246| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|6047| 056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|19373|26858|lyfalmen|V0459|25829|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||19373||19373|26858| 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|A|5|0|0|0|0|CES|1|0|0|100|XEU|28796|50233|vetorma|||00|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28796||28796|50233| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1343|2816|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1343||1343|2816| 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3970|6410|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3970|6410| 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3970|6410|lyfalmen|||00|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3970|6410| 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|248368|313584|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||248368||248368|313584| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|62062|79770|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||62062||62062|79770| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3791|6165|lyfalmen|V0094|6165|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||3791|6165| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|12061|17682|lyfalmen|V0095|15130|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||12061|17682| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|12566|17653|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12566||12566|17653| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|7226|10429|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||7226||7226|10429| 057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|K||0|0|0|1|BAA|0|0|0|100|SEK|257540|325095|lyfsjukr|||00|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||257540||257540|325095| 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|24651|33482|lyfalmen|V0350|33173|00|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||24651||24651|33482| 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5228|7545|lyfsjukr|||00|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5228||5228|7545| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|3984|5750|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3984||3984|5750| 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|K||0|1|0|1|GGL|0|0|0|100|GBP|374539|471929|lyfsjukr|||00|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||374539||374539|471929| 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|A||0|1|0|1|JAS|0|0|0|100|SEK|577421|726546|lyfsjukr|||00|120|0||Vistor hf|Janssen-Cilag AB|Abírateron||577421||577421|726546| 057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|26487|35124|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||26487||26487|35124| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|21561|29604|lyfalmen|||0|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||21561|29604| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|456|1603|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||456||456|1603| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|A||0|1|0|1|GGL|0|0|0|100|GBP|135496|171930|lyfsjukr|||00|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||135496||135496|171930| 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|173004|301797|vetorma|||00|5000|0||Icepharma hf|Lohmann Animal Health|||||173004|301797| 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|262809|458457|vetorma|||00|10000|0||Icepharma hf|Lohmann Animal Health|||||262809|458457| 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|18577|25859|lyfalmen|||02|0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||18577||18577|25859| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1087|2466|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1087||1087|2466| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|107223|136447|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||107223||107223|136447| 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|A||0|0|0|0|JCI|0|1|0|100|SEK|44110|57903|lyfalmen|||00|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||44110||44110|57903| 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1348|2823|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1348||1348|2823| 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2514|4418|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2514||2514|4418| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4547|7199|lyfalmen|||51|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4547||4547|7199| 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|A||0|0|E|0|AGT|0|0|0|100|XEU|2646|3597|lyfalmen|V0006|3013|0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1914||1914|3597| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1600|3168|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1600||1600|3168| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|105878|135422|lyfalmen|||02|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||105878||105878|135422| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|34714|46111|lyfalmen|||51|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||34714||34714|46111| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|96832|123407|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||96832||96832|123407| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|43079|49557|lyfalmen|||00|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||37460||37460|49557| 059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|58717|76235|lyfalmen|||00|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||58717||58717|76235| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|402727|507968|lyfalmen|||00|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||402727||402727|507968| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|201380|255277|lyfalmen|||00|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||201380||201380|255277| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|96648|123838|lyfalmen|||00|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||96648||96648|123838|29.02.2012 060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|6026|9222|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||6026||6026|9222| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993|31.03.2012|L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2061| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2936|5810|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||2936|5810| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1539|3061|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||1539|3061| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9089|17625|vetalmen|||00|20|0||Icepharma hf|Pfizer Animal Health|||||9089|17625| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|A||0|0|E|0|DAC|0|0|0|100|DKK|7465|11191|lyfalmen|V0133|11191|00|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7465||7465|11191| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7466|11192|lyfalmen|V0133|11191|00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7466||7466|11192| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|1819|3173|vetorma|||16|26|0||Icepharma hf|Pfizer Oy Animal Health|||||1819|3173| 061715|L01XE0901|Torisel|irţ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|170880|216337|lyfsjukr|||00|1|0||Icepharma hf|Wyeth Europe|Temsirolímus||170880||170880|216337| 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|4744|6847|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4744||4744|6847| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|16940|23142|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16940||16940|23142| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|23849|31813|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||23849||23849|31813| 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|490|1649|lyfalmen|||10|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||490||490|1649| 062265|M01AB0505|Voltaren|eţ-stíll|50|mg|10|stk|1|pakki||M01AB05|01.11.2010|29.02.2012|R|A||0|0|E|0|NOH|0|0|1|100|DKK|366|1480|lyfalmen|||04|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||366||366|1480| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|A||0|1|*|0|AGP|0|0|0|100|XEU|63597|53370|lyfalmen|V0187|53370|00|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||40498||40498|53370| 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1762|3389|lyfalmen|||00|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1762||1762|3389| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|7110|10262|lyfsjukr|||02|20|0||Icepharma hf|Pfizer ApS|Metótrexat||7110||7110|10262| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|485|700|lyfsjukr|||02|1|0||Icepharma hf|Pfizer ApS|Metótrexat||485||485|700| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|989|2332|lyfalmen|||10|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||989||989|2332| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|1971|3675|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1971||1971|3675| 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|19236|33556|vetorma|||16|1000|0||Icepharma hf|Bayer Animal Health GmbH|||19236||19236|33556| 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|42548|55280|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||42548||42548|55280| 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|51948|67077|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||51948||51948|67077| 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|17209|16983|lyfalmen|||02|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11699||11699|16983| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|4498|7132|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4498||4498|7132| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3081| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|2705|4676|lyfalmen|V0123|4675|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2703||2703|4676| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1655|3243|lyfalmen|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1655||1655|3243|31.01.2012 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|4826|7482|lyfalmen|V0458|7482|00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||4754||4754|7482| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|8312|11996|lyfsjukr|||17|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||8312||8312|11996| 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|PAS|0|0|0|100|XEU|2703|4715|vetorma|||16|12|0||Vistor hf|Pfizer Oy Animal Health|||2703||2703|4715| 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|1039|2400|lyfalmen|||10|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1039||1039|2400| 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2177|3957|lyfalmen|||10|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2177||2177|3957| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|1156869|1453753|lyfsjukr|||00|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1156869|1453753| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|462747|582630|lyfsjukr|||00|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||462747|582630| 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|2286|4106|lyfalmen|||10|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2286||2286|4106| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|4627480|5809370|lyfsjukr|||00|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4627480|5809370| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|2313741|2905627|lyfsjukr|||00|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2313741|2905627| 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|A||0|0|E|0|BOI|0|0|0|100|DKK|2244|4049|lyfalmen|||00|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2244||2244|4049| 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|878|2180|lyfalmen|||51|0|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||878||878|2180| 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|A||0|0|0|1|OCT|0|0|0|100|DKK|62531|80359|lyfsjukr|||00|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||62531||62531|80359| 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2085|3831|lyfalmen|||38|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2085||2085|3831| 065314|G01AF0201|Canesten|sk-stíll|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|16560|22665|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||16560||16560|22665| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|2674|3913|lyfalmen|V0376|2262|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2145||2145|3913| 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|A||0|1|*|0|LVR|0|0|0|100|SEK|64303|81749|lyfalmen|V0451|81749|00|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||63111||63111|81749| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|8015|11463|lyfalmen|V0376|6786|06|8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7664||7664|11463| 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009|29.02.2012|R|K||0|1|0|1|WTE|0|0|0|100|DKK|148737|188547|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148737||148737|188547| 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|5136|7413|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||5136||5136|7413| 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|A||0|0|0|0|DOR|1|0|0|100|DKK|4363|8550|vetalmen|||00|100|0||Icepharma hf|Dopharma Reserch B.V|||4363||4363|8550| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|7138|10743|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||7138||7138|10743| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|35161|46010|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||35161||35161|46010| 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|A||0|0|0|0|GOG|0|0|1|100|DKK|905|2217|lyfalmen|||23|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||905||905|2217| 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1638|3220|lyfalmen|V0036|3220|70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1638||1638|3220| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|A||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|A||0|1|0|1|AGP|0|0|0|100|XEU|16305|22345|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||16305||16305|22345| 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|9225|13314|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||9225||9225|13314| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1542|3088|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1542||1542|3088| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|K||0|0|*|0|APC|0|0|0|100|DKK|1981|2661|lyfalmen|V0376|2262|06|2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1230||1230|2661| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1567|2842|lyfalmen|V0179|1824|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2842| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5748|7816|lyfalmen|V0179|7816|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7816| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0180|875|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0180|1749|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3757| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|14199|15342|lyfalmen|V0419|14972|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||10500||10500|15342| 068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6505|12663|vetalmen|||27|50|0||Icepharma hf|Vétoquinol AG|||6505||6505|12663| 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|K||0|1|0|1|GGL|0|0|0|100|GBP|112362|142897|lyfsjukr|||00|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||112362||112362|142897| 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|A||0|1|0|1|GTS|0|0|0|100|GBP|82655|105615|lyfsjukr|||00|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||82655||82655|105615| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|1888|3562|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1888||1888|3562| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6252|9531|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6252||6252|9531| 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|A||0|0|E|0|MED|0|0|0|100|XEU|28231|30503|lyfalmen|V0342|30503|00|98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||22277||22277|30503| 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|2680|3868|lyfsjukr|||00|400|0||Actavis Group hf|Braun|Natríumklóríđ||2680||2680|3868| 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|3335|4813|lyfsjukr|||00|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3335||3335|4813| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3369|lyfalmen|||00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3369|29.02.2012 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17262|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17262|29.02.2012 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|458|1449|lyfalmen|V0448|1449|00|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||344||344|1449| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|19466|26975|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||19466|26975| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|28154|37878|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||28154|37878| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|36461|48304|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||36461|48304| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|50175|64852|lyfsjukr|||02|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||50175||50175|64852| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen|||27|100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|13230|19149|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13230||13230|19149| 071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PAB|0|0|0|100|SEK|6648|12938|vetalmen|||16|1250|0||Vistor hf|Pharmaxim AB|||6648||6648|12938| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|XEU|743|1995|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||743||743|1995| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|70199|89982|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||70199||70199|89982| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|350997|442384|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||350997||350997|442384| 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|9125|13461|lyfalmen|||00|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||9125|13461| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|11585|11932|lyfalmen|V0144|10862|00|12|0|24,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||8007||8007|11932| 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|A||0|1|0|1|GZE|0|0|0|100|SEK|94568|120565|lyfsjukr|||00|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||94568|120565| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|XEU|3359|3366|lyfalmen|V0009|3231|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1745||1745|3366| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|7498|14570|vetalmen|||27|5|0||Vistor hf|Orion-Farmos|||7498||7498|14570| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|XEU|10563|10950|lyfalmen|V0029|10247|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||7289||7289|10950| 072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|dýr||20405||20405|28153| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|688|993|lyfsjukr|||02|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||688||688|993| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|158232|200464|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||158232||158232|200464| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|17603|24637|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||17603||17603|24637| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|17603|24637|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||17603||17603|24637| 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|A||0|1|0|1|JCI|0|0|0|100|SEK|78881|100878|lyfsjukr|||00|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||78881||78881|100878| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1125|2518|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1125||1125|2518| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|A||0|0|E|0|GSK|0|0|0|100|GBP|3969|6408|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3969||3969|6408| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1752|3376|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1752||1752|3376| 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|54520|48093|lyfalmen|V0185|43772|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||36293||36293|48093| 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|763|1656|lyfalmen|V0066|1656|0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||495||495|1656| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|326|1425|lyfalmen|V0047|1288|00|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||326||326|1425| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|801|2075|lyfalmen|V0305|1020|00|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||801||801|2075| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1023|2378|lyfalmen|V0305|2040|00|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1023||1023|2378| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|551|1733|lyfalmen|V0439|1495|00|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||551||551|1733| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1496|3025|lyfalmen|||00|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1496||1496|3025| 073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|3965|6917|vetorma|||16|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3965||3965|6917| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|1411|2909|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1411||1411|2909| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|4955|7757|lyfalmen|V0142|7757|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4955||4955|7757| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|3831|6220|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3831||3831|6220| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007|29.02.2012|R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|10709|15628|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||10709||10709|15628| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4889|7667|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4889||4889|7667| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007|29.02.2012|R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|13811|19878|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||13811||13811|19878| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4692|7397|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4692||4692|7397|29.02.2012 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|A||0|0|E|0|DAC|0|0|1|100|GBP|425|1555|lyfalmen|V0391|1555|00|28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||421||421|1555| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007|29.02.2012|R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15502|22000|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15502||15502|22000| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|18959|25676|lyfsjukr|||00|50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||18959||18959|25676| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|511|1678|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||511||511|1678| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|731|1979|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||731||731|1979| 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|A||0|0|0|0|AGT|0|0|0|100|DKK|1150|2552|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1150||1150|2552| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|22094|38542|vetorma|||58|25|0||Vistor hf|Scan Vet Animal Health AS|||22094||22094|38542| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|435|1574|lyfalmen|V0510|1569|00|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||435||435|1574| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|794|2065|lyfalmen|V0512|2056|00|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||794||794|2065| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|A|3|0|0|B|0|AEG|0|0|0|100|GBP|1006|2355|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||1006||1006|2355| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|A|5|0|0|B|0|APT|0|0|0|100|GBP|536|1712|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||536||536|1712| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1686|2593|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1180||1180|2593| 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|A||0|0|*|0|AEG|0|0|0|100|GBP|2687|4608|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2653||2653|4608| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5217|8115|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5217||5217|8115| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15650|22186|lyfalmen|||00|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15650||15650|22186| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1872|3540|lyfalmen|||69|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1872||1872|3540| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5217|8115|lyfalmen|||00|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5217||5217|8115| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2118|2912|lyfalmen|V0363|2860|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1413||1413|2912| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15650|22186|lyfalmen|||00|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15650||15650|22186| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|XEU|1991|3702|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1991||1991|3702| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|3323|5525|lyfalmen|||00|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3323||3323|5525| 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|A||0|0|0|0|NBV|0|0|0|100|XEU|2775|4775|lyfalmen|||00|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2775|4775| 075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|35925|47631|lyfalmen|V0295|47631|00|56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||35925||35925|47631| 075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|7352|11036|lyfalmen|V0429|11036|00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||7352||7352|11036| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|14170|20328|lyfalmen|V0196|20328|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||14170||14170|20328| 075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|A||0|0|E|0|LVR|0|0|0|100|DKK|19049|26452|lyfalmen|||00|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||19049|26452| 075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|20527|28307|lyfalmen|V0289|28307|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||20527||20527|28307| 075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|6823|10312|lyfalmen|V0288|10312|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||6823||6823|10312| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|XEU|4370|5749|lyfalmen|V0445|5749|00|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3487||3487|5749| 075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|33549|43986|lyfsjukr|||00|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||33549||33549|43986| 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|125921|159913|lyfsjukr|||00|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||125921||125921|159913| 075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|104409|132916|lyfsjukr|||00|1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||104409||104409|132916| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|A|5|0|0|0|0|DEC|0|0|0|100|DKK|1021|2031|vetalmen|||16|20|0||Vistor hf|Dechra Veterinary Products A/S|||1021||1021|2031| 075787|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas||QS02CA01|01.12.1982|31.01.2012|R|A|3|0|0|0|0|DEC|0|0|0|100|DKK|2132|4241|vetalmen|||13|25|0||Vistor hf|Dechra Veterinary Products A/S|||2132||2132|4241| 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6219|8976|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6219||6219|8976| 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6219|8976|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6219||6219|8976| 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6240|9006|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6240||6240|9006| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|A||0|0|0|0|AUK|0|0|0|100|GBP|465|1615|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||465||465|1615| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|479|1634|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||479||479|1634| 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|951|1956|lyfalmen|V0449|1956|00|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||714||714|1956| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|6992|10544|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6992||6992|10544| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|DKK|23812|32429|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||23812||23812|32429| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0||Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|445|1588|lyfalmen|V0045|1588|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1986|3099|lyfalmen|V0290|3099|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SPL|0|1|0|100|DKK|940|2265|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||940||940|2265| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SPL|0|1|0|100|DKK|1316|2779|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1316|2779| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SPL|0|1|0|100|DKK|1875|3544|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1875|3544| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7593|13246|vetorma|||27|100|0||Vistor hf|Merial (MSD)|||7593||7593|13246| 076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|7420|11018|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7339||7339|11018| 076871|G01AF0202|Canesten (D.A.C.)|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|245|1314|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||245||245|1314| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|722|1967|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||722||722|1967| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|10563|11226|lyfalmen|V0029|10247|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||7491||7491|11226| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|831|2116|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||831||831|2116| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0||D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0||D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|11524|13974|lyfalmen|V0419|13974|10|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||9500||9500|13974| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|561|1746|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||561||561|1746| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|854|2147|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||854||854|2147| 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|A||0|0|0|0|FPL|0|0|1|100|XEU|1484|3009|lyfalmen|V0560|3009|02|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1484||1484|3009| 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|A||0|0|0|0|FPL|0|0|1|100|XEU|2121|3880|lyfalmen|V0561|3880|02|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2121||2121|3880| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|130305|165415|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||130305||130305|165415| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9481|6418|lyfalmen|V0069|3707|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3976||3976|6418| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2925|4222|lyfsjukr|||00|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2925||2925|4222| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4957|7154|lyfsjukr|||00|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||4957||4957|7154| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|9219|13305|lyfsjukr|||00|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||9219||9219|13305| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3885|6293|lyfalmen|||00|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3885||3885|6293| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SPL|0|1|0|100|DKK|19627|27177|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||19627||19627|27177| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|A||0|0|B|0|ACA|0|1|0|100|XEU|3543|5826|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3543||3543|5826|31.03.2012 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2204|3181|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2204||2204|3181| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577| 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|A||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|A||0|0|0|0|ANI|1|0|0|100|XEU|4258|8349|vetalmen|||27|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4258|8349| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|A||0|0|0|0|BAN|1|0|0|100|DKK|10858|18941|vetorma|||00|24|0||Icepharma hf|Bayer Animal Health GmbH|||10858||10858|18941| 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|A||0|0|*|0|RAT|0|0|0|100|XEU|17601|22565|lyfalmen|V0170|22565|00|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||15952||15952|22565| 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|A||0|0|*|0|RAT|0|0|0|100|XEU|38895|46923|lyfalmen|V0185|43772|00|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||35361||35361|46923| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2391|4250|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2391||2391|4250| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|6240|9515|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6240||6240|9515| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2816|3983|lyfalmen|V0143|2669|00|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2196||2196|3983| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|3240|5411|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3240||3240|5411| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|36239|63217|vetorma|||27|500|0||Vistor hf|Merial (MSD)|||36239||36239|63217| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|7959|8092|lyfalmen|V0143|8007|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||5200||5200|8092| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|3109|4243|lyfalmen|V0144|3621|00|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2386||2386|4243| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|15908|21847|lyfsjukr|||00|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||15908||15908|21847| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|11587|12585|lyfalmen|V0144|10862|00|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||8484||8484|12585| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|31362|41242|lyfsjukr|||00|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||31362||31362|41242| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0||Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0||Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0||Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0||Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0||Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0||Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0||Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|A||0|0|0|0|PSA|0|0|0|100|XEU|8531|12353|lyfalmen|V0515|10969|00|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||8315||8315|12353| 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|4901|7683|lyfalmen|||00|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4901||4901|7683| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1942|2803|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1942||1942|2803| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|20773|16400|lyfalmen|V0456|15698|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||11273||11273|16400| 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|6308|9608|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6308||6308|9608| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9476|13942|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9476||9476|13942| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|40278|30904|lyfalmen|V0184|28699|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||22597||22597|30904| 082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|2384|4240|lyfalmen|||20|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2384||2384|4240| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0||Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3339|5046|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2973||2973|5046| 082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5917|9073|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5917||5917|9073| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|979|2318|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||979||979|2318| 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|A||0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||| 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4981|7793|lyfalmen|||00|20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4981||4981|7793| 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5889|9035|lyfalmen|||00|20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5889||5889|9035| 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|A||0|0|0|0|AGP|0|0|0|100|XEU|9528|14013|lyfalmen|V0080|14013|00|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||9528||9528|14013| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13934|20032|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13934||13934|20032| 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|19939|27569|lyfalmen|V0186|17995|00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19939||19939|27569| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14552|20808|lyfalmen|V0344|14535|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14552||14552|20808| 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7782|11624|lyfalmen|||00|20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7782||7782|11624| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|81323|103943|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||81323||81323|103943| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|31578|42176|lyfalmen|V0346|31224|00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||31578||31578|42176| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|9029|13031|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9029||9029|13031| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|284|1367|lyfalmen|||02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||284||284|1367| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|549|1730|lyfalmen|||02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||549||549|1730| 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|K||0|1|0|1|IPI|0|0|0|100|DKK|77493|99136|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||77493||77493|99136| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|64825|83238|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||64825||64825|83238| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|84509|107941|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||84509||84509|107941| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|104549|133091|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||104549||104549|133091| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|21609|29002|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||21609||21609|29002| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|33749|44237|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||33749||33749|44237| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|43216|56119|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||43216||43216|56119| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|13384|18679|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13384|18679| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|51018|65910|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||51018|65910| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|157133|199084|lyfsjukr|||00|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||157133|199084| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|994|2339|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||994||994|2339| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11792|17110|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11792||11792|17110| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|38375|50706|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||38375||38375|50706| 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|16382|23105|lyfalmen|||10|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||16382||16382|23105| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|K|1|0|1|*|0|GAN|0|0|0|100|NOK|46828|61314|lyfalmen|||00|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||46828||46828|61314| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|2772|4771|lyfalmen|||00|15|0||Icepharma hf|Santen Oy|Levófloxacín||2772||2772|4771| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|31578|42176|lyfalmen|V0345|31224|00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||31578||31578|42176| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|822|2103|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||822||822|2103| 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|21489|29514|lyfalmen|V0412|24651|00|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||21489||21489|29514| 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|37257|49303|lyfalmen|V0412|49303|00|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||37257||37257|49303| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|A||0|1|0|1|ELD|0|0|0|100|XEU|99428|126665|lyfsjukr|||00|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||99428||99428|126665| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|K|3|0|0|0|0|AEU|0|0|0|100|DKK|42187|55490|lyfalmen|||00|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||42187||42187|55490| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998|31.03.2012|R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|4084|lyfalmen|||00|10|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Pílókarpín||2270||2270|4084| 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|A||0|0|*|0|API|0|0|0|100|SEK|3110|5233|lyfalmen|V0465|4517|00|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3110||3110|5233| 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|A||0|0|*|0|API|0|0|0|100|SEK|9191|13552|lyfalmen|V0465|13552|00|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||9191||9191|13552| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4399|5486|lyfalmen|V0364|5363|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3295||3295|5486| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5957|6377|lyfalmen|V0365|6230|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3946||3946|6377| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8653|12488|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8653||8653|12488| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|15042|20760|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15042||15042|20760| 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|31934|42622|lyfalmen|||00|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||31934||31934|42622| 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|63867|82698|lyfalmen|||00|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||63867||63867|82698| 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|56668|73001|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||56668||56668|73001| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|53146|68581|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||53146||53146|68581| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3152|5291|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3152||3152|5291| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|170141|215409|lyfsjukr|||00|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||170141||170141|215409| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|315|1410|lyfalmen|V0312|451|00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||315||315|1410| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|277|1358|lyfalmen|V0312|1354|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||277||277|1358| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2332|4169|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2332||2332|4169| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|MEC|0|0|0|100|SEK|925|2244|lyfalmen|||00|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||925||925|2244| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|3693|3246|lyfalmen|V0009|3016|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1657||1657|3246| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|11322|14531|lyfalmen|V0420|14531|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||9907||9907|14531| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|A||0|0|0|0|CHP|0|0|0|100|XEU|33195|57907|vetorma|||00|104|0||Icepharma hf|Chanelle Pharmaceuticals|||33195||33195|57907| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||| 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|A||0|0|0|0|VIR|0|0|0|100|DKK|4699|9195|vetalmen|||00|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4699||4699|9195| 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|A||0|0|0|0|CES|1|0|0|100|SEK|29571|51585|vetorma|||00|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||29571||29571|51585| 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1406|2902|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1406||1406|2902| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1613|3185|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1613||1613|3185| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|6222|9490|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6222||6222|9490| 088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|427|1563|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||427||427|1563| 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|A||0|0|B|0|LEP|0|0|0|100|DKK|5355|8304|lyfalmen|||00|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5355||5355|8304| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10345|15130|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10345||10345|15130| 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|A||0|0|B|0|LEP|0|0|0|100|DKK|15871|22463|lyfalmen|||00|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||15871||15871|22463| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|176882|223869|lyfsjukr|||00|70|0||GlaxoSmithKline ehf|Glaxo Group Limited|||||176882|223869| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|24021|29188|lyfalmen|V0421|29188|00|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||21229||21229|29188| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|6734|6786|lyfalmen|V0376|6786|06|8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4245||4245|6786| 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|A||0|0|0|0|PER|0|0|0|100|DKK|1850|3510|lyfalmen|||23|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1850||1850|3510| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|170141|215409|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||170141||170141|215409| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|A||0|0|E|0|MYD|0|0|0|100|SEK|4228|6763|lyfalmen|||00|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4228||4228|6763| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2455|4337|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2455||2455|4337| 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|1679|3276|lyfalmen|||00|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1679||1679|3276| 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|3334|5540|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3334||3334|5540| 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|A||0|0|0|0|PAD|0|0|1|100|DKK|1002|2350|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1002||1002|2350| 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|A||0|0|0|1|NOM|0|0|0|100|DKK|6136|8856|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||6136||6136|8856| 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1919|3604|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1919||1919|3604| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|915|2231|lyfalmen|||00|60|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||915||915|2231| 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|A||0|1|0|1|ACK|0|0|0|100|USD|16996|23212|lyfsjukr|||00|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||16996|23212| 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|K||0|0|0|1|PER|0|0|0|100|DKK|3011|4346|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3011||3011|4346| 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|K||0|0|0|1|PER|0|0|0|100|DKK|5205|7512|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5205||5205|7512| 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|K||0|0|0|1|PER|0|0|0|100|DKK|15272|21049|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||15272||15272|21049| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|A||1|0|0|0|NOH|0|0|0|100|DKK|3546|5830|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3546||3546|5830| 091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|K||0|1|0|1|APC|0|0|0|100|XEU|1891|2729|lyfsjukr|||00|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1891|2729| 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|K||0|1|0|1|APC|0|0|0|100|XEU|7735|11164|lyfsjukr|||00|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7735|11164| 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|A||0|0|E|0|CHA|0|0|1|100|DKK|4183|6701|lyfalmen|||00|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||4183||4183|6701| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1359|2711|lyfalmen|V0021|1954|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1266||1266|2711| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2350|3719|lyfalmen|V0022|2581|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||2003||2003|3719| 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|657|1878|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||657||657|1878| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4075|6553|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4075|6553| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|1|0|0|100|DKK|9659|18719|vetalmen|||16|100|0||Icepharma hf|Pfizer Oy Animal Health|||9659||9659|18719| 092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012||R|A||0|0|0|0|AGT|0|0|1|100|XEU|470|1622|lyfalmen|||00|8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||470||470|1622| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|8544|11548|lyfalmen|V0009|3016|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7726||7726|11548| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|A||0|0|E|0|NAS|0|0|0|100|DKK|2393|4252|lyfalmen|||05|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2393||2393|4252| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A||0|0|*|0|DAC|0|1|0|100|DKK|9752|14319|lyfalmen|V0277|14319|00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9752||9752|14319| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|25247|34230|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||25247||25247|34230| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|453|1599|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||453||453|1599| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|589|1785|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||589||589|1785| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3524|4473|lyfalmen|V0203|4473|00|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2554||2554|4473| 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|1208|2631|lyfalmen|||00|28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1208|2631| 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|2772|4771|lyfalmen|||00|28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2772|4771| 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|5387|8348|lyfalmen|||00|28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5387|8348| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7166|10782|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7166||7166|10782| 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|A||0|0|B|0|NOH|0|0|0|100|DKK|1545|3092|lyfalmen|||00|160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1545||1545|3092| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|27837|48560|vetorma|||00|100|0||Icepharma hf|Pfizer Oy Animal Health|||27837||27837|48560| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|64303|83097|lyfalmen|V0451|81749|00|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||64185||64185|83097| 093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|A||0|0|B|0|DAC|0|0|0|100|XEU|1248|2686|lyfalmen|V0496|2685|00|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1248||1248|2686| 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16977|23851|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16977||16977|23851| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|23835|32458|lyfalmen|V0183|32458|00|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||23835||23835|32458| 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|47908|62670|lyfalmen|||10|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||47908||47908|62670| 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|579159|728727|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||579159||579159|728727| 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|623724|784656|lyfsjukr|||AC|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||623724||623724|784656| 094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|5381|8340|lyfalmen|V0236|7925|00|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5381||5381|8340| 094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|7974|11887|lyfalmen|V0236|11887|00|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7974||7974|11887| 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1875|3730|vetalmen|||00|15|0||Vistor hf|Boehringer Ingelheim|||1875||1875|3730| 094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13664|19693|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13664||13664|19693| 094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|19572|27108|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19572||19572|27108| 094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|88069|113072|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||88069||88069|113072| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|84355|107748|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||84355||84355|107748| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|A||0|0|0|0|APE|0|0|1|100|XEU|49766|65001|lyfalmen|||00|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||49766|65001| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|6790|11845|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6790||6790|11845| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráđ lyf|||1577||1577|3136| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5305|5756|lyfalmen|V0143|5338|00|8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||3492||3492|5756| 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|6092|9312|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6092||6092|9312| 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18807|26148|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18807||18807|26148| 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18807|26148|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18807||18807|26148| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|2014|3734|lyfalmen|||00|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||2014||2014|3734| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|3155|5295|lyfalmen|||00|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3155||3155|5295| 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18807|26148|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18807||18807|26148| 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|A||0|0|0|1|POF|0|0|0|100|XEU|2644|3816|lyfsjukr|||00|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2644|3816| 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|A||0|0|0|1|POF|0|0|0|100|XEU|3659|5281|lyfsjukr|||00|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3659|5281| 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|A||0|0|E|0|AGP|0|0|1|100|XEU|1118|1530|lyfalmen|V0225|1530|00|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||403||403|1530| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3823|7513|vetalmen|||00|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3823||3823|7513| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5045|9860|vetalmen|||00|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5045||5045|9860| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9187|17813|vetalmen|||00|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9187||9187|17813| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2504|3614|lyfsjukr|||02|60|0||Icepharma hf|Baxter Medical AB|Mesna||2504||2504|3614| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|13454|18767|lyfsjukr|||17|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||13454||13454|18767| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|105176|133878|lyfsjukr|||17|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||105176||105176|133878| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|2124|3884|lyfalmen|||00|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2124||2124|3884| 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16916|23775|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16916||16916|23775| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|720131|905647|lyfsjukr|||0|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||720131||720131|905647| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|763377|959921|lyfsjukr|||0|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||763377||763377|959921| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|802885|1009503|lyfsjukr|||0|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||802885||802885|1009503| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|881138|1107711|lyfsjukr|||0|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||881138||881138|1107711| 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16916|23775|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16916||16916|23775| 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1381|2868|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1381||1381|2868| 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|33834|45007|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||33834||33834|45007| 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|A||0|1|E|0|SNO|0|0|0|100|NOK|19970|27607|lyfalmen|||00|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||19970||19970|27607| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|IPI|0|0|0|100|DKK|93294|118966|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||93294||93294|118966| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|28563|37729|lyfsjukr|||00|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||28563||28563|37729| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|A||0|0|0|0|AUW|1|0|0|100|XEU|8483|16461|vetalmen|||27|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8483|16461| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2304|4110|lyfalmen|V0461|4110|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2289||2289|4110| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1159|2564|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1159||1159|2564| 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998|31.03.2012|R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1||Distica|Distica - óskráđ lyf|Etoposíđ||23026||23026|30780| 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|A||0|0|0|0|PER|0|1|0|100|DKK|22148|30341|lyfalmen|V0335|6282|00|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||22148|30341| 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|A|3|0|0|0|0|PCO|0|0|1|100|DKK|2548|4464|lyfalmen|||00|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2548||2548|4464| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3373|4604|lyfalmen|V0023|2993|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||2650||2650|4604| 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4724|lyfalmen|V0233|4110|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4724| 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3601|lyfalmen|V0234|3170|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3601| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1152|2533|lyfalmen|V0329|2533|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1136||1136|2533| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|6894|3707|lyfalmen|V0072|3707|00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1994||1994|3707| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|8834|3707|lyfalmen|V0073|3707|00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1994||1994|3707| 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|632|1843|lyfalmen|||20|30|0||Icepharma hf|Bioglan AB|Flúócínólón||632||632|1843| 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|632|1843|lyfalmen|||20|30|0||Icepharma hf|Bioglan AB|Flúócínólón||632||632|1843| 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|A||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||| 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|ţpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|3144|5280|lyfalmen|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3144||3144|5280|31.01.2012 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006|31.03.2012|R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2601|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráđ lyf|Betaxólól||1186||1186|2601| 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|19561|26432|lyfsjukr|||02|25|0||Actavis Group hf|Braun|Flúmazeníl||19561||19561|26432| 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|18388|25622|lyfalmen|||02|0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||18388||18388|25622| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|102861|130973|lyfsjukr|||00|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||102861||102861|130973| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|6367|9689|lyfalmen|V0284|9689|00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||6367||6367|9689| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|14618|20789|lyfalmen|V0285|20758|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||14537||14537|20789| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|23897|32201|lyfalmen|V0286|32201|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||23630||23630|32201| 099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|3077|4148|lyfalmen|V0247|4139|00|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2317||2317|4148| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|4255|6323|lyfalmen|V0248|6315|00|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3907||3907|6323| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|8644|10587|lyfalmen|V0249|10585|00|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||7024||7024|10587| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|734|1983|lyfalmen|V0414|1983|00|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||734||734|1983| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13776|19834|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13776|19834| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13776|19834|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13776|19834| 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|A||0|0|B|0|ACA|0|1|0|100|XEU|1988|3698|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1988||1988|3698| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|13167|13913|lyfalmen|||0|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9455||9455|13913| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|18212|25401|lyfalmen|||0|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||18212||18212|25401| 101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2090|3838|lyfalmen|||00|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2090||2090|3838| 101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|6745|10206|lyfalmen|||00|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6745||6745|10206| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|1383|2871|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1383||1383|2871|31.03.2012 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|3230|5397|lyfalmen|V0331|5397|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3230||3230|5397| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|4052|4484|lyfalmen|V0088|4484|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||2562||2562|4484| 101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|A||0|0|0|0|AGP|0|1|0|100|XEU|5785|8892|lyfalmen|V0332|8892|00|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5785||5785|8892| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|4700|4563|lyfalmen|V0089|4563|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||2620||2620|4563| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|5391|8354|lyfalmen|V0227|7775|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5391||5391|8354| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|SEK|18163|35048|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||||18163|35048| 101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|A||0|0|E|0|APR|0|0|0|100|DKK|3360|5575|lyfalmen|||10|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3360|5575| 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3919|6340|lyfalmen|V0041|3735|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3919||3919|6340| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|1964|2835|lyfsjukr|||02|50|0||Vistor hf|AstraZeneca AB|Própófól||1964||1964|2835| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|3193|4608|lyfsjukr|||00|50|0||Vistor hf|AstraZeneca AB|Própófól||3193||3193|4608| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|3640|4406|lyfalmen|V0088|4394|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||2505||2505|4406| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|4606|4489|lyfalmen|V0089|4472|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||2566||2566|4489| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|XEU|3109|3707|lyfalmen|V0069|3707|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1994||1994|3707| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2652|2560|lyfalmen|V0033|2560|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1156||1156|2560| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|10493|9738|lyfalmen|V0182|9691|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||6403||6403|9738| 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|4628|6410|lyfalmen|V0334|6410|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3970||3970|6410| 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|7428|6410|lyfalmen|V0335|6410|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3970||3970|6410| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1956| 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|14623|20234|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||14623||14623|20234| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3300|5493|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3300||3300|5493| 104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2269|4083|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2269||2269|4083| 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8700|12880|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8700||8700|12880| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|4885|7661|lyfalmen|V0017|7661|56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4885||4885|7661| 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5529|8542|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5529||5529|8542| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|135101|171434|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||135101|171434| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4516|6229|lyfalmen|V0004|1856|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3838||3838|6229| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|13743|16961|lyfalmen|V0011|6512|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11683||11683|16961| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|18276|20093|lyfalmen|V0012|6512|00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13982||13982|20093| 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1286|2738|lyfalmen|V0545|2738|23|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1286||1286|2738| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4149|6655|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4149||4149|6655| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14423|20646|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14423||14423|20646| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4782|7520|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4782||4782|7520| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16635|23422|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||16635||16635|23422| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2548|4464|lyfalmen|||02|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2548||2548|4464| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3012|5099|lyfalmen|||02|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||3012||3012|5099| 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|A||0|0|0|0|RRL|0|0|0|100|DKK|1936|3627|lyfalmen|||00|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1936||1936|3627| 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|A||0|0|0|0|RRL|0|0|0|100|DKK|3872|6276|lyfalmen|||00|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3872||3872|6276| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|2801|4811|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2801||2801|4811| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|19496|26350|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19496||19496|26350| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10781|15413|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10781||10781|15413| 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|2126|2233|lyfalmen|V0278|2233|00|28|0|7,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||917||917|2233| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1652|3239|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1652||1652|3239| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|CRO|0|0|0|100|XEU|1617|2821|vetorma|||16|6|0||Portfarma ehf|Cross Vetpharm Group Ltd.|||||1617|2821| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|970|2306|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||970||970|2306| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2980|5055|lyfalmen|||63|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2980||2980|5055| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3464|5717|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3464||3464|5717| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|10282|15044|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10282||10282|15044| 108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|14433|12520|lyfalmen|V0282|9226|00|56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||8437||8437|12520| 108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1232|2664|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1232||1232|2664| 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1709|3317|lyfalmen|V0443|3315|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1709||1709|3317| 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|A||0|0|0|0|APC|0|0|0|100|XEU|2295|1856|lyfalmen|V0004|1856|00|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||641||641|1856| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25488|34533|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||25488||25488|34533| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20405|28153|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20405||20405|28153| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7922|11816|lyfalmen|||02|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7922||7922|11816| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|438|1578|lyfalmen|V0230|1578|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||438||438|1578| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987|31.03.2012|R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|401|1527|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||401||401|1527| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|543|1722|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||543||543|1722| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0||Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1616|3190|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1616||1616|3190| 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4133|6633|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4133||4133|6633| 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|A||0|1|0|1|MLD|0|0|0|100|DKK|118457|150546|lyfsjukr|||00|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||118457||118457|150546| 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|6156|7630|lyfalmen|V0373|7630|06|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4862||4862|7630| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GSH|0|0|1|100|DKK|787|2055|lyfalmen|||00|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||787||787|2055| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|22837|31206|lyfalmen|||00|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||22837||22837|31206| 112615|C01DA0201|Discotrine|forđapl|15|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994|31.03.2012|R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4392|6987|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4392||4392|6987| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8613|4544|lyfalmen|V0203|4473|00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2606||2606|4544| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8933|13199|lyfalmen|V0024|11956|00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8933||8933|13199| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|26552|35868|lyfalmen|V0024|35868|00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||26552||26552|35868| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|9049|13357|lyfalmen|V0025|12086|00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||9049||9049|13357| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4037|6501|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4037||4037|6501| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|26862|36257|lyfalmen|V0025|36257|00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||26862||26862|36257| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6918|10442|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6918||6918|10442| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|699688|879991|lyfsjukr|||00|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||699688||699688|879991| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|753|2009|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||753||753|2009| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|957|2288|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||957||957|2288| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1460|2976|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1460||1460|2976| 114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1001|2348|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1001||1001|2348| 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|55045|70964|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||55045||55045|70964| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|4338|6913|lyfalmen|||00|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4338||4338|6913| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|2475|4365|lyfalmen|V0373|2543|06|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2475||2475|4365| 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2320|4153|lyfalmen|||23|4|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2320||2320|4153| 114664|D10AD5301|Epiduo|hlaup|||30|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|A||0|0|0|0|GAN|0|0|0|100|SEK|3335|5541|lyfalmen|||00|30|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||3335||3335|5541| 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|A||0|0|0|0|GAN|0|0|0|100|SEK|6530|9912|lyfalmen|||00|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6530||6530|9912| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1999|3713|lyfalmen|||0|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1999||1999|3713| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr|||00|10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1645|3229|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1645||1645|3229| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11995|17387|lyfalmen|||0|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11995||11995|17387| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1999|3713|lyfalmen|||0|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1999||1999|3713| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11995|17387|lyfalmen|||0|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11995||11995|17387| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|1992|3704|lyfalmen|V0369|3075|06|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1992||1992|3704| 115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3872|6276|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3872||3872|6276| 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0||Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3889|5613|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3889||3889|5613| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2033|2934|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2033||2033|2934| 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|A||0|0|B|0|BLP|0|0|0|100|XEU|1241|2192|lyfalmen|V0056|2192|00|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||887||887|2192| 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|A||0|0|B|0|BLP|0|0|0|100|XEU|1965|2913|lyfalmen|V0057|2894|00|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||1414||1414|2913| 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|2728|4711|lyfalmen|||0|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2728||2728|4711| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SPL|0|0|1|100|DKK|3135|5267|lyfalmen|||0|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||3135||3135|5267| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|795|2066|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||795||795|2066| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|396|1521|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||396||396|1521| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|964|2298|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||964||964|2298| 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|18593|25879|lyfalmen|||00|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18593||18593|25879| 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|A||0|0|0|0|AGP|0|0|0|100|XEU|7918|11810|lyfalmen|V0081|11810|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7918||7918|11810| 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6336|9646|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6336||6336|9646| 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6804|10286|lyfalmen|||00|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6804||6804|10286| 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|20086|27753|lyfalmen|||00|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||20086||20086|27753| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|8666|12834|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8666||8666|12834| 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|11321|21911|vetalmen|||00|6000|0||Icepharma hf|Kela Laboratoria NV|||11321||11321|21911| 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|3473|5730|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3473||3473|5730| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4760|7490|lyfalmen|V0435|7381|00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4760||4760|7490| 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|15526|22030|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||15526|22030| 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|27441|36984|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||27441|36984| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1687|3287|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1687||1687|3287| 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4745|7470|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4745|7470| 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|47449|62094|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||47449|62094| 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|54882|71422|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||54882|71422| 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|K|1,6|0|1|0|1|JCI|0|0|0|100|SEK|69828|89517|lyfsjukr|||00|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||69828||69828|89517| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10206|17804|vetorma|||00|250|0||Icepharma hf|Bayer Animal Health GmbH|||10206||10206|17804| 117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2434|4308|lyfalmen|||61|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2434||2434|4308| 117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|5817|8936|lyfalmen|||61|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5817||5817|8936| 117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|8710|12894|lyfalmen|||61|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8710||8710|12894| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7908|15357|vetalmen|||00|1200|0||Icepharma hf|Kela Laboratoria NV|||7908||7908|15357| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|13870|26805|vetalmen|||00|6000|0||Icepharma hf|Kela Laboratoria NV|||13870||13870|26805| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4188|2547|lyfalmen|V0278|2233|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1146||1146|2547| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5953|3332|lyfalmen|V0279|2861|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1720||1720|3332| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|23088|13093|lyfalmen|V0282|9226|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||8856||8856|13093| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17638|12374|lyfalmen|V0283|12214|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||8330||8330|12374| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|2316|4147|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2316||2316|4147| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118315|M01AB0505|Voltaren|eţ-stíll|100|mg|5|stk|1|pakki||M01AB05|01.01.1986|29.02.2012|R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|379|1497|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||379||379|1497| 118323|M01AB0505|Voltaren|eţ-stíll|100|mg|50|stk|1|pakki||M01AB05|01.01.1986|29.02.2012|R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|3467|5722|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3467||3467|5722| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|981|2321|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||981||981|2321| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18151|11288|lyfalmen|V0280|11007|00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||7536||7536|11288| 118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|7909|11798|lyfalmen|V0015|11006|00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7909||7909|11798| 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|24282|33019|lyfalmen|V0015|33019|00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||24282||24282|33019| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3110|5233|lyfalmen|V0276|5233|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3110||3110|5233| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9752|14319|lyfalmen|V0277|14319|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9752||9752|14319| 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|A||0|0|B|0|AEG|0|0|0|100|XEU|512|1679|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||512||512|1679| 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|81235|103832|lyfsjukr|||00|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||81235||81235|103832| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|464477|584801|lyfsjukr|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||464477||464477|584801| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|464477|584801|lyfsjukr|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||464477||464477|584801| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|1009|2359|lyfalmen|||06|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1009||1009|2359| 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|50473|65226|lyfsjukr|||00|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||50473||50473|65226| 120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|A||0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa|||00|24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||| 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|K||0|1|0|1|SDG|0|0|0|100|DKK|33379|43773|lyfsjukr|||00|2|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||33379||33379|43773| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|A||0|0|0|0|LVR|0|0|0|100|DKK|18716|26034|lyfalmen|V0253|18223|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||18716||18716|26034| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5906|9058|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5906||5906|9058| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|9959|14373|lyfsjukr|||00|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||9959||9959|14373| 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|468|1619|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||468||468|1619| 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|8391|7965|lyfalmen|||00|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||5107||5107|7965|31.01.2012 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|425|1556|lyfalmen|V0391|1555|00|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||422||422|1556| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|1850|3510|lyfalmen|V0314|2350|00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1850||1850|3510| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|284|1367|lyfalmen|||00|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||284||284|1367| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|K||0|0|0|0|BIV|0|0|0|100|DKK|9995|17436|vetorma|||00|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9995||9995|17436| 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|579|1771|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||579||579|1771| 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|903|2214|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||903||903|2214| 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|A||0|0|0|0|ICE|0|0|0|100|USD|27686|48297|vetorma|||00|100|0||Icepharma hf|Icepharma hf|||27686||27686|48297| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.11.2005|31.01.2012|R|A|3|0|0|0|0|PCO|0|0|1|100|DKK|2447|4326|lyfalmen|||00|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2447||2447|4326| 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|257|1330|lyfalmen|||00|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||257|1330| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|49090|64153|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||49090||49090|64153| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|1910|3799|vetalmen|||00|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1910|3799| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|40973|53966|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||40973|53966| 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|A||0|0|E|0|BLP|0|0|0|100|XEU|2003|3170|lyfalmen|V0234|3170|00|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1602||1602|3170| 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|A||0|0|E|0|BLP|0|0|0|100|XEU|2860|4110|lyfalmen|V0233|4110|00|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||2289||2289|4110| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1050|2415|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1050||1050|2415| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|536|1712|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||536||536|1712| 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|10820|15780|lyfalmen|V0464|15780|00|8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10820||10820|15780| 124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|1337|1930|lyfsjukr|||00|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1337||1337|1930| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|881|1656|lyfalmen|V0066|1656|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||495||495|1656| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|15263|21700|lyfalmen|V0264|21700|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15263||15263|21700| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|118256|150294|lyfsjukr|||00|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||118256|150294| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|30348|39969|lyfsjukr|||00|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||30348|39969| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|26581|35242|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||26581||26581|35242| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8860|12787|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8860||8860|12787| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|49311|63768|lyfsjukr|||00|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||49311||49311|63768| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|98649|125687|lyfsjukr|||00|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||98649||98649|125687| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|197228|249404|lyfsjukr|||00|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||197228||197228|249404| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1084|2462|lyfalmen|V0447|2101|10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1084||1084|2462| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9137|6453|lyfalmen|V0279|2861|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4002||4002|6453| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|12907|24956|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|||12907||12907|24956| 128173|C08DA0108|Verapamil Mylan|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990|29.02.2012|R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|883|2187|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Verapamíl||883||883|2187| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1294|2749|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1294||1294|2749| 128777|N02BA5102|Treo|freyđit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4173|6023|lyfsjukr|||02|100|0||Icepharma hf|Baxter Medical AB|Mesna||4173||4173|6023| 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|32940|31393|lyfalmen|V0280|11007|00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22986||22986|31393| 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|35802|24176|lyfalmen|V0282|9226|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||17236||17236|24176| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|238|1304|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||238||238|1304| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3318| 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4598|7269|lyfalmen|||00|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4598||4598|7269| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|19424|23815|lyfalmen|V0285|20758|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16948||16948|23815| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|30746|36218|lyfalmen|V0286|32201|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||26831||26831|36218| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2442|4319|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2442||2442|4319| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4197|6720|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||4197||4197|6720| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|1909|3590|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1909||1909|3590| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|11942|17315|lyfalmen|||0|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11942|17315| 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|69306|113073|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||69306|113073| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3499|5765|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3499|5765| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|493|1653|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||493||493|1653| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|777|2042|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||777||777|2042| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1036|2396|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||1036||1036|2396| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1147|2548|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1147||1147|2548| 131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|A||0|0|E|0|LVR|0|0|0|100|XEU|2736|3968|lyfalmen|V0009|3016|00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||2185||2185|3968| 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5909|9062|lyfalmen|V0132|9062|23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5909||5909|9062| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|9411|13853|lyfalmen|V0032|12659|0|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||9411|13853| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|28232|37976|lyfalmen|V0032|37976|0|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||28232|37976| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|94106|120648|lyfalmen|||0|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||94106|120648| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|265|1259|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||205||205|1259| 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|8353|12405|lyfalmen|V0348|12290|00|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||8353||8353|12405| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9712|5499|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||3304||3304|5499| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|7783|5459|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||3275||3275|5459| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1551|3101|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1551||1551|3101| 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8117|12083|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8117||8117|12083| 132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||23|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|SAL|0|0|0|100|USD|1150|2552|lyfalmen|||06|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1150||1150|2552| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|ţpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1444|2954|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1444||1444|2954| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|29523|38934|lyfsjukr|||0|0|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||29523||29523|38934| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|39271|51168|lyfsjukr|||0|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||39271||39271|51168| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|51314|66282|lyfsjukr|||0|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||51314|66282| 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|8651|12813|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8651||8651|12813| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|96784|123346|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||96784||96784|123346| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|1588|3151|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1588||1588|3151| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4187|6707|lyfalmen|V0378|6099|00|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4187||4187|6707| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|12551|18297|lyfalmen|V0378|18297|00|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||12551||12551|18297| 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009|29.02.2012|R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|1584|2286|lyfsjukr|||0|5|0||Actavis Group hf|Actavis Group hf|Epírúbicín||1584||1584|2286| 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009|29.02.2012|R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|3827|5523|lyfsjukr|||0|10|0||Actavis Group hf|Actavis Group hf|Epírúbicín||||3827|5523| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4945|7137|lyfsjukr|||0|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4945||4945|7137| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|73667|94335|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||73667||73667|94335| 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|136494|173182|lyfsjukr|||00|30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||136494||136494|173182| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|55485|71516|lyfsjukr|||00|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||55485||55485|71516| 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|A||0|0|B|0|ADG|0|0|0|100|XEU|1935|3626|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1935||1935|3626| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|1055|2422|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1055||1055|2422| 135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2340|4180|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2340||2340|4180| 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|ţpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1739|3358|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1739||1739|3358| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|7242|10886|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7242||7242|10886| 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|K||0|1|0|1|IPI|0|0|0|100|DKK|77493|99136|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||77493||77493|99136| 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|2369|3419|lyfsjukr|||00|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2369||2369|3419| 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|7421|10710|lyfsjukr|||00|17|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7421||7421|10710| 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|5470|7895|lyfsjukr|||00|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5470||5470|7895| 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|8526|12305|lyfsjukr|||00|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8526||8526|12305| 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|6203|8952|lyfsjukr|||00|20|0||Icepharma hf|Hospira Nordic AB|Oxalíplatín||6203||6203|8952| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0||Vistor hf|Novartis Healthcare A/S-|Gervitár og ađrar óvirkar samsetningar|||||1709| 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0||Vistor hf|Novartis Healthcare A/S-|Gervitár og ađrar óvirkar samsetningar|||||2106| 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21813|29258|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21813||21813|29258| 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|XEU|6562|9471|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6562||6562|9471| 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|XEU|11016|15708|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||11016||11016|15708| 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|6260|9035|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6260||6260|9035| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|XEU|777|1121|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||777||777|1121| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1582|2283|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1582||1582|2283| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1771|3402|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1771||1771|3402| 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|A||0|0|*|0|APC|0|0|0|100|XEU|4930|7630|lyfalmen|V0373|7630|06|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4862||4862|7630| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NEH|0|0|1|100|DKK|3126|5255|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín||3126||3126|5255| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|143307|181733|lyfsjukr|||00|20|0||Vistor hf|N.V. Organon|Sugammadex||143307||143307|181733| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|358151|451362|lyfsjukr|||00|50|0||Vistor hf|N.V. Organon|Sugammadex||358151||358151|451362| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1518|3055|lyfalmen|V0266|1190|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1518||1518|3055| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|12277|17290|lyfsjukr|||02|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12277||12277|17290| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|DES|0|0|0|100|DKK|665|960|lyfsjukr|||02|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||665||665|960| 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|A||0|0|0|0|SRR|1|0|0|100|NOK|100398|192952|vetalmen|||00|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||100398||100398|192952| 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1296|2752|lyfalmen|V0413|2458|03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1296||1296|2752| 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3250|5425|lyfalmen|||00|25|0||D.A.C. ehf|D.A.C. ehf|Blöndur||3250||3250|5425|31.01.2012 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|4622|6490|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4497||4497|6490| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|21953|29434|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||21953||21953|29434| 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4025|5809|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||4025||4025|5809| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|2869|4904|lyfalmen|||00|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2869||2869|4904| 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|21191|29140|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||21191||21191|29140| 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4942|7739|lyfalmen|||0|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4942||4942|7739| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|8991|13278|lyfalmen|V0267|3366|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8991||8991|13278| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3518|5077|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3518||3518|5077| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1153|2556|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1153||1153|2556| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|3007|5092|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||3007||3007|5092| 142928|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.09.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|7391|7118|lyfalmen|||06|8|0|75,0000|D.A.C. ehf|D.A.C. ehf|Latanóprost||4488||4488|7118|31.01.2012 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1508|3042|lyfalmen|||03|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1508||1508|3042| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2369|3419|lyfsjukr|||03|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2369||2369|3419| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3974|6415|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3974||3974|6415| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|SAL|0|0|0|100|USD|950|2278|lyfalmen|||06|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||950||950|2278| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1539|3084|lyfalmen|||00|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1539||1539|3084| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1387|2876|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1387||1387|2876| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|8802|13020|lyfalmen|V0386|9911|0|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8802||8802|13020| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|631|1842|lyfalmen|||20|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||631||631|1842| 143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1257|2698|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1257||1257|2698| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2116|3873|lyfalmen|V0174|3873|00|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2116||2116|3873| 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|DKK|2182|3964|lyfalmen|||10|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2182||2182|3964| 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|23988|32650|lyfalmen|||22|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23988||23988|32650| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NAS|0|0|0|100|DKK|84242|107606|lyfsjukr|||AC|2|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||84242||84242|107606| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NAS|0|0|0|100|DKK|62963|80901|lyfsjukr|||AC|2|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||62963||62963|80901| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NAS|0|0|0|100|DKK|39121|50979|lyfsjukr|||AC|2|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||39121||39121|50979| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|682|1912|lyfalmen|||20|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||682||682|1912| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|311|1404|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||311||311|1404| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|479|1634|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||479||479|1634| 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK|89084|113683|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||89084||89084|113683| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SPL|0|0|1|100|DKK|2318|4150|lyfalmen|||20|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2318||2318|4150| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0||Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0||Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21431|20773|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||14524||14524|20773| 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|K||0|1|0|1|GGL|0|0|0|100|GBP|32009|42054|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||32009||32009|42054| 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|3169|4574|lyfsjukr|||0|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3169||3169|4574| 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|6437|9290|lyfsjukr|||0|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6437||6437|9290| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|18759|26088|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18759||18759|26088| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|938|2262|lyfalmen|V0351|1149|41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||938||938|2262| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|2627|3791|lyfsjukr|||0|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2627||2627|3791| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|1628|2350|lyfsjukr|||00|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1628||1628|2350| 147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|A||0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||| 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|118090|150748|lyfalmen|||00|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||118090||118090|150748| 148363|D11AX1901|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AX19|01.03.2012||R|A||0|1|0|0|BLT|0|0|0|100|DKK|87153|111922|lyfalmen|||00|30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||87153||87153|111922| 148374|D11AX1901|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AX19|01.03.2012||R|A||0|1|0|0|BLT|0|0|0|100|DKK|87153|111922|lyfalmen|||00|30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||87153||87153|111922| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|892|2199|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||892||892|2199| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|6606|9534|lyfsjukr|||02|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6606||6606|9534| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|13849|19263|lyfsjukr|||02|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13849||13849|19263| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|29626|39063|lyfsjukr|||00|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||29626||29626|39063| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3803|7475|vetalmen|||27|25|0||Icepharma hf|Bayer Animal Health GmbH|||3803||3803|7475| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|2204|3994|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2204||2204|3994| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2276|2661|lyfalmen|V0376|2262|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1230||1230|2661| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|16878|23727|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16878||16878|23727| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|54892|70772|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||54892|70772| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|3966|6404|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3966|6404| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|6578|9977|lyfalmen|V0120|7833|00|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6578|9977| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3795|6170|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3795|6170| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|6875|10384|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6875||6875|10384| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1265|2709|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1265||1265|2709| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|16695|23497|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16695|23497| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|51549|64158|lyfalmen|||00|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||49094||49094|64158| 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|5332|8273|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5332||5332|8273| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|5612|4521|lyfalmen|V0148|4423|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2589||2589|4521| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|1649|3235|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1649||1649|3235| 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|A||0|0|E|0|RAT|0|0|0|100|XEU|4691|5381|lyfalmen|V0006|5381|00|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||3218||3218|5381| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|2103|3035|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2103||2103|3035| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|A||0|0|0|0|DAC|0|0|0|100|XEU|2705|4675|lyfalmen|V0123|4675|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2702||2702|4675| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4093|6578|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4093||4093|6578| 152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5982|9162|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5982||5982|9162| 152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10976|15994|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10976||10976|15994| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|19692|12040|lyfalmen|V0269|11511|00|100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||8086||8086|12040| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1307|2767|lyfalmen|V0181|1517|10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1307||1307|2767| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1873|3541|lyfalmen|||17|100|0||Vistor hf|AstraZeneca A/S DK|||1873||1873|3541| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|41689|54202|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||41689|54202| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2365|4214|lyfalmen|V0561|3880|02|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2365||2365|4214| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1654|3241|lyfalmen|V0560|3009|02|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1654||1654|3241| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2395|4255|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2395||2395|4255| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|239885|302938|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||239885||239885|302938| 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|570|1759|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||570|1759| 153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|A||0|0|*|0|APC|0|0|0|100|XEU|36759|48678|lyfalmen|V0452|48678|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||36759||36759|48678| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|4515|7155|lyfalmen|V0181|5690|10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4515||4515|7155| 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|K|2|0|0|E|0|SAN|0|0|1|100|DKK|1646|3231|lyfalmen|||02|1|0|50,0000|Vistor hf|Sandoz A/S|Hýdroxókóbalamín||1646||1646|3231| 154464|D05AX5203|Xamiol|hlaup|||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4566|7225|lyfalmen|||00|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4566||4566|7225|29.02.2012 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|8488|12590|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8488||8488|12590| 154484|G04CA0102|Xatral Uno|forđatfl|10|mg|30|stk|1|ţpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3528|5805|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||3528||3528|5805| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1108|2495|lyfalmen|||10|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1108||1108|2495| 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|30571|40249|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||30571||30571|40249| 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|40053|52149|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||40053||40053|52149| 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|44007|57111|lyfsjukr|||00|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||44007||44007|57111| 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|32571|42759|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||32571||32571|42759| 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|40066|52165|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||40066||40066|52165| 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|28703|37905|lyfsjukr|||00|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||28703||28703|37905| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|3974|6415|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3974||3974|6415| 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|37425|48851|lyfsjukr|||00|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||37425||37425|48851| 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|1595|3161|lyfalmen|V0259|3161|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1595||1595|3161| 154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7918|11810|lyfalmen|V0550|7992|00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7918||7918|11810| 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|4535|6302|lyfalmen|V0334|6282|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3891||3891|6302| 154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2498|2530|lyfalmen|V0265|2530|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1134||1134|2530| 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|7278|6302|lyfalmen|V0335|6282|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3891||3891|6302| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|AUG|0|0|0|100|XEU|1647|3232|lyfalmen|||00|25|0||Aspen Europe GmbH|Aspen Europe GmbH|Chlorambucíl||1647||1647|3232| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|2318|4139|lyfalmen|V0247|4139|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2310||2310|4139| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3907|6315|lyfalmen|V0248|6315|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3901||3901|6315| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|7025|10585|lyfalmen|V0249|10585|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||7022||7022|10585| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1596|3162|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1596||1596|3162| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|683|1913|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||683||683|1913| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|7049|10622|lyfalmen|V0181|10622|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||7049||7049|10622| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|ţpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6632|10051|lyfalmen|V0018|7278|00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6632||6632|10051| 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|6138|9375|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||6138||6138|9375| 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|6190|9447|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6190||6190|9447| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|A||0|0|0|0|REP|0|0|1|100|SEK|454|1600|lyfalmen|||00|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||454||454|1600| 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|2463|3555|lyfsjukr|||00|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2463||2463|3555| 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|1444|2084|lyfsjukr|||00|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1444||1444|2084| 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|6745|9735|lyfsjukr|||00|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6745||6745|9735| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9926|14557|lyfalmen|V0018|14557|00|84|0|28,0000|Icepharma hf|Roche|Orlístat||9926||9926|14557| 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|9035|13040|lyfsjukr|||00|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||9035||9035|13040| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|911|2225|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||911||911|2225| 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7647|13340|vetorma|||16|260|0||Icepharma hf|Pfizer Oy Animal Health|||7647||7647|13340| 157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|2844|2861|lyfalmen|V0279|2861|00|28|0|14,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||1376||1376|2861| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|||3,5|g|1|túpa||S01AA30|01.01.2000|31.03.2012|R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|507|1672|lyfalmen|||07|4|1||Distica|Distica - óskráđ lyf|Oxýtetracýklín||507||507|1672| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1599|3166|lyfalmen|V0239|3166|00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1599||1599|3166| 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|1651|3237|lyfalmen|||00|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1651|3237| 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|30417|40718|lyfalmen|||00|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||30417|40718| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|997|2343|lyfalmen|V0239|1583|00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||997||997|2343| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NAS|0|0|0|100|DKK|108491|138039|lyfsjukr|||00|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||108491|138039| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NAS|0|0|0|100|DKK|216984|274197|lyfsjukr|||00|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||216984|274197| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NAS|0|0|0|100|DKK|615251|774023|lyfsjukr|||00|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||615251|774023| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|55361|71361|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||55361|71361| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|78975|100996|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||78975||78975|100996| 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|DES|0|0|0|100|DKK|860|2155|lyfalmen|||23|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||860||860|2155| 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1078|2454|lyfalmen|V0469|2454|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1078|2454| 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3533|5812|lyfalmen|V0219|5812|00|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3533||3533|5812| 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|6082|9299|lyfalmen|V0220|9299|00|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||6082||6082|9299| 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7890|11772|lyfalmen|V0221|11772|00|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7890||7890|11772| 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|9193|13554|lyfalmen|V0223|13554|00|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||9193||9193|13554| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|5440|4852|lyfalmen|V0318|2506|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2831||2831|4852| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|21295|29270|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||21295||21295|29270| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|13949|12910|lyfalmen|V0320|4154|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8722||8722|12910| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|1972|2727|lyfalmen|V0062|2040|00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1278||1278|2727| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|3415|3837|lyfalmen|V0067|1921|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2089||2089|3837| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|7036|5106|lyfalmen|V0071|2164|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3017||3017|5106| 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|487|1645|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||487||487|1645| 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1676|3272|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1676||1676|3272| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|105755|134605|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||105755||105755|134605| 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|4405|8631|vetalmen|||27|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4405||4405|8631| 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|XEU|2316|3659|lyfalmen|V0010|3401|00|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1959||1959|3659| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2385|3442|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2385||2385|3442| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|39031|50866|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||39031||39031|50866| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|56830|73204|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||56830||56830|73204| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1071|2444|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1071||1071|2444| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2484|4377|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2484||2484|4377| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|75815|97030|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||75815||75815|97030| 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1262|2705|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1262||1262|2705| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|78881|100878|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||78881||78881|100878| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PER|0|0|1|100|DKK|624|1833|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||624||624|1833| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|967|1396|lyfsjukr|||03|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||967||967|1396| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|878|1267|lyfsjukr|||03|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||878||878|1267| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|637|1850|lyfalmen|||03|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||637||637|1850| 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5250|8161|lyfalmen|V0131|8161|23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5250||5250|8161| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|63333|82028|lyfalmen|V0452|48678|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||63333||63333|82028| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998|31.03.2012|R|K|2|0|0|0|1|PER|0|0|0|100|DKK|2934|4234|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2934||2934|4234| 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|A||1|1|0|1|RBP|0|0|0|100|DKK|14925|20495|lyfsjukr|||00|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14831||14831|20495| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998|31.03.2012|R|K|2|0|0|0|1|PER|0|0|0|100|DKK|5071|7319|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5071||5071|7319| 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|K||0|1|0|1|SDG|0|0|0|100|DKK|166898|211339|lyfsjukr|||00|8|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||166898||166898|211339| 162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|A||0|0|B|0|LBK|0|1|0|100|DKK|818|2098|lyfalmen|V0512|2098|00|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||818||818|2098| 162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|A||0|0|B|0|LBK|0|1|0|100|DKK|455|1601|lyfalmen|V0510|1601|00|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||455||455|1601| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998|31.03.2012|R|K|2|0|0|0|1|PER|0|0|0|100|DKK|14880|20557|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14880||14880|20557| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|2016|3737|lyfalmen|||00|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||2016||2016|3737| 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|A||0|0|0|0|LEV|1|0|0|100|XEU|5704|11125|vetalmen|||27|5|0||Le Vet B.V.|Le Vet B.V.|||||5704|11125| 162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.03.2012||R|A||0|0|B|0|GUK|0|0|0|100|SEK|2070|3811|lyfalmen|V0041|3811|10|100|0|150,0000|Actavis Group PTC ehf|Generics UK Ltd.|Ísósorbíđ mónónítrat||2070||2070|3811| 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|A||0|0|*|0|APC|0|0|0|100|XEU|1720|3258|lyfalmen|V0373|2543|06|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1666||1666|3258| 162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|4985|4914|lyfalmen|V0148|4914|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2877||2877|4914| 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2340|4180|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2340||2340|4180| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1203|2625|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1203||1203|2625| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1805|3448|lyfalmen|V0351|3448|41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1805||1805|3448| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|213|1270|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||213|1270| 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3460|5046|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2973||2973|5046| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen|||00|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114| 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|A||0|1|0|1|JCI|0|0|0|100|SEK|364603|459459|lyfsjukr|||00|42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||364603||364603|459459| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|AUG|0|0|0|100|XEU|3628|5942|lyfalmen|||00|25|0||Aspen Europe GmbH|Aspen Europe GmbH|Merkaptópúrín||3628||3628|5942| 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4081|5890|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4081||4081|5890| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1,5|0|0|E|0|MYL|0|0|0|100|SEK|3147|5284|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3147|5284| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|10375|15171|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||10375||10375|15171| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|1086|2464|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1086||1086|2464| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|1002|2350|lyfalmen|V0314|2350|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||1002|2350| 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7687|11494|lyfalmen|V0014|11494|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7687||7687|11494| 165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eţ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|A||0|0|0|0|AGT|0|0|1|100|XEU|878|2180|lyfalmen|||00|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||878||878|2180| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7257|14107|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||7257||7257|14107| 165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4715|7429|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4715||4715|7429| 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5325|8263|lyfalmen|V0059|4089|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5325||5325|8263| 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3437|5681|lyfalmen|V0058|2934|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3437||3437|5681| 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|279837|353078|lyfsjukr|||00|8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||279837||279837|353078| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|39031|50866|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||39031||39031|50866| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|56830|73204|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||56830||56830|73204| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|737|1987|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||737||737|1987| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|213|1270|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||213||213|1270| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|A||0|0|E|0|MED|0|0|0|100|XEU|25554|28441|lyfalmen|V0341|28441|00|98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||20634||20634|28441| 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4312|6223|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4312||4312|6223| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|75815|97030|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||75815||75815|97030| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|257000|324418|lyfsjukr|||00|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||257000||257000|324418| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|4922|9624|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||4922|9624| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007|31.01.2012|R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1049|2414|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1049||1049|2414| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2037|3765|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2037||2037|3765| 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PER|0|0|0|100|DKK|15983|22604|lyfalmen|||23|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15983||15983|22604| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2332|4169|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2332||2332|4169| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|4415|7018|lyfalmen|V0428|7018|10|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4415||4415|7018| 166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|5127|7992|lyfalmen|V0550|7992|00|90|0|120,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||5127||5127|7992| 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|A||0|1|0|0|IPI|0|0|0|100|DKK|140622|179026|lyfalmen|||02|1|0||Icepharma hf|Pfizer Limited|Clostridíum||||140622|179026| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|472|1625|lyfalmen|V0333|1625|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||472||472|1625| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|651|1869|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||651|1869| 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|XEU|4962|6378|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3947||3947|6378| 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3211|5371|lyfalmen|||10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3211||3211|5371| 168761|C07AB0209|Metoprolol Actavis|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2738|4385|lyfalmen|||00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2490||2490|4385|31.03.2012 168815|N03AF0105|Tegretol Retard|forđatfl|400|mg|30|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1261|2704|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1261||1261|2704| 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5925|9084|lyfalmen|||10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5925||5925|9084| 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|56694|73033|lyfsjukr|||00|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||56694||56694|73033| 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|246493|311231|lyfsjukr|||00|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||246493||246493|311231| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|22825|30528|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||22825||22825|30528| 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5577|8608|lyfalmen|||02|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5577||5577|8608| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196|67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3102|5222|lyfalmen|||02|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3102||3102|5222| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3338|5545|lyfalmen|||02|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3338||3338|5545| 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|25552|33950|lyfsjukr|||00|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||25552|33950| 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|63417|81471|lyfsjukr|||00|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||63417|81471| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5996|9181|lyfalmen|||00|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5996||5996|9181| 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|119873|152323|lyfsjukr|||00|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||119873||119873|152323| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|DKK|4103|6592|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||4103||4103|6592| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|DKK|7181|10802|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||7181||7181|10802| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2538|4451|lyfalmen|||17|100|0||Vistor hf|AstraZeneca A/S DK|||2538||2538|4451| 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|12001|16944|lyfsjukr|||00|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||12001||12001|16944| 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|28870|38114|lyfsjukr|||00|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||28870||28870|38114| 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|43306|56232|lyfsjukr|||00|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||43306||43306|56232| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|3524|4473|lyfalmen|V0203|4473|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2554||2554|4473| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|A||0|0|E|0|POF|0|0|0|100|IKR|12363|4397|lyfalmen|V0207|4397|00|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4397| 170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|60445|77741|lyfsjukr|||00|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||60445||60445|77741| 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|A||0|0|0|0|DEC|1|0|0|100|DKK|2220|4416|vetalmen|||13|25|0||Vistor hf|Dechra Veterinary Products A/S|||2220||2220|4416| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3845|6239|lyfalmen|||17|100|0||Vistor hf|AstraZeneca A/S DK|||3845||3845|6239| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|4142|6645|lyfalmen|||17|100|0||Vistor hf|AstraZeneca A/S DK|||4142||4142|6645| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1675|3270|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|||1675||1675|3270| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4694|7400|lyfalmen|V0247|4139|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4694||4694|7400| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7726|11548|lyfalmen|V0248|6315|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7726||7726|11548| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|44651|57920|lyfsjukr|||02|75|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||44651||44651|57920| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|29768|39241|lyfsjukr|||02|50|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||29768||29768|39241| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13953|20056|lyfalmen|V0249|10585|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13953||13953|20056| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|26186|35409|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||26186||26186|35409| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|68466|87807|lyfsjukr|||02|100|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||68466||68466|87807| 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|31506|31224|lyfalmen|V0346|31224|00|112|0|74,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||22852||22852|31224| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|1|*|0|AUG|0|0|0|100|XEU|3665|5992|lyfalmen|||00|100|0||Aspen Europe GmbH|Aspen Europe GmbH|Búsúlfan||3665||3665|5992| 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|12216|17876|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||12216||12216|17876| 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6693|10135|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6693||6693|10135| 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|12434|18150|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||12434||12434|18150| 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|21572|29618|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||21572||21572|29618| 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|1466|00|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114| 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|28131|37850|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||28131||28131|37850| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|451|1596|lyfalmen|||00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||451||451|1596| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|3027|5120|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||3027||3027|5120| 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3709| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|6463|9820|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6463||6463|9820| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|ţpakki||M01AC02|01.04.1988|31.03.2012|R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1073|2447|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1073||1073|2447| 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|K||0|1|0|1|AMG|0|0|0|100|DKK|17479|23683|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||17371||17371|23683| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|371|1486|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||371||371|1486| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998|31.03.2012|R|A||0|0|0|0|PCO|0|0|0|100|SEK|3017|5106|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráđ lyf|Pyridostigmin||3017||3017|5106| 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|K||0|1|0|1|SDG|0|0|0|100|DKK|16691|22830|lyfsjukr|||00|2|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||16691||16691|22830| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998|31.03.2012|R|A||0|0|0|0|PCO|0|0|0|100|SEK|13212|19126|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráđ lyf|Pyridostigmin||13212||13212|19126| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1448|2090|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1448||1448|2090| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|709|1949|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||709||709|1949| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|725|1971|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||725||725|1971| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1872|3540|lyfalmen|V0368|2830|00|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1872||1872|3540| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|274|1354|lyfalmen|V0312|1354|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||274|1354| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5490|8489|lyfalmen|V0368|8489|00|15|0|75,0000|Vistor hf|Allergan|Brímónidín||5490||5490|8489| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2652|2560|lyfalmen|V0033|2560|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1156||1156|2560| 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|6961|5159|lyfalmen|V0278|2233|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3056||3056|5159| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986|31.03.2012|R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|841|2129|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||841||841|2129| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968| 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK|175593|222252|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||175593||175593|222252| 179171|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.02.2012||R|A||1|0|0|1|AGP|0|0|0|100|XEU|5533|7986|lyfsjukr|||00|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5533||5533|7986| 179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|A||0|0|0|0|LYF|0|0|0|100|XEU|13484|18223|lyfalmen|V0253|18223|00|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||12492||12492|18223| 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|136642|173368|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||136642||136642|173368| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5895|9043|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5895||5895|9043| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|839|2127|lyfalmen|||30|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||839||839|2127| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8467|16430|vetalmen|||16|100|0||Icepharma hf|Pfizer vet.|||8467||8467|16430| 181750|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|10292|14799|lyfsjukr|||00|10|0||Icepharma hf|Pfizer ApS|Metótrexat||10292||10292|14799| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|SEK|6169|12018|vetalmen|||16|100|0||Vistor hf|Intervet International BV|||6169||6169|12018| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5676|11071|vetalmen|||27|50|0||Vistor hf|Intervet International BV|||5676||5676|11071| 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|A||0|0|B|0|ALK|0|0|1|100|DKK|6094|9315|lyfalmen|||00|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||6094|9315| 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|A||0|1|0|1|JCI|0|0|0|100|SEK|1458402|1832177|lyfsjukr|||00|168|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1458402||1458402|1832177| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1251|2690|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1251||1251|2690| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|895|2203|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||895||895|2203| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|514|1682|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||514||514|1682| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|651|1869|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||651||651|1869| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|5173|8055|lyfalmen|V0017|7661|98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5173||5173|8055| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|22874|31252|lyfalmen|V0170|22565|00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||22874||22874|31252| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|58133|75502|lyfalmen|V0185|43772|00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||58133||58133|75502| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|1239|2674|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1239||1239|2674| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5596|8634|lyfalmen|V0235|8177|00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5596||5596|8634| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998|31.03.2012|R|A||0|0|E|0|PCO|0|0|0|100|DKK|5419|8392|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráđ lyf|Díkúmaról||5419||5419|8392| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3078|5189|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3078||3078|5189| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|USD|2067|3806|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||2067||2067|3806| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7537|10878|lyfsjukr|||00|10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7537||7537|10878| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|2626|4571|lyfalmen|||03|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2626||2626|4571| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1081|2458|lyfalmen|V0413|2458|03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1081||1081|2458| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|523|1694|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||523||523|1694| 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|A||0|1|0|1|PER|0|0|0|100|DKK|485|700|lyfsjukr|||02|1|0||Icepharma hf|Pfizer ApS|Metótrexat||485||485|700| 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|1050|2415|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1050||1050|2415| 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4066|5868|lyfsjukr|||00|100|0||Icepharma hf|Fresenius Kabi|Vítamín||4066||4066|5868| 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3873|5590|lyfsjukr|||00|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3873||3873|5590| 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|3996|5767|lyfsjukr|||00|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3996||3996|5767| 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A||0|0|E|0|PER|0|0|1|100|DKK|549|1730|lyfalmen|||07|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||549||549|1730| 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|A||0|0|B|0|AGP|0|1|0|100|XEU|4024|6484|lyfalmen|||00|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4024||4024|6484| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1691|3292|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1691||1691|3292| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|471|1623|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||471||471|1623| 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972|31.01.2012|R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|873|2173|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||873||873|2173| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|1120|1616|lyfsjukr|||02|2|0||Icepharma hf|Pfizer ApS|Metótrexat||1120||1120|1616| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972|29.02.2012|R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2077|3820|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2077||2077|3820| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1927|3615|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1927||1927|3615| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2600|4536|lyfalmen|||03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2600||2600|4536| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|826|2109|lyfalmen|||03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||826||826|2109| 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|14386|6596|lyfalmen|V0012|6382|00|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||4106||4106|6596| 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|93279|118948|lyfsjukr|||00|2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||93279||93279|118948| 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK|175593|222252|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||175593||175593|222252| 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|794|2065|lyfalmen|||20|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||794||794|2065| 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|407|1536|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||407||407|1536| 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|861|2157|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||861||861|2157| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|2462|4347|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2462||2462|4347| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1534|3077|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1534||1534|3077| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27969|36984|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||27969|36984| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2691|5340|vetalmen|||27|10|0||Icepharma hf|Intervet International B.V.|||2691||2691|5340| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|LTH|0|0|0|100|DKK|769|2031|lyfalmen|||06|10|0||Vistor hf|Laboratoires THEA|Nafazólín í blöndum međ öđrum efnum||769||769|2031|29.02.2012 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|896|2205|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||896||896|2205| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2933|4991|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2933||2933|4991| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2278|4095|lyfalmen|||00|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2278||2278|4095| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|AUG|0|0|0|100|XEU|2214|4008|lyfalmen|||00|25|0||Aspen Europe GmbH|Aspen Europe GmbH|Melphalan||2214||2214|4008| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|7506|10833|lyfsjukr|||02|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7506||7506|10833| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|426|615|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||426||426|615| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|37722|49886|lyfalmen|||00|100|0||Icepharma hf|Pfizer ApS|Estramústín||37722||37722|49886| 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|XEU|8898|12353|lyfalmen|V0515|10969|00|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8315||8315|12353| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PER|0|0|1|100|DKK|662|1884|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||662||662|1884| 199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|A||0|0|E|0|APC|0|0|0|100|XEU|8516|6382|lyfalmen|V0011|6382|00|98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3950||3950|6382| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|98512|125515|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||98512|125515| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|4884|7660|lyfalmen|V0126|7660|44|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4884||4884|7660| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|JAB|0|0|0|100|XEU|58769|75638|lyfsjukr|||00|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||58769||58769|75638| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5596|8453|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráđ lyf|||5464||5464|8453| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|705|1017|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||705||705|1017| 370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|A||0|0|E|0|APC|0|0|0|100|XEU|12851|6382|lyfalmen|V0012|6382|00|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3950||3950|6382| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|614|886|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||614||614|886| 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10388| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|ţpakki||N05AL05|01.01.2005|29.02.2012|R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|1776|3408|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||1776||1776|3408| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|6824|10314|lyfalmen|V0288|10312|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6824||6824|10314| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3826|6213|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3826||3826|6213| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2624|4568|lyfalmen|||23|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2624||2624|4568| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|20528|28308|lyfalmen|V0289|28307|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||20528||20528|28308| 373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4286|6842|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4286||4286|6842| 373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|7080|10664|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7080||7080|10664| 373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|9773|14348|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9773||9773|14348| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1653|3240|lyfalmen|V0126|1915|44|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1653||1653|3240| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|SEK|717|1960|lyfalmen|V0500|1690|00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||717||717|1960| 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|5998|8657|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5998||5998|8657| 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|ASP|0|0|0|100|XEU|4805|7552|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4805||4805|7552| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11956|17334|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11956||11956|17334| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9680|14221|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9680||9680|14221| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|11489|16695|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11489||11489|16695| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|13423|19391|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13423||13423|19391| 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|32547|43392|lyfalmen|V0459|43392|00|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||32547||32547|43392| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|21234|29194|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||21234||21234|29194| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|97298|124654|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||97298||97298|124654| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4486|7116|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4486||4486|7116| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11579|10176|lyfalmen|V0182|10176|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6723||6723|10176| 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|K||0|1|0|1|IPI|0|0|0|100|DKK|154965|196364|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||154965||154965|196364| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|120321|152885|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||120321||120321|152885| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|169525|214636|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||169525||169525|214636| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|214638|271253|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||214638||214638|271253| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1580|3140|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1580||1580|3140| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1953|3651|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1953||1953|3651| 380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|A||0|0|0|0|LYF|0|0|0|100|XEU|8752|10969|lyfalmen|V0515|10969|00|100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||7303||7303|10969| 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5849|8980|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5849||5849|8980| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7958|8007|lyfalmen|V0143|8007|00|12|0|12,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||5138||5138|8007| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7327|11002|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7327||7327|11002| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1346|2348|vetorma|||00|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1346|2348| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8109|14146|vetorma|||00|20|0||Icepharma hf|Bayer Animal Health GmbH|||8109||8109|14146| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 383990|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.11.2011|31.01.2012|R|A||0|0|0|0|NOB|1|0|0|100|XEU|3735|7344|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3735||3735|7344| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6436|7241|lyfalmen|V0144|7241|00|8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4578||4578|7241| 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|60504|78478|lyfalmen|V0184|28699|00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||60504||60504|78478| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|765|1522|vetalmen|||00|100|0||Icepharma hf|Icepharma hf|||765||765|1522| 387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|CEP|0|0|0|100|DKK|210391|265923|lyfsjukr|||00|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||210391||210391|265923| 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3483|5743|lyfalmen|||00|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3483||3483|5743| 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4391|6986|lyfalmen|||00|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4391||4391|6986| 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|8520|12634|lyfalmen|||23|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8520||8520|12634| 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|A|2|0|0|0|0|APC|0|0|0|100|XEU|839|1856|lyfalmen|V0466|1752|00|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||641||641|1856| 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2491|4386|lyfalmen|V0410|4386|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2491||2491|4386| 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2276|4092|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2276||2276|4092| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|722|1967|lyfalmen|V0128|1967|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||722||722|1967| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|668|1893|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||668||668|1893| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1018|2371|lyfalmen|V0367|1382|00|3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1018||1018|2371| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|2815|3928|lyfalmen|V0143|2669|00|4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2156||2156|3928| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|5461|3374|lyfalmen|V0267|3366|00|100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||1751||1751|3374| 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|61070|79188|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||61070||61070|79188| 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|A||0|1|*|0|APE|0|0|0|100|XEU|19573|27109|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19573||19573|27109| 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|A||0|1|0|1|ORC|0|0|0|100|DKK|86179|110037|lyfsjukr|||00|50|0||Vistor hf|Orion Corporation|Dexmedetómid||86179||86179|110037| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3069|5177|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||3069||3069|5177| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|7354|11039|lyfalmen|V0429|11036|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7354||7354|11039| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|2904|4951|lyfalmen|V0037|4951|00|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2904||2904|4951| 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|31757|42400|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||31757||31757|42400| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|14171|20330|lyfalmen|V0196|20328|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||14171||14171|20330| 391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2805|4816|lyfalmen|||00|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2805||2805|4816| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|257000|324418|lyfsjukr|||00|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||257000||257000|324418| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen|||00|50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|DKK|5905|11511|vetalmen|||16|24|0||Icepharma hf|Pfizer Oy Animal Health|||5905||5905|11511| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|4962|5793|lyfalmen|V0327|5793|00|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3519||3519|5793| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|K||0|1|0|1|AMG|0|0|0|100|DKK|156234|196734|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||155260||155260|196734| 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|SEK|29351|38860|lyfalmen|V0356|38860|00|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28936||28936|38860| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|178607|226034|lyfsjukr|||02|300|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||178607||178607|226034| 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|K||0|1|0|1|MKA|0|0|0|100|SEK|38103|49702|lyfsjukr|||00|20|0||Icepharma hf|Merck KgaA|Cetúxímab||38103||38103|49702| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|10402|14937|lyfsjukr|||00|60|0||Icepharma hf|Roche|Capecitabín||10402||10402|14937| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|59642|76733|lyfsjukr|||00|120|0||Icepharma hf|Roche|Capecitabín||59642||59642|76733| 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|A||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||00|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||| 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7997|4014|lyfalmen|V0012|3647|00|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2219||2219|4014| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|3693|3016|lyfalmen|V0009|3016|00|28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||1489||1489|3016| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3325|lyfalmen|V0244|3325|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1715||1715|3325| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|9482|13950|lyfalmen|||02|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9482||9482|13950| 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|42548|55280|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||42548||42548|55280| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1607|3177|lyfalmen|||06|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1607||1607|3177| 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0||Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5415|8386|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5415||5415|8386| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|235|1300|lyfalmen|||00|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||235||235|1300| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|426|1562|lyfalmen|||00|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||426||426|1562| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|203|1257|lyfalmen|||00|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||203||203|1257| 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|11245|16361|lyfalmen|V0459|14464|00|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||11245||11245|16361| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|797|2069|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||797||797|2069| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1275|2723|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1275||1275|2723| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|1251|2690|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1251||1251|2690| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2008|3726|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2008||2008|3726| 402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|AHP|0|0|0|100|XEU|684|1915|lyfalmen|||51|0|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||684||684|1915| 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1755|3491|vetalmen|||58|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1755||1755|3491| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|21614|24752|lyfalmen|V0470|24752|00|100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||17695||17695|24752| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5400|10541|vetalmen|||27|20|0||Vistor hf|Intervet International BV|||5400||5400|10541| 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6167|9415|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||6167||6167|9415| 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|A||0|1|0|1|PER|0|0|0|100|DKK|38851|50641|lyfsjukr|||00|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||38851|50641| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1533|3076|lyfalmen|||06|14|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1533||1533|3076| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1900| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|68430|87762|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||68430||68430|87762| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|719|1038|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||719||719|1038| 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|K||0|0|0|0|AEL|1|0|0|100|XEU|8523|16538|vetalmen|||00|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8523||8523|16538| 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1862|3526|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1862||1862|3526| 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|19841|27446|lyfalmen|||00|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19841||19841|27446| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|19045|26447|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19045||19045|26447| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|21728|29814|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21728||21728|29814| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|23815|32433|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23815||23815|32433| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|21483|29506|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21483||21483|29506| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|64772|83834|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||64772||64772|83834| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|76036|97970|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||76036||76036|97970| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|86208|110736|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||86208||86208|110736| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|6574|9972|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6574||6574|9972| 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|K||0|1|0|1|SDG|0|0|0|100|DKK|83452|106615|lyfsjukr|||00|8|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||83452||83452|106615| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2295|4118|lyfalmen|||00|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2295||2295|4118| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|1|100|DKK|176|1220|lyfalmen|||00|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||176||176|1220| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|0|100|DKK|383|1503|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||383||383|1503| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SPL|0|0|1|100|DKK|3017|5106|lyfalmen|||20|100|0||Vistor hf|Schering-Plough Europe|Betametasón||3017||3017|5106| 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SPL|0|0|1|100|DKK|2365|4214|lyfalmen|||20|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2365||2365|4214| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|4489|7120|lyfalmen|||08|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4489||4489|7120| 409326|N05CD0307|Flunipam|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.2011|31.01.2012|R|A||1|0|0|0|MYL|0|0|0|100|NOK|522|1693|lyfalmen|||00|30|1|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||522||522|1693| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3904|6319|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3904||3904|6319| 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4448|7064|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4448||4448|7064| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|13072|18951|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||13072||13072|18951| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3118|5244|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3118||3118|5244| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PAB|1|0|0|100|DKK|11125|21534|vetalmen|||27|120|0||Vistor hf|Pharmaxim AB|||11125||11125|21534| 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|A||0|0|0|0|JCI|0|1|0|100|SEK|81720|105104|lyfalmen|||00|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||81720||81720|105104| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|10593|15470|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10593||10593|15470| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1193|2611|lyfalmen|||00|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1193||1193|2611| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|815|2094|lyfalmen|||23|30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||815||815|2094| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|713|1954|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||713||713|1954| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|5121|7391|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5121||5121|7391| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|26372|34979|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||26372||26372|34979| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|ţpakki||M01AB05|01.11.1981|31.03.2012|R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1560|3113|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1560||1560|3113| 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7715|11533|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7715||7715|11533| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|23837|32461|lyfalmen|V0183|32458|00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||23837||23837|32461| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|4030|5816|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4030||4030|5816| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|8954|17366|vetalmen|||02|100|0||Vistor hf|Merial|||8954||8954|17366| 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|K||0|1|0|1|BIB|0|0|0|100|XEU|134135|170222|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||134135||134135|170222| 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|A||0|0|0|0|JCI|0|1|0|100|SEK|63557|82309|lyfalmen|||00|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||63557||63557|82309| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3582|5879|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3582||3582|5879| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4400|6998|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4400||4400|6998| 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|29837|31790|lyfalmen|V0342|30503|00|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||23303||23303|31790| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998|31.03.2012|R|K||0|0|0|0|LDR|0|0|0|100|DKK|2193|3979|lyfalmen|||00|2|1||Parlogis hf|Parlogis - óskráđ lyf|Lyf til berklarannsókna||2193||2193|3979| 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4000|6451|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4000||4000|6451| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1388|2878|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1388||1388|2878| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15746|19779|lyfalmen|V0034|19779|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||13732||13732|19779| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NAS|0|0|0|100|DKK|1994|3707|lyfalmen|||05|15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1994||1994|3707| 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|A||0|0|0|0|PSA|0|0|0|100|XEU|13484|18263|lyfalmen|V0253|18223|00|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||12524||12524|18263| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9974|9977|lyfalmen|V0088|4394|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6578||6578|9977| 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|4378|1935|lyfalmen|V0005|1897|00|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||699||699|1935| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5284|8207|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5284||5284|8207| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|5150|7433|lyfsjukr|||00|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5150||5150|7433| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3032|5127|lyfalmen|||23|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||3032||3032|5127| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|DKK|27304|36812|lyfalmen|||23|150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||27304||27304|36812| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1292|2746|lyfalmen|||00|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1292||1292|2746| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|43165|56055|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||43165||43165|56055| 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|A||0|0|E|0|BII|0|0|0|100|DKK|35985|47706|lyfalmen|V0460|47706|00|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||35985|47706| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|5213|8110|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5213||5213|8110| 418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SPL|0|0|1|100|DKK|1682|3280|lyfalmen|||20|50|0||Vistor hf|Schering-Plough Europe|Betametasón||1682||1682|3280| 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|7941|11842|lyfalmen|V0014|11494|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7941||7941|11842| 418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|24746|25430|lyfalmen|V0475|25430|00|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||18235||18235|25430| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2150|4277|vetalmen|||13|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2150||2150|4277| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2789|5528|vetalmen|||13|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2789||2789|5528| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3495|5760|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3495||3495|5760| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7474|11203|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7474||7474|11203| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|DKK|54874|70749|lyfsjukr|||00|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||54874||54874|70749| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|41639|54139|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||41639||41639|54139| 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|872|2172|lyfalmen|||20|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||872||872|2172| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|12669|18445|lyfalmen|||02|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12669||12669|18445| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1639|3221|lyfalmen|V0036|3220|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1639||1639|3221| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1589|3153|lyfalmen|V0051|2993|00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1589||1589|3153| 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3631|5946|lyfalmen|||43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3631||3631|5946| 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6257|9538|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6257||6257|9538| 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|A|2|0|1|0|1|CSB|0|0|0|100|SEK|77000|98518|lyfsjukr|||63|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||77000||77000|98518| 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7114|3823|lyfalmen|V0011|3647|0|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2079||2079|3823| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|1704|2973|vetorma|||16|24|0||Icepharma hf|Intervet International B.V.|||||1704|2973| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|847|2138|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||847||847|2138| 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|A||1|1|0|1|RBP|0|0|0|100|DKK|5015|7190|lyfsjukr|||00|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4982||4982|7190| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|709|1949|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||709||709|1949| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|925|2244|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||925||925|2244| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|903|2214|lyfalmen|||20|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||903||903|2214| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SPL|0|0|1|100|DKK|1060|2429|lyfalmen|||20|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1060||1060|2429| 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|51948|67077|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||51948||51948|67077| 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246|00|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1657||1657|3246| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|28975|29070|lyfalmen|V0344|29070|00|112|0|37,3300|Lyfis ehf|Lyfis ehf|Rívastigmín||21135||21135|29070| 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4430|7039|lyfalmen|||AC|0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4430||4430|7039| 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|43583|57242|lyfalmen|||AC|5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||43583||43583|57242| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|4292|6850|lyfalmen|||00|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4292||4292|6850| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1787|2579|lyfsjukr|||02|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1787||1787|2579| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1515|2187|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1515||1515|2187| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4701|9199|vetalmen|||27|100|0||Vistor hf|Intervet International BV|||4701||4701|9199| 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|A||0|0|*|0|WIH|0|0|0|100|XEU|30714|28699|lyfalmen|V0184|28699|00|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||20840||20840|28699| 430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|35057|46542|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||35057||35057|46542| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|3108|4102|lyfalmen|V0144|3621|00|4|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2283||2283|4102| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2571|4496|lyfalmen|||02|0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2571||2571|4496| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|800|2073|lyfalmen|||20|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||800||800|2073| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1222|2651|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1222||1222|2651| 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|A||0|1|0|1|AVS|0|0|0|100|NOK|251843|317945|lyfsjukr|||00|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||251843||251843|317945| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|1485|3010|lyfalmen|||00|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1485|3010| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|5035|7867|lyfalmen|||00|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||5035||5035|7867| 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|A||0|0|E|0|NDR|0|0|0|100|SEK|39485|52099|lyfalmen|||02|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||39485|52099| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|1205|2627|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1205||1205|2627| 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|A||0|0|0|0|NOB|1|0|0|100|XEU|3888|7638|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3888||3888|7638| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11618|16872|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11618||11618|16872| 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2717|4696|lyfalmen|||00|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2717||2717|4696| 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5948|9115|lyfalmen|||00|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5948||5948|9115| 433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|9079|13399|lyfalmen|||00|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||9079||9079|13399| 433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|621|1828|lyfalmen|||00|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||621||621|1828|31.01.2012 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1193|2081|vetorma|||99|10|0||Icepharma hf|Intervet International B.V.|||||1193|2081| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCS|0|0|1|100|SEK|942|2268|lyfalmen|||20|50|0||Vistor hf|McNeil Sweden AB|Blöndur||942||942|2268| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|MEB|0|0|1|100|DKK|6094|9315|lyfalmen|||00|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6094||6094|9315| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|MEB|0|0|1|100|DKK|6094|9315|lyfalmen|||00|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6094||6094|9315| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|XEU|10776|15720|lyfalmen|||00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10776||10776|15720| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|7050|10623|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||7050||7050|10623| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4892|7671|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4892||4892|7671| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8699|11360|lyfalmen|V0284|9689|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7589||7589|11360| 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|3558|5824|lyfalmen|V0284|5813|00|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||3542||3542|5824| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2943|5005|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2943||2943|5005| 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|248055|313192|lyfsjukr|||02|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||248055||248055|313192| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3716|6062|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3716||3716|6062| 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999|29.02.2012|R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9897|14518|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||9897||9897|14518| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|778|2043|lyfalmen|||20|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||778||778|2043| 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|254388|321139|lyfsjukr|||02|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||254388||254388|321139| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|1005|2354|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1005||1005|2354| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3676|6007|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3676||3676|6007| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|10562|10247|lyfalmen|V0029|10247|00|100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||6775||6775|10247| 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|71302|91367|lyfsjukr|||02|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||71302||71302|91367| 438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|A||0|1|0|1|BIB|0|0|0|100|XEU|34230|44841|lyfsjukr|||00|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||34230||34230|44841| 438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|6476|9838|lyfalmen|V0265|2530|00|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6476||6476|9838| 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998|31.03.2012|R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1994|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráđ lyf|Metadón||742||742|1994| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|1271|2718|lyfalmen|||00|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1271||1271|2718| 438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|3393|5620|lyfalmen|V0259|3161|00|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3393||3393|5620| 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11666|16937|lyfalmen|V0334|6282|00|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11666||11666|16937| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|A|4|0|0|0|0|SCP|0|0|1|100|DKK|1976|3682|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1976||1976|3682| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6222|9490|lyfalmen|V0362|3324|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6222||6222|9490| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|172882|218849|lyfsjukr|||00|3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||172882||172882|218849| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2863|4895|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2863||2863|4895| 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8988|13274|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8988||8988|13274| 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1555|2244|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1555||1555|2244| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2456|3545|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2456||2456|3545| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|972|2309|lyfalmen|V0046|2309|00|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||972||972|2309| 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1320|2785|lyfalmen|||20|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1320||1320|2785| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1048|2413|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1048||1048|2413| 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|A||0|0|E|0|BII|0|0|0|100|DKK|11995|17387|lyfalmen|V0460|15902|00|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11995|17387| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NAS|0|0|1|100|DKK|3622|5934|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3622||3622|5934| 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|27616|37203|lyfalmen|||10|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||27616||27616|37203| 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|7996|11917|lyfalmen|||22|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7996||7996|11917| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|DKK|3283|5470|lyfalmen|V0061|3437|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3283||3283|5470| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2390|4248|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2390||2390|4248| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1667|3259|lyfalmen|||00|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1667||1667|3259| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1519|3022|vetalmen|||27|50|0||Icepharma hf|Intervet International B.V.|||1519||1519|3022| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|11121|16192|lyfalmen|||00|4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11121||11121|16192| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6338|9649|lyfalmen|||00|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6338||6338|9649| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7845|11710|lyfalmen|||00|2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7845||7845|11710| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|9335|13749|lyfalmen|||00|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9335||9335|13749| 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|0|0|IGB|0|0|0|100|SEK|664|1887|lyfalmen|||04|10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||664||664|1887| 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1296|2752|lyfalmen|||00|30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1296||1296|2752| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2223|4020|lyfalmen|V0202|3697|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2223||2223|4020| 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|A||0|0|0|1|Bru|0|0|0|100|XEU|1202|1735|lyfsjukr|||00|0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1202||1202|1735| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1465|2983|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1465||1465|2983| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5824|8405|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5824||5824|8405| 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|K||0|0|*|0|ELI|0|0|0|100|XEU|5645|8701|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5645||5645|8701| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|2367|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|945|1811|lyfalmen|V0060|1787|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||608||608|1811| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3280|4332|lyfalmen|V0313|4239|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2451||2451|4332| 450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|7812|13628|vetorma|||16|2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||7812||7812|13628| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A||0|0|0|1|GEH|0|0|0|100|NOK|59110|76066|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||59110||59110|76066| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A||0|0|0|1|GEH|0|0|0|100|NOK|88666|113158|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||88666||88666|113158| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A||0|0|0|1|GEH|0|0|0|100|NOK|118220|150249|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||118220||118220|150249| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6013|8381|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5411||5411|8381| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|15879|22473|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15879||15879|22473| 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|A||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1220|2648|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1220||1220|2648| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|K||0|0|0|0|LHS|0|0|0|100|XEU|11705|20419|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11705||11705|20419| 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|12501|18234|lyfalmen|||00|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||12501||12501|18234| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCC|0|0|0|100|DKK|2462|4347|lyfalmen|||00|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2462||2462|4347| 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2496|4393|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2496||2496|4393| 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7337|11016|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7337||7337|11016| 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4819|7571|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4819||4819|7571| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1546|2697|vetorma|||16|6|0||Vistor hf|Merial (MSD)|||||1546|2697| 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14209|20377|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||14209||14209|20377| 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9223|13596|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||9223||9223|13596| 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|25898|35047|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||25898||25898|35047| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PER|0|1|0|100|DKK|2893|4175|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2893||2893|4175| 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dćla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2411|4277|lyfalmen|||00|0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2411||2411|4277| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|16117|22772|lyfalmen|||00|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||16117||16117|22772| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|45724|40824|lyfalmen|V0341|28441|00|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||30501||30501|40824| 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|2433|4020|lyfalmen|||00|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||2223||2223|4020|31.01.2012 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|18092|25251|lyfalmen|||00|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||18092||18092|25251| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|50377|45509|lyfalmen|V0342|30503|00|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||34234||34234|45509| 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|A||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|SKB|0|0|0|100|GBP|55618|71683|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||55618||55618|71683| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1206|2399|vetalmen|||16|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1206||1206|2399| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|1069|2441|lyfalmen|||00|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1069||1069|2441| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|3840|6232|lyfalmen|||00|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3840||3840|6232| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|23042|31463|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||23042||23042|31463| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|966|2300|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||966||966|2300| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1093|2474|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1093||1093|2474| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2266|4079|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2266||2266|4079| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999|31.03.2012|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10270|14771|lyfsjukr|||00|10000|0||Icepharma hf|Baxter|Ísótónískar lausnir||10270||10270|14771| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999|31.03.2012|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10012|14448|lyfsjukr|||00|10000|0||Icepharma hf|Baxter|Hýpertónískar lausnir||10012||10012|14448| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999|31.03.2012|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12664|17776|lyfsjukr|||00|10000|0||Icepharma hf|Baxter|Hýpertónískar lausnir||12664||12664|17776| 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|A||0|0|0|0|APC|0|0|0|100|XEU|839|1856|lyfalmen|V0003|1752|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||641||641|1856| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|CHE|0|0|1|100|SEK|1233|2666|lyfalmen|||00|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1233||1233|2666| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1515|3051|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1515||1515|3051| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|ţpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2202|3991|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2202||2202|3991| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|ţpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9109|13440|lyfalmen|V0161|13440|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9109||9109|13440| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12959|18146|lyfsjukr|||00|10000|0||Icepharma hf|Baxter|Ísótónískar lausnir||12959||12959|18146| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12959|18146|lyfsjukr|||00|10000|0||Icepharma hf|Baxter|Hýpertónískar lausnir||12959||12959|18146| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12959|18146|lyfsjukr|||00|10000|0||Icepharma hf|Baxter|Hýpertónískar lausnir||12959||12959|18146| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|25448|34482|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||25448||25448|34482| 459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|2606|2508|lyfalmen|V0278|2233|00|28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1118||1118|2508| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|900|1299|lyfsjukr|||02|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||900||900|1299| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|1648|2378|lyfsjukr|||02|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1648||1648|2378| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995|31.03.2012|R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1449|2961|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1449||1449|2961| 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995|31.03.2012|R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1353|2830|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1353||1353|2830| 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|7996|11917|lyfalmen|||22|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7996||7996|11917| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2303|4129|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2303||2303|4129| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4675|7374|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4675||4675|7374| 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4217|6748|lyfalmen|||51|0|0||Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4217||4217|6748| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|590|1786|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||590||590|1786| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992|29.02.2012|L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|7473|14522|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7473||7473|14522| 460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|AHP|0|0|0|100|XEU|5873|9013|lyfalmen|||51|5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||5873||5873|9013| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|197|1248|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||197||197|1248| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|697|1932|lyfalmen|||20|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||697||697|1932| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|697|1932|lyfalmen|||20|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||697||697|1932| 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7999|11921|lyfalmen|||56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7999||7999|11921| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|12707|18492|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12707||12707|18492| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7046|13702|vetalmen|||02|20|0||Icepharma hf|Pfizer Oy Animal Health|||||7046|13702| 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|9365|13790|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9365||9365|13790| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5620|10964|vetalmen|||00|100|0||Icepharma hf|Pfizer Oy Animal Health|||5620||5620|10964| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPL|0|1|0|100|DKK|1860|3523|lyfalmen|||00|100|0|8,3333|Swedish Orphan Biovitrum A/S|Lundbeck Pharmaceuticals|Melperón||1860||1860|3523| 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|K||0|0|*|0|APC|0|0|0|100|DKK|4286|6786|lyfalmen|V0376|6786|06|8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4245||4245|6786| 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1248|2482|vetalmen|||58|100|0||Icepharma hf|Intervet International B.V.|||1248||1248|2482| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1179|2345|vetalmen|||58|100|0||Icepharma hf|Intervet International B.V.|||1179||1179|2345| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1264|2514|vetalmen|||27|100|0||Icepharma hf|Intervet International B.V.|||1264||1264|2514| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|665|1323|vetalmen|||16|12|0||Icepharma hf|Intervet International B.V.|||665||665|1323| 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|701|1938|lyfalmen|||10|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||701||701|1938| 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2170|3947|lyfalmen|||10|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2170||2170|3947| 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1553|3103|lyfalmen|||10|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1553||1553|3103| 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|6071|9284|lyfalmen|||10|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||6071||6071|9284| 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2888|4930|lyfalmen|||10|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2888||2888|4930| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8319|12359|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8319||8319|12359| 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|4752|7479|lyfalmen|||10|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4752||4752|7479| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4772|7507|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4772||4772|7507| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|16048|22023|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||16048||16048|22023| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|24594|32748|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||24594||24594|32748| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|19425|26261|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||19425||19425|26261| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|31330|41202|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||31330||31330|41202| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|35599|47222|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||35599||35599|47222| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|16230|22914|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16230||16230|22914| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|58269|75010|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||58269||58269|75010| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|30903|41328|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||30903||30903|41328| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|531|766|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||531||531|766| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6735|6949|lyfalmen|V0317|4676|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4364||4364|6949| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|404|583|lyfsjukr|||02|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||404||404|583| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|9806|6619|lyfalmen|V0318|4475|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4123||4123|6619| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|24778|13378|lyfalmen|V0320|7418|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9064||9064|13378| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|4530|4397|lyfalmen|V0207|4397|00|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2499||2499|4397| 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|A||0|0|E|0|APC|0|0|0|100|XEU|4650|6503|lyfalmen|V0467|6129|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||4038||4038|6503| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5921|9079|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5921||5921|9079| 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|7973|11507|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7973||7973|11507| 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6631|10050|lyfalmen|V0228|10027|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6631||6631|10050| 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|5392|8355|lyfalmen|V0227|7775|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5392||5392|8355| 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3520|5794|lyfalmen|V0226|5079|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3520||3520|5794| 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6134|9370|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6134||6134|9370| 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|A||0|1|0|1|ORC|0|0|0|100|DKK|32484|42650|lyfsjukr|||00|16|0||Vistor hf|Orion Corporation|Dexmedetómid||32484||32484|42650| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|7704|11119|lyfsjukr|||02|150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7704||7704|11119| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|10282|14786|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10282||10282|14786| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|10273|14775|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10273||10273|14775| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|14753|20398|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||14753||14753|20398| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|1280|2730|lyfalmen|||68|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1280||1280|2730| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|2233|3895|vetorma|||99|20|0||Icepharma hf|Intervet International B.V.|||||2233|3895| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|3498|5764|lyfalmen|||00|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3498||3498|5764| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5003|9779|vetalmen|||27|10|0||Vistor hf|Orion Corporation|||5003||5003|9779| 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2231|4031|lyfalmen|||43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2231||2231|4031| 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3272|5455|lyfalmen|||02|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3272||3272|5455| 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|14498|6512|lyfalmen|V0012|6382|00|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||4045||4045|6512| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|16280|22314|lyfsjukr|||00|400|0||Vistor hf|Meda AB|Dextran||16280||16280|22314| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1074|2448|lyfalmen|||00|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1074||1074|2448| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|38392|50064|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||38392||38392|50064| 474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|15130|15698|lyfalmen|V0456|15698|00|28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||10760||10760|15698| 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SPL|0|0|1|100|DKK|1945|3640|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1945||1945|3640| 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|S||0|0|0|0|PHM|0|0|0|100|DKK|29046|55945|vetalmen|||02|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||29046|55945| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|838|1224|lyfalmen|V0266|1190|00|30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||179||179|1224| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|930|2251|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2251| 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3349|5560|lyfalmen|V0130|5560|23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3349||3349|5560| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|308|1400|lyfalmen|||00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||308||308|1400| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|376|1493|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||376||376|1493| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|1050|2415|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1050||1050|2415| 475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3857|6255|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3857||3857|6255| 475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|5081|7929|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||5081||5081|7929| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5850|8981|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5850||5850|8981| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|6321|9626|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6321||6321|9626| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|81415|104058|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||81415|104058| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1202|2623|lyfalmen|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1202||1202|2623| 476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|12446|9226|lyfalmen|V0282|9226|00|56|0|56,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||6029||6029|9226| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|5389|8351|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5389||5389|8351| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|A||0|0|*|0|APC|0|0|0|100|XEU|520|1690|lyfalmen|V0500|1690|00|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||520||520|1690| 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|A||0|1|*|0|WIL|0|0|0|100|XEU|30791|41188|lyfalmen|V0454|41188|00|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||30791||30791|41188| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|ţpakki||C09AA07|01.07.1991|29.02.2012|R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|9916|14543|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||9916||9916|14543| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|ţpakki||C09AA07|01.07.1991|29.02.2012|R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|20722|28551|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||20722||20722|28551| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|ţpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4395|6991|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4395||4395|6991| 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|27467|29600|lyfalmen|V0341|28441|00|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||21558||21558|29600| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|13310|19249|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13310||13310|19249| 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|14529|20779|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14529||14529|20779| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2913|4204|lyfsjukr|||00|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2913||2913|4204| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|5028|7257|lyfsjukr|||00|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||5028||5028|7257| 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|K||0|0|*|0|POF|0|0|0|100|DKK|2547|4463|lyfalmen|V0374|4463|06|2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2547||2547|4463| 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|A||0|0|E|0|AGP|0|0|1|100|XEU|305|1284|lyfalmen|V0055|1284|00|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||223||223|1284| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|60092|77298|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||60092||60092|77298| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|6244|9520|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||6244||6244|9520| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|K||0|1|0|1|AEU|0|0|0|100|DKK|160833|203728|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||160833||160833|203728| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1446|2957|lyfalmen|||00|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1446||1446|2957| 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|A||0|1|*|0|APE|0|0|0|100|XEU|58717|76235|lyfalmen|||00|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||58717||58717|76235| 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|A||0|0|E|0|ANS|0|0|1|100|XEU|1303|2761|lyfalmen|||07|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1303||1303|2761| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|SAL|0|0|1|100|USD|485|1642|lyfalmen|||29|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||485||485|1642| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|693|1927|lyfalmen|||29|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||693||693|1927| 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|4962|5793|lyfalmen|V0326|5793|00|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3519||3519|5793| 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|A||0|1|*|0|WIL|0|0|0|100|XEU|34388|45702|lyfalmen|V0453|45702|00|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||34388||34388|45702| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1000|2347|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||1000||1000|2347| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2780|4782|lyfalmen|V0198|3949|00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2780||2780|4782| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6601|10009|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6601||6601|10009| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|11872|17219|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11872||11872|17219| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|108525|138081|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||108525|138081| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|463|67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1389|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618| 490417|G03FB0504|Evorel Sequi|forđapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2502|4402|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2502||2502|4402| 490425|G03FA0104|Evorel Conti|forđapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2637|4586|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2637||2637|4586| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4157|6665|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4157||4157|6665| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|11377|11070|lyfalmen|V0112|2527|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7377||7377|11070| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5526|8538|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5526||5526|8538| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|16145|15024|lyfalmen|V0113|3246|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10267||10267|15024| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|20534|18805|lyfalmen|V0114|6047|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12956||12956|18805| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|51879|66991|lyfsjukr|||00|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||51879||51879|66991| 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3449|5697|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3449||3449|5697| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13221|19137|lyfalmen|V0002|7295|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||13221||13221|19137| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|XEU|25147|34105|lyfalmen|V0516|32049|00|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||25147||25147|34105| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1513|3049|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1513||1513|3049| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2593|4526|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2593||2593|4526| 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|84930|108470|lyfsjukr|||00|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||84930||84930|108470| 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|212326|268352|lyfsjukr|||00|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||212326||212326|268352| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2116|3873|lyfalmen|||00|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2116||2116|3873| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NAS|0|0|0|100|DKK|2373|4225|lyfalmen|V0128|1967|23|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2373||2373|4225| 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NAS|0|0|0|100|DKK|3449|5697|lyfalmen|V0410|4386|23|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3449||3449|5697| 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1961|3661|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1961||1961|3661| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|19369|26853|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||19369||19369|26853| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7533|8746|lyfalmen|V0382|6650|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5678||5678|8746| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10763|13418|lyfalmen|V0383|10423|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9093||9093|13418| 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2955|5021|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2955||2955|5021| 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|31506|31224|lyfalmen|V0345|31224|00|112|0|56,0000|Lyfis ehf|Lyfis ehf|Rívastigmín||22852||22852|31224| 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4440|8698|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||||4440|8698| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|AUG|0|0|0|100|GBP|6146|9386|lyfalmen|||02|100|0|0,8333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||6146||6146|9386| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|AUG|0|0|0|100|GBP|1078|2454|lyfalmen|||00|50|0|8,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||1078||1078|2454| 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|K||0|1|0|1|SOI|0|0|0|100|DKK|90315|115228|lyfsjukr|||00|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||90315||90315|115228| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|AUG|0|0|0|100|GBP|3382|5605|lyfalmen|||00|100|0|33,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||3382||3382|5605| 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|492|1652|lyfalmen|||04|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||492||492|1652| 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|889|2195|lyfalmen|||00|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||889||889|2195| 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|3391|5618|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3391||3391|5618| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|356|1466|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||356||356|1466| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|528|1449|lyfalmen|V0448|1449|00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||344||344|1449| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1098|1956|lyfalmen|V0449|1956|00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||714||714|1956| 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|1578|3075|lyfalmen|V0369|3075|06|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1532||1532|3075| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|1430|2935|lyfalmen|||03|2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1430||1430|2935| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|17815|24903|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17815||17815|24903| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|19003|26394|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||19003||19003|26394| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|23672|32254|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||23672||23672|32254| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|28598|38436|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||28598||28598|38436| 501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2920|4973|lyfalmen|||67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2920||2920|4973| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3216|5378|lyfalmen|V0434|4622|10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3216||3216|5378| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AML|0|1|0|100|DKK|3135|5267|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||3135||3135|5267| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|31621|41567|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||31621||31621|41567| 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|6948|7397|lyfalmen|||00|28|0|4,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||4692||4692|7397| 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|1735|3352|lyfalmen|V0494|3352|00|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1735||1735|3352| 504191|N02BA5102|Treo|freyđit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2145|3913|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2145||2145|3913| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1219|2646|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1219||1219|2646| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AML|0|1|0|100|DKK|8625|12777|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8625||8625|12777| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|1896|2736|lyfsjukr|||02|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1896||1896|2736| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|3786|5464|lyfsjukr|||02|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3786||3786|5464| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|8640|12470|lyfsjukr|||02|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8640||8640|12470| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2589|4521|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2589||2589|4521| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|420|1553|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||420||420|1553| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|692|1207|vetorma|||16|24|0||Icepharma hf|Pfizer Oy Animal Health|||||692|1207| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2943|5134|vetorma|||16|120|0||Icepharma hf|Pfizer Oy Animal Health|||||2943|5134| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|16893|29469|vetorma|||13|1000|0||Icepharma hf|Intervet International B.V.|||16893||16893|29469| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2641|5244|vetalmen|||27|50|0||Vistor hf|Intervet International BV|||2641||2641|5244| 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2686|4653|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2686||2686|4653| 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5368|10480|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|||||5368|10480| 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4305|8439|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|||4305||4305|8439| 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13320|25749|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|||13320||13320|25749| 508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|A||0|1|0|1|SAA|0|0|0|100|NOK|774061|973329|lyfsjukr|||00|15|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||774061||774061|973329| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|9554|14048|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9554||9554|14048| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2913| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|50095|64752|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||50095||50095|64752| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|17480|23820|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||17480||17480|23820| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|26166|34721|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||26166||26166|34721| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|42920|55747|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||42920||42920|55747| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|84877|108403|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||84877||84877|108403| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|197074|249210|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||197074|249210| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4370|5749|lyfalmen|V0445|5749|00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3487||3487|5749| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2847|4873|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2847||2847|4873| 511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|38151|44002|lyfalmen|V0540|44002|00|28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||33033||33033|44002| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NAS|0|0|0|100|DKK|2828|4847|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2828||2828|4847| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|24490|32617|lyfsjukr|||00|6000|0||Vistor hf|Meda AB|Dextran||24490||24490|32617| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15320|21109|lyfsjukr|||00|6000|0||Vistor hf|Meda AB|Dextran||15320||15320|21109| 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|4962|6059|lyfalmen|V0325|5805|00|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3714||3714|6059| 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5520|7967|lyfsjukr|||00|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5520||5520|7967| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|23988|32650|lyfalmen|||22|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23988||23988|32650| 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|2222|4420|vetalmen|||27|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2222||2222|4420| 514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2146|3915|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2146||2146|3915| 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|A||0|0|B|0|ADG|0|0|0|100|XEU|2194|3980|lyfalmen|||00|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2194||2194|3980| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|4639|4477|lyfalmen|||00|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2557||2557|4477| 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|10,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2649| 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|20,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2663| 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|0|0|APC|0|0|0|100|XEU|5698|8773|lyfalmen|V0010|7287|00|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||5698||5698|8773| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NAS|0|0|0|100|DKK|3103|5224|lyfalmen|V0462|3366|00|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3103||3103|5224| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NAS|0|0|0|100|DKK|3379|5601|lyfalmen|V0471|3646|00|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3379||3379|5601| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NAS|0|0|0|100|DKK|3633|5949|lyfalmen|V0472|3841|00|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3633||3633|5949| 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|964|2298|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||964||964|2298| 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3552|5838|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3552||3552|5838| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2190|3975|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2190||2190|3975| 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|13392|19352|lyfalmen|V0286|19321|00|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||13392||13392|19352| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1160|2566|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1160||1160|2566| 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|A||0|0|0|0|AEG|0|0|1|100|SEK|1738|3356|lyfalmen|||01|100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1738||1738|3356| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|7627|11412|lyfalmen|V0431|9917|02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||7627||7627|11412| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5056|7895|lyfalmen|V0142|7757|00|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5056||5056|7895| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5710|8790|lyfalmen|V0143|2669|00|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5710||5710|8790| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|16089|22737|lyfalmen|V0143|8007|00|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16089||16089|22737| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|6124|9356|lyfalmen|V0144|3621|00|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||6124||6124|9356| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|16944|23810|lyfalmen|V0144|10862|00|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16944||16944|23810| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2298|lyfalmen|V0056|2192|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||964||964|2298| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3068|lyfalmen|V0057|2894|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||1527||1527|3068| 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|374|1491|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||374||374|1491| 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1752| 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1761| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|33679|44812|lyfalmen|V0269|11511|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||33679||33679|44812| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998|31.03.2012|R|A||0|1|0|1|PCO|0|0|0|100|IKR|11102|15816|lyfsjukr|||00|100|1||Distica|Distica - óskráđ lyf|Hýdroxýkarbamíđ||11102||11102|15816| 521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|18290|25499|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||18290||18290|25499| 521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3165|3678|lyfalmen|V0471|3646|00|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1973||1973|3678| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8811|17091|vetalmen|||16|320|0||Vistor hf|Boehringer Ingelheim Danmark|||8811||8811|17091| 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2396|4257|lyfalmen|||AC|0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2396||2396|4257| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|195350|247047|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||195350||195350|247047| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|SEK|349|1456|lyfalmen|V0055|1284|00|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||349||349|1456| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|SEK|414|1545|lyfalmen|V0225|1530|00|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||414||414|1545| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|DKK|2908|4957|lyfalmen|||00|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2908||2908|4957| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|DKK|414|1545|lyfalmen|||02|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||414||414|1545| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörđ|D05AX02|01.12.2001|29.02.2012|R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7241|10884|lyfalmen|||00|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól||7241||7241|10884| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|480|1636|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||480||480|1636| 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1357|2835|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1357||1357|2835| 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|467|1618|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||467||467|1618| 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2944|5006|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2944||2944|5006| 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5951|00|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983|31.03.2012|L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1273| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1995|3968|vetalmen|||00|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1995||1995|3968| 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|917|2233|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||917||917|2233| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|812|2090|lyfalmen|||00|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||812||812|2090| 525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|A||0|0|E|0|LVR|0|0|0|100|IKR|4621|5533|lyfalmen|V0006|5381|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||3329||3329|5533| 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1564|3118|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1564||1564|3118| 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5212|8109|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5212||5212|8109| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|11378|16543|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||11378||11378|16543| 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5684|8203|lyfsjukr|||00|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5684||5684|8203| 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5175|7469|lyfsjukr|||00|1000|0||Actavis Group hf|Braun|Natríumklóríđ||5175||5175|7469| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|4680|7381|lyfalmen|V0435|7381|00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4680||4680|7381| 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4352|6932|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4352||4352|6932| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|6999|13612|vetalmen|||16|188|0||Vistor hf|Intervet International BV|||6999||6999|13612| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3723|6072|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3723||3723|6072| 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|A||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||00|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|16408|22475|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||16408||16408|22475| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1283|2734|lyfalmen|||00|5|0||K.Pétursson hf|Alcon|Emedastín||1283||1283|2734| 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|SEK|10301|14174|lyfalmen|V0356|12953|00|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9646||9646|14174| 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|A|1,5|0|0|0|0|PAL|0|0|0|100|DKK|4716|9228|vetalmen|||16|72|0||Icepharma hf|Pfizer Oy Animal Health|||4716||4716|9228| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5014|9800|vetalmen|||16|100|0||Icepharma hf|Pfizer Oy Animal Health|||5014||5014|9800| 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|71984|92222|lyfsjukr|||00|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||71984||71984|92222| 529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|A||0|0|*|0|BLP|0|0|0|100|XEU|29812|29820|lyfalmen|V0184|28699|00|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||21733||21733|29820| 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|A||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||00|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7128| 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|A||0|0|*|0|BLP|0|0|0|100|XEU|12311|17995|lyfalmen|V0186|17995|00|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||12311||12311|17995| 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NAS|0|0|0|100|DKK|3256|5433|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3256||3256|5433| 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|6258|9032|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6258||6258|9032| 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3118|5244|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3118||3118|5244| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|8605|12419|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8605||8605|12419| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|21197|17941|lyfalmen|V0187|17790|00|50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||12268||12268|17941| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|689|1921|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||689||689|1921| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|364|1477|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||364||364|1477| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1058|2426|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1058||1058|2426| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|293|1380|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||293||293|1380| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1865|3530|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1865||1865|3530| 533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|15148|12303|lyfalmen|V0283|12214|00|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||8278||8278|12303| 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2114|3871|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2114||2114|3871| 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|3408|3270|lyfalmen|V0279|2861|00|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1675||1675|3270| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7024|10587|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||7024||7024|10587| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|452|1597|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||452||452|1597| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|577|1768|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||577||577|1768| 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|IKR|12900|18735|lyfalmen|V0115|18735|00|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18735| 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|A||0|0|0|0|JCI|0|1|0|100|SEK|113324|144767|lyfalmen|||00|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||113324||113324|144767| 536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|A||0|1|0|1|BIB|0|0|0|100|XEU|68460|87800|lyfsjukr|||00|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||68460||68460|87800| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|618|1078|vetorma|||16|2|0||Icepharma hf|Pfizer Oy Animal Health|||||618|1078| 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|6628|9566|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6628||6628|9566| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2481| 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|141586|179573|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||141586||141586|179573| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|11259|16381|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||11259||11259|16381| 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|8407|12455|lyfalmen|V0285|12455|00|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||8389||8389|12455| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|232|1296|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||232||232|1296| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|575|1765|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||575||575|1765| 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||20|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1885|3557|lyfalmen|||23|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1885||1885|3557| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2927|4983|lyfalmen|||00|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2927||2927|4983| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|6175|9426|lyfalmen|V0373|7630|06|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||6175||6175|9426| 541060|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2104|3857|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2104||2104|3857| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9984|14637|lyfalmen|V0199|14637|10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9984||9984|14637| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|16172|22841|lyfalmen|V0200|22841|10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||16172||16172|22841| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|6156|8885|lyfsjukr|||00|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||6156||6156|8885| 542803|C08DA0103|Isoptin retard|forđatfl|240|mg|28|stk|1|ţpakki||C08DA01|01.10.1993|31.03.2012|R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1531|3073|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1531||1531|3073| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|3052|5154|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||3052||3052|5154| 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|2321|3258|lyfalmen|V0373|2543|06|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1666||1666|3258| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|7726|8262|lyfalmen|V0457|8262|00|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5324||5324|8262| 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|A||0|1|0|1|MLD|0|0|0|100|DKK|539281|678680|lyfsjukr|||00|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||539281||539281|678680| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A|3|0|1|*|0|ASP|0|0|0|100|XEU|13627|19647|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13627||13627|19647| 544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|1024|2303|lyfalmen|V0005|474|00|7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||968||968|2303| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1020|2374|lyfalmen|||00|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1020||1020|2374| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|950|2278|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||950||950|2278| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|2344|4185|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2344||2344|4185| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|31734|42371|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||31734||31734|42371| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|25586|34656|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||25586||25586|34656| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|31921|42606|lyfalmen|||02|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||31921||31921|42606| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27118|36578|lyfalmen|||02|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||27118||27118|36578| 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|1195|2614|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1195||1195|2614| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001|31.03.2012|R|A||0|0|E|0|LDR|0|0|0|100|DKK|8449|12537|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráđ lyf|Ísókarboxasíđ||8449||8449|12537| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791| 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|3583|2191|lyfalmen|V0004|1856|00|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||886||886|2191| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10697|15307|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10697||10697|15307| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3525|5087|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3525||3525|5087| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|8188|12180|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||8188||8188|12180| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|ţpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|5740|8831|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5740||5740|8831| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|16518|23275|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||16518||16518|23275| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|99268|126464|lyfsjukr|||17|1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||99268||99268|126464| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9961|14605|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9961||9961|14605| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|146995|186361|lyfsjukr|||17|1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||146995||146995|186361| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2233|4034|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir mótefnavakar||2233||2233|4034| 550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|11827|11007|lyfalmen|V0280|11007|00|56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||7331||7331|11007| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|11239|16353|lyfalmen|V0235|16353|00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||11239||11239|16353| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1919|3604|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1919||1919|3604| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4096|6582|lyfalmen|V0198|6582|00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4096||4096|6582| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1752|00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|3432|00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|1516|3053|lyfalmen|V0003|876|00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1516||1516|3053| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1752|00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|3401|00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|A||0|0|0|0|LYF|0|0|0|100|XEU|25147|34105|lyfalmen|V0516|32049|00|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||25147||25147|34105| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAP|0|0|0|100|SEK|3744|6101|lyfalmen|||63|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3744||3744|6101| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|5283|8206|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5283||5283|8206| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3455|5705|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3455||3455|5705| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3124|5252|lyfalmen|||00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3124||3124|5252|29.02.2012 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PER|0|0|0|100|DKK|12602|18361|lyfalmen|V0237|18361|00|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12602|18361| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|4310|6875|lyfalmen|V0237|6120|00|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4310||4310|6875| 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7988|15511|vetalmen|||27|500|0||Vistor hf|Boehringer Ingelheim Danmark|||7988||7988|15511| 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|28007|37031|lyfsjukr|||00|1|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||28007||28007|37031| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5119|7981|lyfalmen|||00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5119||5119|7981| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6962|10503|lyfalmen|V0242|7315|00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6962||6962|10503| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9979|14630|lyfalmen|V0242|14630|00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9979||9979|14630| 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1673|3267|lyfalmen|||38|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1673||1673|3267| 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|294654|371673|lyfsjukr|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||294654|371673| 559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|889|2195|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||889||889|2195| 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2040|3770|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2040||2040|3770| 559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|692|1926|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||692||692|1926| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1637|3218|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1637||1637|3218| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6010|9200|lyfalmen|||23|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||6010||6010|9200| 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3668|5997|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3668||3668|5997| 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|13895|19321|lyfsjukr|||00|240|0||Icepharma hf|Baxter|Desflúran||13895||13895|19321| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1443| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3187|5339|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3187||3187|5339| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||20|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1586|3148|lyfalmen|||07|4|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1586||1586|3148| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6074|9288|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6074||6074|9288| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6586|9988|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6586||6586|9988| 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|105228|133944|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||105228||105228|133944| 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|486648|612626|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||486648||486648|612626| 561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|5886|9031|lyfalmen|||00|63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5886||5886|9031| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1798|3438|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1798||1798|3438| 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|A||0|0|B|0|APC|0|0|0|100|XEU|2617|4559|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2617||2617|4559| 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|K||0|1|0|1|GGL|0|0|0|100|GBP|106696|135786|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||106696||106696|135786| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|22216|30426|lyfalmen|V0431|29751|02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||22216||22216|30426| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|37482|49585|lyfalmen|V0431|49585|02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||37482||37482|49585| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|785|2053|lyfalmen|||20|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||785||785|2053| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|709|1949|lyfalmen|||20|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||709||709|1949| 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1450|2962|lyfalmen|||10|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1450||1450|2962| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|216102|273753|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||216102||216102|273753| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3752|6111|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3752||3752|6111| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3890|6300|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3890||3890|6300| 563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|11909|20775|vetorma|||00|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||11909||11909|20775| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|85957|109759|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||85957||85957|109759| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||01|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12125|17762|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||12125||12125|17762| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1433|2939|lyfalmen|V0444|2254|06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1433||1433|2939| 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000|29.02.2012|R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|74379|95228|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||74379||74379|95228| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2415|4282|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2415||2415|4282| 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|A||0|1|0|1|GGL|0|0|0|100|GBP|215329|272120|lyfsjukr|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||215329||215329|272120| 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|A||0|0|B|0|ALK|0|0|1|100|DKK|6094|9315|lyfalmen|||00|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||6094|9315| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|3523|5798|lyfalmen|V0291|3373|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3523||3523|5798| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|7130|10732|lyfalmen|V0292|5566|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7130||7130|10732| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|10421|15234|lyfalmen|V0293|8178|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10421||10421|15234| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13685|19720|lyfalmen|V0294|10467|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13685||13685|19720| 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1139|2537|lyfalmen|||00|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1139||1139|2537| 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|XEU|1473|2994|lyfalmen|V0058|2994|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1473||1473|2994| 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|XEU|2334|4172|lyfalmen|V0059|4172|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2334||2334|4172| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|18046|24530|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||18046||18046|24530| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|20750|27924|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||20750||20750|27924| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|A||0|1|*|0|APE|0|0|0|100|XEU|88069|113072|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||88069||88069|113072| 572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|XEU|13484|19468|lyfalmen|V0253|18223|00|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||13484||13484|19468| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|167726|212379|lyfsjukr|||00|5|0||Icepharma hf|Baxter|Fíbrínógen manna||167726||167726|212379| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|199019|251651|lyfsjukr|||00|10|0||Icepharma hf|Baxter|Fíbrínógen manna||199019||199019|251651| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|419099|527852|lyfsjukr|||00|20|0||Icepharma hf|Baxter|Fíbrínógen manna||419099||419099|527852| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|10904|6512|lyfalmen|V0011|6382|00|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||4045||4045|6512| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|5300|8229|lyfalmen|V0245|8229|00|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||5300||5300|8229| 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|3676|6007|lyfalmen|V0464|5260|00|2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3676||3676|6007| 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3398|5627|lyfalmen|V0129|5627|23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3398||3398|5627| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|101445|129196|lyfsjukr|||00|1|0||Icepharma hf|Roche|Trastuzumab||101445||101445|129196| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|25115|33402|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||25115||25115|33402| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|42524|55250|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||42524||42524|55250| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2116|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2597|2162|lyfalmen|V0151|2049|00|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||865||865|2162| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|8091|7236|lyfalmen|V0322|4247|00|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4574||4574|7236| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|4790|2162|lyfalmen|V0152|2049|00|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||865||865|2162| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|14339|7236|lyfalmen|V0323|6676|00|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4574||4574|7236| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0||Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|7403|10684|lyfsjukr|||00|12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||7403||7403|10684| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|1150|2552|lyfalmen|V0243|2552|00|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||1150||1150|2552| 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|A||0|0|0|0|ICE|0|0|0|100|USD|5891|10277|vetorma|||00|20|0||Icepharma hf|Icepharma hf|||5891||5891|10277| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1353|2830|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1353||1353|2830| 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5014|2247|lyfalmen|V0005|1897|00|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||927||927|2247| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|741|1993|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||741||741|1993| 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|2909|3536|lyfalmen|V0324|3536|00|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1869||1869|3536| 580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3053|3406|lyfalmen|V0462|3366|00|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1774||1774|3406| 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3522|3841|lyfalmen|V0472|3841|00|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||2092||2092|3841| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|A||0|0|0|0|ANI|1|0|0|100|XEU|15081|29130|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||15081||15081|29130| 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|2392|4251|lyfalmen|||00|2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2392||2392|4251| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|29466|38862|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||29466||29466|38862| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|56865|73248|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||56865||56865|73248| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|113729|144612|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||113729||113729|144612| 582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|70910|90875|lyfsjukr|||02|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||70910||70910|90875| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5214|9096|vetorma|||16|50|0||Icepharma hf|Pfizer Oy Animal Health|||5214||5214|9096| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|19648|34275|vetorma|||16|200|0||Icepharma hf|Pfizer Oy Animal Health|||19648||19648|34275| 582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|4746|7142|lyfalmen|||00|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||4505||4505|7142|31.01.2012 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|47681|61722|lyfsjukr|||02|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||47681||47681|61722| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|108477|138021|lyfsjukr|||02|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||108477||108477|138021| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|857|2151|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||857||857|2151| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|52562|67848|lyfsjukr|||02|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||52562||52562|67848| 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|55967|72121|lyfsjukr|||00|2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||55967||55967|72121| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|104526|133063|lyfsjukr|||02|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||104526||104526|133063| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1153|2556|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1153||1153|2556| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|124761|158458|lyfsjukr|||02|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||124761||124761|158458| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|56969|73379|lyfsjukr|||02|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||56969||56969|73379| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|117353|149161|lyfsjukr|||02|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||117353||117353|149161| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|128281|162875|lyfsjukr|||02|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||128281||128281|162875| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3992|5761|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3992||3992|5761| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2418|3490|lyfsjukr|||00|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2418||2418|3490| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|1940|3633|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1940||1940|3633| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10437|14981|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10437||10437|14981| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|4799|6926|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4799||4799|6926| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4618|7296|lyfalmen|||02|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4618||4618|7296| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|34108|45351|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||34108||34108|45351| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1816|3463|lyfalmen|||20|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1816||1816|3463| 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|14811|20470|lyfsjukr|||00|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14811||14811|20470| 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|A||0|1|0|1|NOE|0|0|0|100|DKK|396595|499609|lyfsjukr|||00|224|0|20,9100|Vistor hf|Novartis Europharm Ltd|Tobramýcín||396595||396595|499609| 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|A||0|0|0|0|AGP|0|0|0|100|XEU|10571|15439|lyfalmen|V0095|15439|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||10571||10571|15439| 588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|4806|7553|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4806||4806|7553| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2290|4112|lyfalmen|V0461|4110|43|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2290||2290|4112| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|10288|15052|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||10288||10288|15052| 588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9187|13546|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9187||9187|13546| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6360|11095|vetorma|||16|3|0||Icepharma hf|Pfizer Animal Health|||6360||6360|11095| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2465|4300|vetorma|||16|1|0||Icepharma hf|Pfizer Animal Health|||2465||2465|4300| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6136|10704|vetorma|||16|6|0||Icepharma hf|Pfizer Animal Health|||6136||6136|10704| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3314|5781|vetorma|||16|1|0||Icepharma hf|Pfizer Animal Health|||3314||3314|5781| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3442|6004|vetorma|||16|2|0||Icepharma hf|Pfizer Animal Health|||3442||3442|6004| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|DKK|3324|5799|vetorma|||16|2|0||Icepharma hf|Pfizer Animal Health|||3324||3324|5799| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998|31.03.2012|R|A||0|0|0|0|LDR|0|0|0|100|USD|6225|9494|lyfalmen|||00|8|1||Parlogis hf|Parlogis - óskráđ lyf|Lyf viđ vörtum og líkţornum||6225||6225|9494| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998|31.03.2012|R|A||0|0|0|0|LDR|0|0|0|100|USD|7908|11797|lyfalmen|||00|8|1||Parlogis hf|Parlogis - óskráđ lyf|Lyf viđ vörtum og líkţornum||7908||7908|11797| 590244|N03AF0202|Trileptal (D.A.C.)|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.07.2011||R|A||0|0|E|0|DAC|0|0|0|100|DKK|3124|4341|lyfalmen|||00|50|0|15,0000|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||2458||2458|4341|31.01.2012 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||00|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||| 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2121|3880|lyfalmen|V0041|3735|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2121||2121|3880| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|23998|32663|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||23998||23998|32663| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|188459|238399|lyfsjukr|||00|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||188459||188459|238399| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|ţpakki||N02BE01|01.01.1995|29.02.2012|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|541|1719|lyfalmen|V0238|764|00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||541||541|1719| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|959|2291|lyfalmen|V0238|2291|00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||959||959|2291| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1414|2913|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1414||1414|2913| 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|21792|29894|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21792||21792|29894| 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047|00|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3705||3705|6047| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|354|618|vetorma|||16|10|0||Icepharma hf|Pfizer Oy Animal Health|||||354|618| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2943|5134|vetorma|||16|100|0||Icepharma hf|Pfizer Oy Animal Health|||||2943|5134| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|6246|9015|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||6246||6246|9015| 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|645|1861|lyfalmen|||02|0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||645||645|1861| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|67940|87147|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||67940|87147| 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|A||0|1|0|1|ORC|0|0|0|100|DKK|20303|27363|lyfsjukr|||00|10|0||Vistor hf|Orion Corporation|Dexmedetómid||20303||20303|27363| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2447|4326|lyfalmen|||43|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2447||2447|4326| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||00|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|486|1644|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||486||486|1644| 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|A||1|0|0|0|PCO|0|0|0|100|DKK|4309|6873|lyfalmen|||00|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4309|6873| 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005|31.03.2012|R|A||0|0|0|0|LDR|0|0|0|100|DKK|1358|2837|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráđ lyf|Bíótín||1358||1358|2837| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998|31.03.2012|R|A||0|0|E|0|PCO|0|0|0|100|SEK|5196|8087|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráđ lyf|Flunarizín||5196||5196|8087| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2898|4943|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2898||2898|4943| 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen|||00|4|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005|31.03.2012|R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17724|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráđ lyf|Prógesterón||12095||12095|17724| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000|31.03.2012|R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16460|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráđ lyf|Metadón||11317||11317|16460| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|6426|9769|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6426||6426|9769| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998|31.03.2012|R|A||0|0|E|0|LDR|0|0|0|100|IKR|50663|66127|lyfalmen|||00|100|1||Parlogis hf|Parlogis - óskráđ lyf|Pentósan pólýsúlfat natríum||50663||50663|66127| 938665|A12CX0001|K-Phos Neutral|töflur|||100|stk|1|glas||A12CX00|01.03.2001|31.03.2012|R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6548|lyfalmen|||00|100|1||Parlogis hf|Parlogis - óskráđ lyf|Málmlyf ýmisleg||4071||4071|6548| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|18461|25714|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18461||18461|25714| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005|31.03.2012|R|A||0|1|E|0|PCO|0|0|0|100|GBP|10858|15832|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráđ lyf|Prógesterón||10858||10858|15832| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998|31.03.2012|R|A||0|0|E|0|PCO|0|0|0|100|DKK|2772|4771|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráđ lyf|Estradíól||2772||2772|4771| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998|31.01.2012|R|A||0|0|E|0|PCO|0|0|0|100|DKK|5450|8434|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráđ lyf|Estradíól||5450||5450|8434| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|3012|5099|lyfalmen|||00|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3012||3012|5099| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5662|8724|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5662||5662|8724| 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen|||00|12|1||Parlogis hf|Parlogis - óskráđ lyf|||342||342|1447| 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen|||00|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|||5033||5033|7864| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003|31.03.2012|R|A||0|0|0|1|LDR|0|0|0|100|IKR|1335|1927|lyfsjukr|||55|10|1|26,6700|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1335||1335|1927| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002|31.03.2012|R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2125|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráđ lyf|Ethinýl estradíól||838||838|2125| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5662|8724|lyfalmen|||00|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5662||5662|8724| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763| 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009|31.03.2012|R|A||0|1|0|1|PCO|0|0|0|100|DKK|17523|23874|lyfsjukr|||00|30|1|30,0000|Distica|Distica - óskráđ lyf|Megestról||17523||17523|23874| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen|||00|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4320|6888|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6888| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|||||3451|5700| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207| 965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|A||0|1|E|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen|||00|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579|